| GO Terms | Score | Description |
|---|---|---|
| GO:0008150 | 82.92% | biological_process |
| GO:0009987 | 80.84% | cellular process |
| GO:0008152 | 79.39% | metabolic process |
| GO:0071704 | 78.71% | organic substance metabolic process |
| GO:0044237 | 78.57% | cellular metabolic process |
| GO:0044238 | 76.04% | primary metabolic process |
| GO:0044281 | 73.95% | small molecule metabolic process |
| GO:0019752 | 73.17% | carboxylic acid metabolic process |
| GO:0006082 | 72.81% | organic acid metabolic process |
| GO:0043436 | 72.29% | oxoacid metabolic process |
| GO:0065007 | 70.25% | biological regulation |
| GO:1901575 | 68.69% | organic substance catabolic process |
| GO:0009056 | 68.62% | catabolic process |
| GO:0006629 | 68.18% | lipid metabolic process |
| GO:0032787 | 67.88% | monocarboxylic acid metabolic process |
| GO:0044248 | 67.77% | cellular catabolic process |
| GO:0055114 | 67.75% | oxidation-reduction process |
| GO:0044255 | 67.52% | cellular lipid metabolic process |
| GO:0065008 | 67.11% | regulation of biological quality |
| GO:0044282 | 66.84% | small molecule catabolic process |
| GO:0046395 | 66.52% | carboxylic acid catabolic process |
| GO:0016054 | 66.37% | organic acid catabolic process |
| GO:0006631 | 65.12% | fatty acid metabolic process |
| GO:0016042 | 64.54% | lipid catabolic process |
| GO:0042592 | 64.37% | homeostatic process |
| GO:0044242 | 64.08% | cellular lipid catabolic process |
| GO:0072329 | 63.74% | monocarboxylic acid catabolic process |
| GO:0048878 | 63.69% | chemical homeostasis |
| GO:0030258 | 63.63% | lipid modification |
| GO:0055088 | 62.89% | lipid homeostasis |
| GO:0009062 | 62.60% | fatty acid catabolic process |
| GO:0034440 | 62.53% | lipid oxidation |
| GO:0019395 | 62.51% | fatty acid oxidation |
| GO:0006635 | 61.98% | fatty acid beta-oxidation |
| GO:0009058 | 50.25% | biosynthetic process |
| GO:0044249 | 49.50% | cellular biosynthetic process |
| GO:0000038 | 40.89% | very long-chain fatty acid metabolic process |
| GO:0017144 | 34.16% | drug metabolic process |
| GO:0006091 | 33.45% | generation of precursor metabolites and energy |
| GO:0051186 | 32.26% | cofactor metabolic process |
| GO:0051188 | 31.85% | cofactor biosynthetic process |
| GO:0016999 | 31.51% | antibiotic metabolic process |
| GO:0072593 | 29.05% | reactive oxygen species metabolic process |
| GO:1901568 | 28.88% | fatty acid derivative metabolic process |
| GO:0006690 | 28.29% | icosanoid metabolic process |
| GO:0017000 | 28.28% | antibiotic biosynthetic process |
| GO:1903409 | 27.93% | reactive oxygen species biosynthetic process |
| GO:0033559 | 27.90% | unsaturated fatty acid metabolic process |
| GO:0042743 | 27.63% | hydrogen peroxide metabolic process |
| GO:0006692 | 27.52% | prostanoid metabolic process |
| GO:0006693 | 27.52% | prostaglandin metabolic process |
| GO:0032502 | 27.20% | developmental process |
| GO:0022414 | 26.23% | reproductive process |
| GO:0003006 | 25.31% | developmental process involved in reproduction |
| GO:0048609 | 24.04% | multicellular organismal reproductive process |
| GO:0007276 | 23.21% | gamete generation |
| GO:0050789 | 23.17% | regulation of biological process |
| GO:0050794 | 22.47% | regulation of cellular process |
| GO:0007283 | 22.17% | spermatogenesis |
| GO:0048232 | 22.14% | male gamete generation |
| GO:0071840 | 21.47% | cellular component organization or biogenesis |
| GO:0016043 | 21.42% | cellular component organization |
| GO:0048518 | 21.03% | positive regulation of biological process |
| GO:0048522 | 20.23% | positive regulation of cellular process |
| GO:0048583 | 18.80% | regulation of response to stimulus |
| GO:0006996 | 18.52% | organelle organization |
| GO:0010941 | 17.94% | regulation of cell death |
| GO:0080134 | 17.89% | regulation of response to stress |
| GO:0048584 | 17.43% | positive regulation of response to stimulus |
| GO:1901576 | 17.19% | organic substance biosynthetic process |
| GO:0010817 | 17.12% | regulation of hormone levels |
| GO:0010942 | 16.84% | positive regulation of cell death |
| GO:0042446 | 16.71% | hormone biosynthetic process |
| GO:0042445 | 16.48% | hormone metabolic process |
| GO:1902882 | 16.09% | regulation of response to oxidative stress |
| GO:0006807 | 15.10% | nitrogen compound metabolic process |
| GO:1902884 | 14.88% | positive regulation of response to oxidative stress |
| GO:0050896 | 14.24% | response to stimulus |
| GO:0048285 | 14.23% | organelle fission |
| GO:0044283 | 13.69% | small molecule biosynthetic process |
| GO:1901564 | 13.21% | organonitrogen compound metabolic process |
| GO:0001676 | 13.20% | long-chain fatty acid metabolic process |
| GO:0016053 | 13.03% | organic acid biosynthetic process |
| GO:0043170 | 13.02% | macromolecule metabolic process |
| GO:0046394 | 12.98% | carboxylic acid biosynthetic process |
| GO:0055092 | 12.93% | sterol homeostasis |
| GO:0042632 | 12.90% | cholesterol homeostasis |
| GO:0044550 | 12.56% | secondary metabolite biosynthetic process |
| GO:0019748 | 12.34% | secondary metabolic process |
| GO:0006950 | 12.30% | response to stress |
| GO:0044260 | 11.84% | cellular macromolecule metabolic process |
| GO:0034641 | 11.50% | cellular nitrogen compound metabolic process |
| GO:1901360 | 11.41% | organic cyclic compound metabolic process |
| GO:0009605 | 11.24% | response to external stimulus |
| GO:0051704 | 11.23% | multi-organism process |
| GO:0046483 | 11.09% | heterocycle metabolic process |
| GO:0019538 | 10.93% | protein metabolic process |
| GO:0006725 | 10.84% | cellular aromatic compound metabolic process |
| GO:0044267 | 10.63% | cellular protein metabolic process |
| GO:0043412 | 10.38% | macromolecule modification |
| GO:0009607 | 10.34% | response to biotic stimulus |
| GO:0043207 | 10.31% | response to external biotic stimulus |
| GO:0006520 | 10.26% | cellular amino acid metabolic process |
| GO:0051707 | 10.16% | response to other organism |
| GO:0006464 | 9.69% | cellular protein modification process |
| GO:0006139 | 9.67% | nucleobase-containing compound metabolic process |
| GO:0036211 | 9.64% | protein modification process |
| GO:0006793 | 9.59% | phosphorus metabolic process |
| GO:0044271 | 9.45% | cellular nitrogen compound biosynthetic process |
| GO:0016070 | 9.41% | RNA metabolic process |
| GO:0072330 | 9.41% | monocarboxylic acid biosynthetic process |
| GO:1901605 | 9.25% | alpha-amino acid metabolic process |
| GO:1901362 | 9.14% | organic cyclic compound biosynthetic process |
| GO:1901566 | 8.99% | organonitrogen compound biosynthetic process |
| GO:0090304 | 8.95% | nucleic acid metabolic process |
| GO:0006796 | 8.82% | phosphate-containing compound metabolic process |
| GO:0019438 | 8.50% | aromatic compound biosynthetic process |
| GO:0018130 | 8.49% | heterocycle biosynthetic process |
| GO:0048856 | 8.31% | anatomical structure development |
| GO:0009059 | 8.29% | macromolecule biosynthetic process |
| GO:0048869 | 8.24% | cellular developmental process |
| GO:0009611 | 8.11% | response to wounding |
| GO:0005975 | 8.02% | carbohydrate metabolic process |
| GO:0042221 | 7.95% | response to chemical |
| GO:0034660 | 7.86% | ncRNA metabolic process |
| GO:0043603 | 7.84% | cellular amide metabolic process |
| GO:0019222 | 7.74% | regulation of metabolic process |
| GO:0032501 | 7.72% | multicellular organismal process |
| GO:0034645 | 7.71% | cellular macromolecule biosynthetic process |
| GO:0022607 | 7.57% | cellular component assembly |
| GO:0006399 | 7.57% | tRNA metabolic process |
| GO:0009225 | 7.56% | nucleotide-sugar metabolic process |
| GO:1901135 | 7.40% | carbohydrate derivative metabolic process |
| GO:0019637 | 7.19% | organophosphate metabolic process |
| GO:0051716 | 7.11% | cellular response to stimulus |
| GO:1901565 | 7.09% | organonitrogen compound catabolic process |
| GO:0051179 | 7.08% | localization |
| GO:0009620 | 7.08% | response to fungus |
| GO:1901607 | 7.08% | alpha-amino acid biosynthetic process |
| GO:0006396 | 7.03% | RNA processing |
| GO:0008652 | 6.95% | cellular amino acid biosynthetic process |
| GO:0010468 | 6.91% | regulation of gene expression |
| GO:0043604 | 6.90% | amide biosynthetic process |
| GO:0031323 | 6.88% | regulation of cellular metabolic process |
| GO:0010033 | 6.81% | response to organic substance |
| GO:0009889 | 6.78% | regulation of biosynthetic process |
| GO:1901700 | 6.74% | response to oxygen-containing compound |
| GO:0006518 | 6.72% | peptide metabolic process |
| GO:0055086 | 6.70% | nucleobase-containing small molecule metabolic process |
| GO:0009064 | 6.67% | glutamine family amino acid metabolic process |
| GO:0042398 | 6.65% | cellular modified amino acid biosynthetic process |
| GO:0006575 | 6.63% | cellular modified amino acid metabolic process |
| GO:0008610 | 6.63% | lipid biosynthetic process |
| GO:0034654 | 6.62% | nucleobase-containing compound biosynthetic process |
| GO:0016310 | 6.60% | phosphorylation |
| GO:0006508 | 6.60% | proteolysis |
| GO:0070085 | 6.60% | glycosylation |
| GO:0006486 | 6.58% | protein glycosylation |
| GO:0060255 | 6.57% | regulation of macromolecule metabolic process |
| GO:0032259 | 6.57% | methylation |
| GO:0043039 | 6.54% | tRNA aminoacylation |
| GO:0033554 | 6.51% | cellular response to stress |
| GO:0009628 | 6.50% | response to abiotic stimulus |
| GO:0030154 | 6.47% | cell differentiation |
| GO:0043038 | 6.46% | amino acid activation |
| GO:0043413 | 6.45% | macromolecule glycosylation |
| GO:0031326 | 6.45% | regulation of cellular biosynthetic process |
| GO:0009072 | 6.44% | aromatic amino acid family metabolic process |
| GO:0006732 | 6.43% | coenzyme metabolic process |
| GO:0080090 | 6.41% | regulation of primary metabolic process |
| GO:0009653 | 6.38% | anatomical structure morphogenesis |
| GO:0051234 | 6.36% | establishment of localization |
| GO:0006810 | 6.35% | transport |
| GO:0018193 | 6.35% | peptidyl-amino acid modification |
| GO:0009063 | 6.30% | cellular amino acid catabolic process |
| GO:0050793 | 6.28% | regulation of developmental process |
| GO:0015980 | 6.27% | energy derivation by oxidation of organic compounds |
| GO:0009108 | 6.26% | coenzyme biosynthetic process |
| GO:0034470 | 6.26% | ncRNA processing |
| GO:0006418 | 6.24% | tRNA aminoacylation for protein translation |
| GO:1901606 | 6.19% | alpha-amino acid catabolic process |
| GO:0043933 | 6.17% | protein-containing complex subunit organization |
| GO:2000112 | 6.17% | regulation of cellular macromolecule biosynthetic process |
| GO:0065003 | 6.15% | protein-containing complex assembly |
| GO:1901137 | 6.14% | carbohydrate derivative biosynthetic process |
| GO:0043648 | 6.09% | dicarboxylic acid metabolic process |
| GO:0090407 | 6.09% | organophosphate biosynthetic process |
| GO:0051171 | 6.05% | regulation of nitrogen compound metabolic process |
| GO:1901615 | 6.02% | organic hydroxy compound metabolic process |
| GO:0010556 | 6.01% | regulation of macromolecule biosynthetic process |
| GO:0051128 | 6.00% | regulation of cellular component organization |
| GO:0006790 | 5.95% | sulfur compound metabolic process |
| GO:0009226 | 5.92% | nucleotide-sugar biosynthetic process |
| GO:0032989 | 5.91% | cellular component morphogenesis |
| GO:0007165 | 5.89% | signal transduction |
| GO:0008033 | 5.82% | tRNA processing |
| GO:0006040 | 5.80% | amino sugar metabolic process |
| GO:0006468 | 5.77% | protein phosphorylation |
| GO:0043043 | 5.77% | peptide biosynthetic process |
| GO:0005996 | 5.76% | monosaccharide metabolic process |
| GO:0006412 | 5.73% | translation |
| GO:0009057 | 5.70% | macromolecule catabolic process |
| GO:0044265 | 5.68% | cellular macromolecule catabolic process |
| GO:1901617 | 5.66% | organic hydroxy compound biosynthetic process |
| GO:0048519 | 5.65% | negative regulation of biological process |
| GO:0009451 | 5.64% | RNA modification |
| GO:0006952 | 5.62% | defense response |
| GO:0051252 | 5.61% | regulation of RNA metabolic process |
| GO:0006576 | 5.60% | cellular biogenic amine metabolic process |
| GO:0097164 | 5.58% | ammonium ion metabolic process |
| GO:0044262 | 5.57% | cellular carbohydrate metabolic process |
| GO:0009893 | 5.55% | positive regulation of metabolic process |
| GO:0048513 | 5.55% | animal organ development |
| GO:0019318 | 5.55% | hexose metabolic process |
| GO:0016071 | 5.52% | mRNA metabolic process |
| GO:0033036 | 5.48% | macromolecule localization |
| GO:0046349 | 5.47% | amino sugar biosynthetic process |
| GO:0016192 | 5.45% | vesicle-mediated transport |
| GO:0006541 | 5.45% | glutamine metabolic process |
| GO:0051641 | 5.44% | cellular localization |
| GO:0008104 | 5.44% | protein localization |
| GO:0051239 | 5.42% | regulation of multicellular organismal process |
| GO:0007275 | 5.40% | multicellular organism development |
| GO:0007154 | 5.39% | cell communication |
| GO:0007010 | 5.39% | cytoskeleton organization |
| GO:0009725 | 5.37% | response to hormone |
| GO:0006720 | 5.34% | isoprenoid metabolic process |
| GO:0019219 | 5.33% | regulation of nucleobase-containing compound metabolic process |
| GO:0032543 | 5.33% | mitochondrial translation |
| GO:0006259 | 5.32% | DNA metabolic process |
| GO:0010035 | 5.32% | response to inorganic substance |
| GO:0000902 | 5.28% | cell morphogenesis |
| GO:0006066 | 5.27% | alcohol metabolic process |
| GO:1901361 | 5.25% | organic cyclic compound catabolic process |
| GO:0019439 | 5.25% | aromatic compound catabolic process |
| GO:0070887 | 5.24% | cellular response to chemical stimulus |
| GO:0062012 | 5.24% | regulation of small molecule metabolic process |
| GO:0006355 | 5.22% | regulation of transcription, DNA-templated |
| GO:0006721 | 5.19% | terpenoid metabolic process |
| GO:0030163 | 5.17% | protein catabolic process |
| GO:0071702 | 5.16% | organic substance transport |
| GO:0048646 | 5.15% | anatomical structure formation involved in morphogenesis |
| GO:0022402 | 5.15% | cell cycle process |
| GO:0000959 | 5.14% | mitochondrial RNA metabolic process |
| GO:0009719 | 5.12% | response to endogenous stimulus |
| GO:0007049 | 5.12% | cell cycle |
| GO:0010608 | 5.11% | posttranscriptional regulation of gene expression |
| GO:0042180 | 5.10% | cellular ketone metabolic process |
| GO:1903506 | 5.10% | regulation of nucleic acid-templated transcription |
| GO:0044270 | 5.10% | cellular nitrogen compound catabolic process |
| GO:0006112 | 5.10% | energy reserve metabolic process |
| GO:0009066 | 5.09% | aspartate family amino acid metabolic process |
| GO:0051246 | 5.08% | regulation of protein metabolic process |
| GO:0001101 | 5.08% | response to acid chemical |
| GO:0016485 | 5.07% | protein processing |
| GO:0008299 | 5.06% | isoprenoid biosynthetic process |
| GO:0048523 | 5.06% | negative regulation of cellular process |
| GO:0044106 | 5.05% | cellular amine metabolic process |
| GO:0022412 | 5.04% | cellular process involved in reproduction in multicellular organism |
| GO:0048589 | 5.03% | developmental growth |
| GO:0040007 | 5.02% | growth |
| GO:0032446 | 4.99% | protein modification by small protein conjugation |
| GO:2001141 | 4.99% | regulation of RNA biosynthetic process |
| GO:0006744 | 4.98% | ubiquinone biosynthetic process |
| GO:0046165 | 4.98% | alcohol biosynthetic process |
| GO:0071705 | 4.97% | nitrogen compound transport |
| GO:2000026 | 4.96% | regulation of multicellular organismal development |
| GO:0006397 | 4.96% | mRNA processing |
| GO:0006047 | 4.96% | UDP-N-acetylglucosamine metabolic process |
| GO:0016114 | 4.95% | terpenoid biosynthetic process |
| GO:1901663 | 4.95% | quinone biosynthetic process |
| GO:0018195 | 4.95% | peptidyl-arginine modification |
| GO:0048468 | 4.95% | cell development |
| GO:0009314 | 4.94% | response to radiation |
| GO:0007017 | 4.94% | microtubule-based process |
| GO:0009416 | 4.93% | response to light stimulus |
| GO:0046700 | 4.93% | heterocycle catabolic process |
| GO:0032268 | 4.92% | regulation of cellular protein metabolic process |
| GO:0009308 | 4.92% | amine metabolic process |
| GO:0048608 | 4.90% | reproductive structure development |
| GO:0043414 | 4.90% | macromolecule methylation |
| GO:0044272 | 4.90% | sulfur compound biosynthetic process |
| GO:0008380 | 4.89% | RNA splicing |
| GO:0042181 | 4.89% | ketone biosynthetic process |
| GO:0006325 | 4.89% | chromatin organization |
| GO:0006733 | 4.88% | oxidoreduction coenzyme metabolic process |
| GO:0033993 | 4.87% | response to lipid |
| GO:0000226 | 4.85% | microtubule cytoskeleton organization |
| GO:0001505 | 4.85% | regulation of neurotransmitter levels |
| GO:0007610 | 4.83% | behavior |
| GO:0003008 | 4.83% | system process |
| GO:1901698 | 4.83% | response to nitrogen compound |
| GO:0044087 | 4.83% | regulation of cellular component biogenesis |
| GO:0031325 | 4.82% | positive regulation of cellular metabolic process |
| GO:0000096 | 4.81% | sulfur amino acid metabolic process |
| GO:0046148 | 4.81% | pigment biosynthetic process |
| GO:0022900 | 4.80% | electron transport chain |
| GO:0070647 | 4.80% | protein modification by small protein conjugation or removal |
| GO:0009067 | 4.79% | aspartate family amino acid biosynthetic process |
| GO:0016049 | 4.78% | cell growth |
| GO:0006081 | 4.77% | cellular aldehyde metabolic process |
| GO:0006743 | 4.74% | ubiquinone metabolic process |
| GO:0034622 | 4.73% | cellular protein-containing complex assembly |
| GO:0009991 | 4.72% | response to extracellular stimulus |
| GO:0006955 | 4.72% | immune response |
| GO:0051604 | 4.71% | protein maturation |
| GO:0006400 | 4.71% | tRNA modification |
| GO:0098542 | 4.70% | defense response to other organism |
| GO:0051603 | 4.68% | proteolysis involved in cellular protein catabolic process |
| GO:0009555 | 4.67% | pollen development |
| GO:0006928 | 4.67% | movement of cell or subcellular component |
| GO:0035556 | 4.65% | intracellular signal transduction |
| GO:0009309 | 4.65% | amine biosynthetic process |
| GO:0051726 | 4.64% | regulation of cell cycle |
| GO:0010604 | 4.64% | positive regulation of macromolecule metabolic process |
| GO:0006487 | 4.63% | protein N-linked glycosylation |
| GO:0042133 | 4.63% | neurotransmitter metabolic process |
| GO:0007166 | 4.63% | cell surface receptor signaling pathway |
| GO:0006739 | 4.62% | NADP metabolic process |
| GO:0006974 | 4.62% | cellular response to DNA damage stimulus |
| GO:0042401 | 4.61% | cellular biogenic amine biosynthetic process |
| GO:0006979 | 4.61% | response to oxidative stress |
| GO:0006766 | 4.60% | vitamin metabolic process |
| GO:0002376 | 4.60% | immune system process |
| GO:0016311 | 4.59% | dephosphorylation |
| GO:0051321 | 4.59% | meiotic cell cycle |
| GO:0034248 | 4.59% | regulation of cellular amide metabolic process |
| GO:0060560 | 4.58% | developmental growth involved in morphogenesis |
| GO:0009790 | 4.58% | embryo development |
| GO:0006281 | 4.57% | DNA repair |
| GO:0010038 | 4.56% | response to metal ion |
| GO:0006536 | 4.54% | glutamate metabolic process |
| GO:0009826 | 4.54% | unidimensional cell growth |
| GO:0006644 | 4.54% | phospholipid metabolic process |
| GO:1903046 | 4.53% | meiotic cell cycle process |
| GO:0040008 | 4.52% | regulation of growth |
| GO:0010243 | 4.52% | response to organonitrogen compound |
| GO:0009617 | 4.52% | response to bacterium |
| GO:0006570 | 4.52% | tyrosine metabolic process |
| GO:0022904 | 4.51% | respiratory electron transport chain |
| GO:0022603 | 4.51% | regulation of anatomical structure morphogenesis |
| GO:0031667 | 4.51% | response to nutrient levels |
| GO:0009892 | 4.50% | negative regulation of metabolic process |
| GO:0032774 | 4.50% | RNA biosynthetic process |
| GO:0006767 | 4.50% | water-soluble vitamin metabolic process |
| GO:0009117 | 4.49% | nucleotide metabolic process |
| GO:0050877 | 4.49% | nervous system process |
| GO:0050667 | 4.49% | homocysteine metabolic process |
| GO:0070727 | 4.48% | cellular macromolecule localization |
| GO:0015833 | 4.48% | peptide transport |
| GO:0009074 | 4.48% | aromatic amino acid family catabolic process |
| GO:0016052 | 4.47% | carbohydrate catabolic process |
| GO:0072350 | 4.47% | tricarboxylic acid metabolic process |
| GO:0010628 | 4.47% | positive regulation of gene expression |
| GO:0061024 | 4.45% | membrane organization |
| GO:0051173 | 4.44% | positive regulation of nitrogen compound metabolic process |
| GO:0010605 | 4.44% | negative regulation of macromolecule metabolic process |
| GO:0016567 | 4.43% | protein ubiquitination |
| GO:0031328 | 4.42% | positive regulation of cellular biosynthetic process |
| GO:0006753 | 4.42% | nucleoside phosphate metabolic process |
| GO:0006760 | 4.41% | folic acid-containing compound metabolic process |
| GO:0044042 | 4.40% | glucan metabolic process |
| GO:0042440 | 4.40% | pigment metabolic process |
| GO:0040011 | 4.39% | locomotion |
| GO:0042558 | 4.39% | pteridine-containing compound metabolic process |
| GO:0006073 | 4.39% | cellular glucan metabolic process |
| GO:0009110 | 4.39% | vitamin biosynthetic process |
| GO:0042493 | 4.38% | response to drug |
| GO:0042364 | 4.38% | water-soluble vitamin biosynthetic process |
| GO:0014070 | 4.37% | response to organic cyclic compound |
| GO:0009791 | 4.37% | post-embryonic development |
| GO:0048731 | 4.37% | system development |
| GO:0043632 | 4.37% | modification-dependent macromolecule catabolic process |
| GO:0042742 | 4.36% | defense response to bacterium |
| GO:0006970 | 4.36% | response to osmotic stress |
| GO:0000910 | 4.36% | cytokinesis |
| GO:0009894 | 4.35% | regulation of catabolic process |
| GO:0019751 | 4.35% | polyol metabolic process |
| GO:0009081 | 4.35% | branched-chain amino acid metabolic process |
| GO:0023052 | 4.35% | signaling |
| GO:0008219 | 4.35% | cell death |
| GO:0019941 | 4.32% | modification-dependent protein catabolic process |
| GO:0042430 | 4.32% | indole-containing compound metabolic process |
| GO:0042886 | 4.32% | amide transport |
| GO:0009891 | 4.31% | positive regulation of biosynthetic process |
| GO:0032879 | 4.31% | regulation of localization |
| GO:0097305 | 4.31% | response to alcohol |
| GO:0061982 | 4.30% | meiosis I cell cycle process |
| GO:0000904 | 4.30% | cell morphogenesis involved in differentiation |
| GO:0030030 | 4.29% | cell projection organization |
| GO:0033043 | 4.28% | regulation of organelle organization |
| GO:0048229 | 4.28% | gametophyte development |
| GO:0034613 | 4.28% | cellular protein localization |
| GO:0045184 | 4.28% | establishment of protein localization |
| GO:0006417 | 4.27% | regulation of translation |
| GO:0009266 | 4.27% | response to temperature stimulus |
| GO:0016569 | 4.26% | covalent chromatin modification |
| GO:0015031 | 4.25% | protein transport |
| GO:0006740 | 4.25% | NADPH regeneration |
| GO:0043161 | 4.25% | proteasome-mediated ubiquitin-dependent protein catabolic process |
| GO:0008654 | 4.24% | phospholipid biosynthetic process |
| GO:0006109 | 4.24% | regulation of carbohydrate metabolic process |
| GO:0051094 | 4.24% | positive regulation of developmental process |
| GO:0046173 | 4.22% | polyol biosynthetic process |
| GO:0007005 | 4.22% | mitochondrion organization |
| GO:0048511 | 4.22% | rhythmic process |
| GO:0050790 | 4.20% | regulation of catalytic activity |
| GO:0031329 | 4.20% | regulation of cellular catabolic process |
| GO:0006120 | 4.20% | mitochondrial electron transport, NADH to ubiquinone |
| GO:0051156 | 4.19% | glucose 6-phosphate metabolic process |
| GO:0006413 | 4.19% | translational initiation |
| GO:0070925 | 4.19% | organelle assembly |
| GO:0045595 | 4.18% | regulation of cell differentiation |
| GO:0046903 | 4.18% | secretion |
| GO:0046907 | 4.17% | intracellular transport |
| GO:0005977 | 4.17% | glycogen metabolic process |
| GO:0010498 | 4.14% | proteasomal protein catabolic process |
| GO:0045087 | 4.14% | innate immune response |
| GO:0016570 | 4.11% | histone modification |
| GO:0010675 | 4.09% | regulation of cellular carbohydrate metabolic process |
| GO:0010646 | 4.09% | regulation of cell communication |
| GO:0046777 | 4.08% | protein autophosphorylation |
| GO:0042737 | 4.08% | drug catabolic process |
| GO:1901661 | 4.08% | quinone metabolic process |
| GO:0012501 | 4.08% | programmed cell death |
| GO:0006006 | 4.07% | glucose metabolic process |
| GO:0009084 | 4.07% | glutamine family amino acid biosynthetic process |
| GO:0006414 | 4.07% | translational elongation |
| GO:0071310 | 4.06% | cellular response to organic substance |
| GO:0007267 | 4.06% | cell-cell signaling |
| GO:0065009 | 4.05% | regulation of molecular function |
| GO:0010906 | 4.04% | regulation of glucose metabolic process |
| GO:0010629 | 4.04% | negative regulation of gene expression |
| GO:0006099 | 4.03% | tricarboxylic acid cycle |
| GO:0042136 | 4.02% | neurotransmitter biosynthetic process |
| GO:0023051 | 4.02% | regulation of signaling |
| GO:0009636 | 4.01% | response to toxic substance |
| GO:0006470 | 4.00% | protein dephosphorylation |
| GO:0010257 | 3.99% | NADH dehydrogenase complex assembly |
| GO:0006558 | 3.98% | L-phenylalanine metabolic process |
| GO:0007281 | 3.98% | germ cell development |
| GO:0009073 | 3.98% | aromatic amino acid family biosynthetic process |
| GO:0006595 | 3.97% | polyamine metabolic process |
| GO:0015931 | 3.97% | nucleobase-containing compound transport |
| GO:0000963 | 3.96% | mitochondrial RNA processing |
| GO:0050658 | 3.96% | RNA transport |
| GO:0009737 | 3.96% | response to abscisic acid |
| GO:0032981 | 3.96% | mitochondrial respiratory chain complex I assembly |
| GO:1902221 | 3.95% | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process |
| GO:0005976 | 3.95% | polysaccharide metabolic process |
| GO:0002183 | 3.94% | cytoplasmic translational initiation |
| GO:0043067 | 3.93% | regulation of programmed cell death |
| GO:1901071 | 3.92% | glucosamine-containing compound metabolic process |
| GO:0048870 | 3.91% | cell motility |
| GO:0140053 | 3.91% | mitochondrial gene expression |
| GO:0044264 | 3.91% | cellular polysaccharide metabolic process |
| GO:0006596 | 3.90% | polyamine biosynthetic process |
| GO:0009065 | 3.90% | glutamine family amino acid catabolic process |
| GO:0006551 | 3.89% | leucine metabolic process |
| GO:0006534 | 3.88% | cysteine metabolic process |
| GO:0018209 | 3.88% | peptidyl-serine modification |
| GO:0051236 | 3.85% | establishment of RNA localization |
| GO:0006643 | 3.85% | membrane lipid metabolic process |
| GO:0071496 | 3.84% | cellular response to external stimulus |
| GO:0048638 | 3.84% | regulation of developmental growth |
| GO:0010557 | 3.84% | positive regulation of macromolecule biosynthetic process |
| GO:0051130 | 3.84% | positive regulation of cellular component organization |
| GO:0031668 | 3.83% | cellular response to extracellular stimulus |
| GO:0050657 | 3.83% | nucleic acid transport |
| GO:0006493 | 3.82% | protein O-linked glycosylation |
| GO:0006805 | 3.82% | xenobiotic metabolic process |
| GO:0071941 | 3.81% | nitrogen cycle metabolic process |
| GO:0000377 | 3.80% | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile |
| GO:0006479 | 3.80% | protein methylation |
| GO:0008213 | 3.80% | protein alkylation |
| GO:0000375 | 3.80% | RNA splicing, via transesterification reactions |
| GO:0099120 | 3.79% | socially cooperative development |
| GO:0097435 | 3.79% | supramolecular fiber organization |
| GO:0090567 | 3.79% | reproductive shoot system development |
| GO:0006909 | 3.79% | phagocytosis |
| GO:0120036 | 3.79% | plasma membrane bounded cell projection organization |
| GO:1990830 | 3.79% | cellular response to leukemia inhibitory factor |
| GO:0043647 | 3.78% | inositol phosphate metabolic process |
| GO:0009408 | 3.78% | response to heat |
| GO:0016051 | 3.78% | carbohydrate biosynthetic process |
| GO:0042981 | 3.78% | regulation of apoptotic process |
| GO:0006730 | 3.77% | one-carbon metabolic process |
| GO:0051049 | 3.77% | regulation of transport |
| GO:0006401 | 3.77% | RNA catabolic process |
| GO:0006525 | 3.76% | arginine metabolic process |
| GO:0048588 | 3.75% | developmental cell growth |
| GO:0140352 | 3.75% | export from cell |
| GO:0009888 | 3.74% | tissue development |
| GO:0031669 | 3.73% | cellular response to nutrient levels |
| GO:0051276 | 3.73% | chromosome organization |
| GO:0031123 | 3.72% | RNA 3'-end processing |
| GO:0033108 | 3.72% | mitochondrial respiratory chain complex assembly |
| GO:0044273 | 3.71% | sulfur compound catabolic process |
| GO:0009966 | 3.70% | regulation of signal transduction |
| GO:0001539 | 3.70% | cilium or flagellum-dependent cell motility |
| GO:0006108 | 3.70% | malate metabolic process |
| GO:0072521 | 3.70% | purine-containing compound metabolic process |
| GO:0006457 | 3.69% | protein folding |
| GO:0018958 | 3.69% | phenol-containing compound metabolic process |
| GO:0006511 | 3.69% | ubiquitin-dependent protein catabolic process |
| GO:0031324 | 3.69% | negative regulation of cellular metabolic process |
| GO:0034599 | 3.68% | cellular response to oxidative stress |
| GO:0051253 | 3.68% | negative regulation of RNA metabolic process |
| GO:0009792 | 3.67% | embryo development ending in birth or egg hatching |
| GO:0009651 | 3.67% | response to salt stress |
| GO:0009311 | 3.67% | oligosaccharide metabolic process |
| GO:0051172 | 3.67% | negative regulation of nitrogen compound metabolic process |
| GO:0022604 | 3.67% | regulation of cell morphogenesis |
| GO:0051240 | 3.66% | positive regulation of multicellular organismal process |
| GO:0007274 | 3.66% | neuromuscular synaptic transmission |
| GO:0006002 | 3.65% | fructose 6-phosphate metabolic process |
| GO:0006555 | 3.64% | methionine metabolic process |
| GO:0030435 | 3.64% | sporulation resulting in formation of a cellular spore |
| GO:0006260 | 3.64% | DNA replication |
| GO:0009812 | 3.63% | flavonoid metabolic process |
| GO:0006357 | 3.63% | regulation of transcription by RNA polymerase II |
| GO:0022411 | 3.63% | cellular component disassembly |
| GO:0043255 | 3.63% | regulation of carbohydrate biosynthetic process |
| GO:0080135 | 3.63% | regulation of cellular response to stress |
| GO:0043062 | 3.62% | extracellular structure organization |
| GO:0007623 | 3.62% | circadian rhythm |
| GO:0042559 | 3.62% | pteridine-containing compound biosynthetic process |
| GO:1990823 | 3.62% | response to leukemia inhibitory factor |
| GO:0046486 | 3.62% | glycerolipid metabolic process |
| GO:0006650 | 3.62% | glycerophospholipid metabolic process |
| GO:0032940 | 3.62% | secretion by cell |
| GO:0007051 | 3.61% | spindle organization |
| GO:0018205 | 3.61% | peptidyl-lysine modification |
| GO:0007292 | 3.61% | female gamete generation |
| GO:0051703 | 3.61% | intraspecies interaction between organisms |
| GO:0051301 | 3.61% | cell division |
| GO:0010927 | 3.60% | cellular component assembly involved in morphogenesis |
| GO:0045333 | 3.60% | cellular respiration |
| GO:0042594 | 3.60% | response to starvation |
| GO:0045935 | 3.59% | positive regulation of nucleobase-containing compound metabolic process |
| GO:0043094 | 3.59% | cellular metabolic compound salvage |
| GO:0009404 | 3.59% | toxin metabolic process |
| GO:0006405 | 3.59% | RNA export from nucleus |
| GO:0060285 | 3.58% | cilium-dependent cell motility |
| GO:0046467 | 3.58% | membrane lipid biosynthetic process |
| GO:0009860 | 3.57% | pollen tube growth |
| GO:0045934 | 3.56% | negative regulation of nucleobase-containing compound metabolic process |
| GO:0006568 | 3.56% | tryptophan metabolic process |
| GO:0021700 | 3.56% | developmental maturation |
| GO:0009932 | 3.56% | cell tip growth |
| GO:0030198 | 3.56% | extracellular matrix organization |
| GO:0006302 | 3.56% | double-strand break repair |
| GO:0006591 | 3.55% | ornithine metabolic process |
| GO:0009743 | 3.55% | response to carbohydrate |
| GO:0022618 | 3.54% | ribonucleoprotein complex assembly |
| GO:0002682 | 3.54% | regulation of immune system process |
| GO:0010467 | 3.54% | gene expression |
| GO:0006633 | 3.54% | fatty acid biosynthetic process |
| GO:0007030 | 3.54% | Golgi organization |
| GO:0071826 | 3.54% | ribonucleoprotein complex subunit organization |
| GO:0032101 | 3.54% | regulation of response to external stimulus |
| GO:0033365 | 3.53% | protein localization to organelle |
| GO:0031347 | 3.53% | regulation of defense response |
| GO:0009082 | 3.53% | branched-chain amino acid biosynthetic process |
| GO:0042537 | 3.53% | benzene-containing compound metabolic process |
| GO:0000398 | 3.53% | mRNA splicing, via spliceosome |
| GO:0044764 | 3.53% | multi-organism cellular process |
| GO:0034637 | 3.53% | cellular carbohydrate biosynthetic process |
| GO:0046365 | 3.52% | monosaccharide catabolic process |
| GO:0051259 | 3.52% | protein complex oligomerization |
| GO:0008340 | 3.52% | determination of adult lifespan |
| GO:0006306 | 3.51% | DNA methylation |
| GO:0006304 | 3.51% | DNA modification |
| GO:0009069 | 3.51% | serine family amino acid metabolic process |
| GO:0061640 | 3.51% | cytoskeleton-dependent cytokinesis |
| GO:0016072 | 3.51% | rRNA metabolic process |
| GO:0042127 | 3.51% | regulation of cell population proliferation |
| GO:0009086 | 3.50% | methionine biosynthetic process |
| GO:0006364 | 3.50% | rRNA processing |
| GO:0018105 | 3.48% | peptidyl-serine phosphorylation |
| GO:0043900 | 3.48% | regulation of multi-organism process |
| GO:0034097 | 3.48% | response to cytokine |
| GO:1901701 | 3.48% | cellular response to oxygen-containing compound |
| GO:0043934 | 3.47% | sporulation |
| GO:0009698 | 3.47% | phenylpropanoid metabolic process |
| GO:0000097 | 3.47% | sulfur amino acid biosynthetic process |
| GO:0009396 | 3.47% | folic acid-containing compound biosynthetic process |
| GO:2001057 | 3.46% | reactive nitrogen species metabolic process |
| GO:0006586 | 3.46% | indolalkylamine metabolic process |
| GO:0048477 | 3.46% | oogenesis |
| GO:0019725 | 3.45% | cellular homeostasis |
| GO:0006305 | 3.45% | DNA alkylation |
| GO:0000302 | 3.45% | response to reactive oxygen species |
| GO:1902652 | 3.45% | secondary alcohol metabolic process |
| GO:0046034 | 3.44% | ATP metabolic process |
| GO:0043650 | 3.44% | dicarboxylic acid biosynthetic process |
| GO:1901293 | 3.44% | nucleoside phosphate biosynthetic process |
| GO:0060627 | 3.44% | regulation of vesicle-mediated transport |
| GO:0009165 | 3.43% | nucleotide biosynthetic process |
| GO:0009746 | 3.43% | response to hexose |
| GO:0006351 | 3.43% | transcription, DNA-templated |
| GO:2000241 | 3.43% | regulation of reproductive process |
| GO:0034284 | 3.42% | response to monosaccharide |
| GO:0048367 | 3.42% | shoot system development |
| GO:0006665 | 3.42% | sphingolipid metabolic process |
| GO:0006338 | 3.42% | chromatin remodeling |
| GO:0032990 | 3.42% | cell part morphogenesis |
| GO:0070482 | 3.41% | response to oxygen levels |
| GO:0046677 | 3.41% | response to antibiotic |
| GO:1903047 | 3.41% | mitotic cell cycle process |
| GO:0009100 | 3.41% | glycoprotein metabolic process |
| GO:0048729 | 3.41% | tissue morphogenesis |
| GO:0031175 | 3.41% | neuron projection development |
| GO:0051247 | 3.40% | positive regulation of protein metabolic process |
| GO:0008283 | 3.39% | cell population proliferation |
| GO:0060284 | 3.39% | regulation of cell development |
| GO:0009415 | 3.38% | response to water |
| GO:0010564 | 3.38% | regulation of cell cycle process |
| GO:0097659 | 3.37% | nucleic acid-templated transcription |
| GO:0009908 | 3.36% | flower development |
| GO:0034976 | 3.36% | response to endoplasmic reticulum stress |
| GO:0050776 | 3.36% | regulation of immune response |
| GO:0005984 | 3.36% | disaccharide metabolic process |
| GO:0010224 | 3.35% | response to UV-B |
| GO:0007420 | 3.35% | brain development |
| GO:0033013 | 3.35% | tetrapyrrole metabolic process |
| GO:0032270 | 3.35% | positive regulation of cellular protein metabolic process |
| GO:0030855 | 3.35% | epithelial cell differentiation |
| GO:0051028 | 3.35% | mRNA transport |
| GO:0016458 | 3.34% | gene silencing |
| GO:0071695 | 3.34% | anatomical structure maturation |
| GO:0006915 | 3.34% | apoptotic process |
| GO:0034728 | 3.34% | nucleosome organization |
| GO:0022610 | 3.34% | biological adhesion |
| GO:0043085 | 3.34% | positive regulation of catalytic activity |
| GO:0051960 | 3.33% | regulation of nervous system development |
| GO:0009267 | 3.33% | cellular response to starvation |
| GO:0046653 | 3.33% | tetrahydrofolate metabolic process |
| GO:2000765 | 3.33% | regulation of cytoplasmic translation |
| GO:0031047 | 3.32% | gene silencing by RNA |
| GO:0019321 | 3.32% | pentose metabolic process |
| GO:0009896 | 3.31% | positive regulation of catabolic process |
| GO:0048193 | 3.30% | Golgi vesicle transport |
| GO:1901657 | 3.30% | glycosyl compound metabolic process |
| GO:0090305 | 3.30% | nucleic acid phosphodiester bond hydrolysis |
| GO:0072657 | 3.30% | protein localization to membrane |
| GO:0050829 | 3.29% | defense response to Gram-negative bacterium |
| GO:0001701 | 3.29% | in utero embryonic development |
| GO:0051168 | 3.29% | nuclear export |
| GO:0010638 | 3.29% | positive regulation of organelle organization |
| GO:0006310 | 3.28% | DNA recombination |
| GO:0009753 | 3.28% | response to jasmonic acid |
| GO:0044703 | 3.28% | multi-organism reproductive process |
| GO:0051254 | 3.28% | positive regulation of RNA metabolic process |
| GO:0023056 | 3.28% | positive regulation of signaling |
| GO:0044728 | 3.27% | DNA methylation or demethylation |
| GO:0010647 | 3.27% | positive regulation of cell communication |
| GO:0006020 | 3.26% | inositol metabolic process |
| GO:0009310 | 3.26% | amine catabolic process |
| GO:0006886 | 3.26% | intracellular protein transport |
| GO:0097722 | 3.26% | sperm motility |
| GO:0051592 | 3.26% | response to calcium ion |
| GO:0034655 | 3.26% | nucleobase-containing compound catabolic process |
| GO:0002697 | 3.26% | regulation of immune effector process |
| GO:0051341 | 3.24% | regulation of oxidoreductase activity |
| GO:0015979 | 3.24% | photosynthesis |
| GO:0042435 | 3.24% | indole-containing compound biosynthetic process |
| GO:0007169 | 3.24% | transmembrane receptor protein tyrosine kinase signaling pathway |
| GO:0007626 | 3.23% | locomotory behavior |
| GO:0007389 | 3.22% | pattern specification process |
| GO:0043009 | 3.22% | chordate embryonic development |
| GO:0070192 | 3.22% | chromosome organization involved in meiotic cell cycle |
| GO:0009850 | 3.22% | auxin metabolic process |
| GO:0071345 | 3.21% | cellular response to cytokine stimulus |
| GO:0090702 | 3.20% | non-reproductive fruiting body development |
| GO:0099536 | 3.20% | synaptic signaling |
| GO:0035999 | 3.19% | tetrahydrofolate interconversion |
| GO:0048585 | 3.19% | negative regulation of response to stimulus |
| GO:0010558 | 3.19% | negative regulation of macromolecule biosynthetic process |
| GO:0009312 | 3.19% | oligosaccharide biosynthetic process |
| GO:0052803 | 3.19% | imidazole-containing compound metabolic process |
| GO:0009247 | 3.19% | glycolipid biosynthetic process |
| GO:0007268 | 3.18% | chemical synaptic transmission |
| GO:0043687 | 3.18% | post-translational protein modification |
| GO:0019320 | 3.18% | hexose catabolic process |
| GO:0033044 | 3.18% | regulation of chromosome organization |
| GO:0018410 | 3.18% | C-terminal protein amino acid modification |
| GO:0009699 | 3.18% | phenylpropanoid biosynthetic process |
| GO:0001510 | 3.17% | RNA methylation |
| GO:0042402 | 3.17% | cellular biogenic amine catabolic process |
| GO:0006012 | 3.17% | galactose metabolic process |
| GO:0009410 | 3.17% | response to xenobiotic stimulus |
| GO:0006090 | 3.17% | pyruvate metabolic process |
| GO:0007411 | 3.17% | axon guidance |
| GO:0034227 | 3.16% | tRNA thio-modification |
| GO:0006471 | 3.16% | protein ADP-ribosylation |
| GO:0006163 | 3.16% | purine nucleotide metabolic process |
| GO:0007155 | 3.16% | cell adhesion |
| GO:0006734 | 3.16% | NADH metabolic process |
| GO:2000113 | 3.15% | negative regulation of cellular macromolecule biosynthetic process |
| GO:0009890 | 3.15% | negative regulation of biosynthetic process |
| GO:0008202 | 3.15% | steroid metabolic process |
| GO:0030317 | 3.14% | flagellated sperm motility |
| GO:0009749 | 3.14% | response to glucose |
| GO:0009414 | 3.14% | response to water deprivation |
| GO:0009250 | 3.14% | glucan biosynthetic process |
| GO:0031331 | 3.13% | positive regulation of cellular catabolic process |
| GO:0006972 | 3.13% | hyperosmotic response |
| GO:0098916 | 3.13% | anterograde trans-synaptic signaling |
| GO:0001666 | 3.13% | response to hypoxia |
| GO:0019693 | 3.13% | ribose phosphate metabolic process |
| GO:0046474 | 3.13% | glycerophospholipid biosynthetic process |
| GO:0099537 | 3.12% | trans-synaptic signaling |
| GO:0006577 | 3.12% | amino-acid betaine metabolic process |
| GO:0030587 | 3.12% | sorocarp development |
| GO:0045893 | 3.11% | positive regulation of transcription, DNA-templated |
| GO:0007568 | 3.11% | aging |
| GO:0051260 | 3.11% | protein homooligomerization |
| GO:0048580 | 3.11% | regulation of post-embryonic development |
| GO:0072524 | 3.11% | pyridine-containing compound metabolic process |
| GO:0051093 | 3.11% | negative regulation of developmental process |
| GO:0050890 | 3.11% | cognition |
| GO:0030097 | 3.11% | hemopoiesis |
| GO:0007600 | 3.10% | sensory perception |
| GO:0009411 | 3.10% | response to UV |
| GO:0045017 | 3.10% | glycerolipid biosynthetic process |
| GO:0006778 | 3.09% | porphyrin-containing compound metabolic process |
| GO:0006000 | 3.09% | fructose metabolic process |
| GO:2000243 | 3.09% | positive regulation of reproductive process |
| GO:0019220 | 3.09% | regulation of phosphate metabolic process |
| GO:0032870 | 3.09% | cellular response to hormone stimulus |
| GO:0006491 | 3.09% | N-glycan processing |
| GO:0043467 | 3.08% | regulation of generation of precursor metabolites and energy |
| GO:0007167 | 3.08% | enzyme linked receptor protein signaling pathway |
| GO:0051174 | 3.08% | regulation of phosphorus metabolic process |
| GO:0007584 | 3.07% | response to nutrient |
| GO:0097485 | 3.07% | neuron projection guidance |
| GO:0007611 | 3.07% | learning or memory |
| GO:1902679 | 3.07% | negative regulation of RNA biosynthetic process |
| GO:0019098 | 3.07% | reproductive behavior |
| GO:1903507 | 3.06% | negative regulation of nucleic acid-templated transcription |
| GO:0044093 | 3.06% | positive regulation of molecular function |
| GO:0045597 | 3.06% | positive regulation of cell differentiation |
| GO:0044085 | 3.06% | cellular component biogenesis |
| GO:0018126 | 3.05% | protein hydroxylation |
| GO:0042168 | 3.05% | heme metabolic process |
| GO:0009887 | 3.05% | animal organ morphogenesis |
| GO:0006406 | 3.05% | mRNA export from nucleus |
| GO:0043254 | 3.05% | regulation of protein complex assembly |
| GO:0031327 | 3.05% | negative regulation of cellular biosynthetic process |
| GO:0036293 | 3.04% | response to decreased oxygen levels |
| GO:0035239 | 3.04% | tube morphogenesis |
| GO:0006694 | 3.04% | steroid biosynthetic process |
| GO:0098754 | 3.04% | detoxification |
| GO:0009755 | 3.04% | hormone-mediated signaling pathway |
| GO:0071824 | 3.04% | protein-DNA complex subunit organization |
| GO:0044089 | 3.04% | positive regulation of cellular component biogenesis |
| GO:0007346 | 3.04% | regulation of mitotic cell cycle |
| GO:0002831 | 3.03% | regulation of response to biotic stimulus |
| GO:0002097 | 3.03% | tRNA wobble base modification |
| GO:0006402 | 3.03% | mRNA catabolic process |
| GO:0009060 | 3.03% | aerobic respiration |
| GO:0006261 | 3.03% | DNA-dependent DNA replication |
| GO:0032881 | 3.03% | regulation of polysaccharide metabolic process |
| GO:1902680 | 3.02% | positive regulation of RNA biosynthetic process |
| GO:0043434 | 3.02% | response to peptide hormone |
| GO:0043543 | 3.02% | protein acylation |
| GO:0006089 | 3.02% | lactate metabolic process |
| GO:1903508 | 3.02% | positive regulation of nucleic acid-templated transcription |
| GO:0022613 | 3.02% | ribonucleoprotein complex biogenesis |
| GO:0051050 | 3.01% | positive regulation of transport |
| GO:0045786 | 3.01% | negative regulation of cell cycle |
| GO:0001558 | 3.01% | regulation of cell growth |
| GO:0000003 | 3.01% | reproduction |
| GO:1901652 | 3.01% | response to peptide |
| GO:0050808 | 3.00% | synapse organization |
| GO:0044706 | 3.00% | multi-multicellular organism process |
| GO:0009070 | 3.00% | serine family amino acid biosynthetic process |
| GO:0051640 | 3.00% | organelle localization |
| GO:0046209 | 2.99% | nitric oxide metabolic process |
| GO:0002119 | 2.99% | nematode larval development |
| GO:0023014 | 2.98% | signal transduction by protein phosphorylation |
| GO:0031099 | 2.98% | regeneration |
| GO:0016226 | 2.98% | iron-sulfur cluster assembly |
| GO:0042128 | 2.98% | nitrate assimilation |
| GO:0099402 | 2.97% | plant organ development |
| GO:0008360 | 2.97% | regulation of cell shape |
| GO:0045892 | 2.97% | negative regulation of transcription, DNA-templated |
| GO:0009083 | 2.97% | branched-chain amino acid catabolic process |
| GO:0046189 | 2.97% | phenol-containing compound biosynthetic process |
| GO:0031503 | 2.97% | protein-containing complex localization |
| GO:0002009 | 2.97% | morphogenesis of an epithelium |
| GO:0090501 | 2.96% | RNA phosphodiester bond hydrolysis |
| GO:0050778 | 2.96% | positive regulation of immune response |
| GO:0023061 | 2.96% | signal release |
| GO:0045229 | 2.96% | external encapsulating structure organization |
| GO:0006111 | 2.95% | regulation of gluconeogenesis |
| GO:0006749 | 2.95% | glutathione metabolic process |
| GO:0000271 | 2.95% | polysaccharide biosynthetic process |
| GO:0006573 | 2.95% | valine metabolic process |
| GO:0016477 | 2.95% | cell migration |
| GO:0000278 | 2.94% | mitotic cell cycle |
| GO:0050801 | 2.94% | ion homeostasis |
| GO:1900864 | 2.94% | mitochondrial RNA modification |
| GO:0008344 | 2.94% | adult locomotory behavior |
| GO:0033692 | 2.94% | cellular polysaccharide biosynthetic process |
| GO:0034661 | 2.94% | ncRNA catabolic process |
| GO:0002098 | 2.93% | tRNA wobble uridine modification |
| GO:0009793 | 2.93% | embryo development ending in seed dormancy |
| GO:0071554 | 2.93% | cell wall organization or biogenesis |
| GO:0031163 | 2.92% | metallo-sulfur cluster assembly |
| GO:0071241 | 2.92% | cellular response to inorganic substance |
| GO:0071396 | 2.92% | cellular response to lipid |
| GO:0002164 | 2.91% | larval development |
| GO:0009658 | 2.91% | chloroplast organization |
| GO:0071229 | 2.91% | cellular response to acid chemical |
| GO:0009657 | 2.91% | plastid organization |
| GO:0090693 | 2.91% | plant organ senescence |
| GO:0042126 | 2.90% | nitrate metabolic process |
| GO:0009886 | 2.90% | post-embryonic animal morphogenesis |
| GO:0072525 | 2.90% | pyridine-containing compound biosynthetic process |
| GO:0016036 | 2.90% | cellular response to phosphate starvation |
| GO:0046885 | 2.90% | regulation of hormone biosynthetic process |
| GO:0048598 | 2.89% | embryonic morphogenesis |
| GO:0016032 | 2.89% | viral process |
| GO:0018212 | 2.89% | peptidyl-tyrosine modification |
| GO:0072347 | 2.89% | response to anesthetic |
| GO:0032922 | 2.88% | circadian regulation of gene expression |
| GO:0009733 | 2.88% | response to auxin |
| GO:0007417 | 2.88% | central nervous system development |
| GO:0030036 | 2.88% | actin cytoskeleton organization |
| GO:0007399 | 2.88% | nervous system development |
| GO:0045927 | 2.87% | positive regulation of growth |
| GO:0044403 | 2.87% | symbiotic process |
| GO:0031638 | 2.87% | zymogen activation |
| GO:0071555 | 2.86% | cell wall organization |
| GO:0031399 | 2.86% | regulation of protein modification process |
| GO:0008285 | 2.86% | negative regulation of cell population proliferation |
| GO:0042254 | 2.85% | ribosome biogenesis |
| GO:0006547 | 2.85% | histidine metabolic process |
| GO:0010506 | 2.85% | regulation of autophagy |
| GO:0043044 | 2.85% | ATP-dependent chromatin remodeling |
| GO:0031100 | 2.84% | animal organ regeneration |
| GO:0060341 | 2.84% | regulation of cellular localization |
| GO:0032880 | 2.84% | regulation of protein localization |
| GO:0070873 | 2.84% | regulation of glycogen metabolic process |
| GO:1990778 | 2.84% | protein localization to cell periphery |
| GO:0044782 | 2.84% | cilium organization |
| GO:1901659 | 2.84% | glycosyl compound biosynthetic process |
| GO:0043068 | 2.83% | positive regulation of programmed cell death |
| GO:0006913 | 2.83% | nucleocytoplasmic transport |
| GO:0051187 | 2.83% | cofactor catabolic process |
| GO:0042325 | 2.82% | regulation of phosphorylation |
| GO:1902115 | 2.82% | regulation of organelle assembly |
| GO:0051493 | 2.82% | regulation of cytoskeleton organization |
| GO:0046890 | 2.82% | regulation of lipid biosynthetic process |
| GO:0000165 | 2.82% | MAPK cascade |
| GO:0009259 | 2.82% | ribonucleotide metabolic process |
| GO:0001525 | 2.81% | angiogenesis |
| GO:0048831 | 2.81% | regulation of shoot system development |
| GO:0061061 | 2.81% | muscle structure development |
| GO:0001522 | 2.81% | pseudouridine synthesis |
| GO:0006473 | 2.81% | protein acetylation |
| GO:1902850 | 2.80% | microtubule cytoskeleton organization involved in mitosis |
| GO:0009967 | 2.80% | positive regulation of signal transduction |
| GO:0046500 | 2.80% | S-adenosylmethionine metabolic process |
| GO:0043069 | 2.79% | negative regulation of programmed cell death |
| GO:0007018 | 2.79% | microtubule-based movement |
| GO:0042330 | 2.79% | taxis |
| GO:0010565 | 2.79% | regulation of cellular ketone metabolic process |
| GO:0009914 | 2.79% | hormone transport |
| GO:0050767 | 2.79% | regulation of neurogenesis |
| GO:0034250 | 2.79% | positive regulation of cellular amide metabolic process |
| GO:0016125 | 2.78% | sterol metabolic process |
| GO:0006526 | 2.78% | arginine biosynthetic process |
| GO:0010150 | 2.78% | leaf senescence |
| GO:0030162 | 2.78% | regulation of proteolysis |
| GO:0019674 | 2.78% | NAD metabolic process |
| GO:0016126 | 2.77% | sterol biosynthetic process |
| GO:0008406 | 2.77% | gonad development |
| GO:0043486 | 2.77% | histone exchange |
| GO:0060548 | 2.77% | negative regulation of cell death |
| GO:0006664 | 2.77% | glycolipid metabolic process |
| GO:0000272 | 2.77% | polysaccharide catabolic process |
| GO:0006103 | 2.77% | 2-oxoglutarate metabolic process |
| GO:0072594 | 2.76% | establishment of protein localization to organelle |
| GO:0000281 | 2.76% | mitotic cytokinesis |
| GO:0034754 | 2.76% | cellular hormone metabolic process |
| GO:0019216 | 2.76% | regulation of lipid metabolic process |
| GO:0055082 | 2.75% | cellular chemical homeostasis |
| GO:0006672 | 2.75% | ceramide metabolic process |
| GO:0055076 | 2.75% | transition metal ion homeostasis |
| GO:0051129 | 2.74% | negative regulation of cellular component organization |
| GO:0060271 | 2.74% | cilium assembly |
| GO:0009409 | 2.74% | response to cold |
| GO:0009615 | 2.73% | response to virus |
| GO:0043171 | 2.73% | peptide catabolic process |
| GO:0051169 | 2.73% | nuclear transport |
| GO:0043628 | 2.73% | ncRNA 3'-end processing |
| GO:0009566 | 2.72% | fertilization |
| GO:0005978 | 2.72% | glycogen biosynthetic process |
| GO:0007617 | 2.72% | mating behavior |
| GO:0048812 | 2.72% | neuron projection morphogenesis |
| GO:0009855 | 2.72% | determination of bilateral symmetry |
| GO:0071248 | 2.71% | cellular response to metal ion |
| GO:0009799 | 2.71% | specification of symmetry |
| GO:0016973 | 2.71% | poly(A)+ mRNA export from nucleus |
| GO:0032386 | 2.71% | regulation of intracellular transport |
| GO:0043066 | 2.71% | negative regulation of apoptotic process |
| GO:0032107 | 2.70% | regulation of response to nutrient levels |
| GO:0098771 | 2.70% | inorganic ion homeostasis |
| GO:0007052 | 2.70% | mitotic spindle organization |
| GO:0120039 | 2.70% | plasma membrane bounded cell projection morphogenesis |
| GO:0048534 | 2.69% | hematopoietic or lymphoid organ development |
| GO:0044092 | 2.69% | negative regulation of molecular function |
| GO:0048858 | 2.68% | cell projection morphogenesis |
| GO:0051241 | 2.68% | negative regulation of multicellular organismal process |
| GO:0072527 | 2.68% | pyrimidine-containing compound metabolic process |
| GO:0006811 | 2.68% | ion transport |
| GO:0044057 | 2.68% | regulation of system process |
| GO:0046655 | 2.67% | folic acid metabolic process |
| GO:0046364 | 2.67% | monosaccharide biosynthetic process |
| GO:0007349 | 2.67% | cellularization |
| GO:0033014 | 2.67% | tetrapyrrole biosynthetic process |
| GO:0007131 | 2.67% | reciprocal meiotic recombination |
| GO:0023057 | 2.66% | negative regulation of signaling |
| GO:0040029 | 2.66% | regulation of gene expression, epigenetic |
| GO:0018202 | 2.66% | peptidyl-histidine modification |
| GO:0044275 | 2.66% | cellular carbohydrate catabolic process |
| GO:0030182 | 2.66% | neuron differentiation |
| GO:0051649 | 2.66% | establishment of localization in cell |
| GO:0043065 | 2.65% | positive regulation of apoptotic process |
| GO:0090502 | 2.65% | RNA phosphodiester bond hydrolysis, endonucleolytic |
| GO:0006482 | 2.65% | protein demethylation |
| GO:1902369 | 2.65% | negative regulation of RNA catabolic process |
| GO:0072528 | 2.65% | pyrimidine-containing compound biosynthetic process |
| GO:0051235 | 2.64% | maintenance of location |
| GO:0035082 | 2.64% | axoneme assembly |
| GO:0048509 | 2.64% | regulation of meristem development |
| GO:0003012 | 2.64% | muscle system process |
| GO:0055072 | 2.64% | iron ion homeostasis |
| GO:0009150 | 2.63% | purine ribonucleotide metabolic process |
| GO:0010821 | 2.63% | regulation of mitochondrion organization |
| GO:0044419 | 2.63% | interspecies interaction between organisms |
| GO:0018394 | 2.63% | peptidyl-lysine acetylation |
| GO:0018196 | 2.63% | peptidyl-asparagine modification |
| GO:0007368 | 2.63% | determination of left/right symmetry |
| GO:0035825 | 2.63% | homologous recombination |
| GO:0071897 | 2.63% | DNA biosynthetic process |
| GO:0016101 | 2.63% | diterpenoid metabolic process |
| GO:0030148 | 2.63% | sphingolipid biosynthetic process |
| GO:0006360 | 2.62% | transcription by RNA polymerase I |
| GO:0070201 | 2.62% | regulation of establishment of protein localization |
| GO:0030534 | 2.62% | adult behavior |
| GO:1902653 | 2.62% | secondary alcohol biosynthetic process |
| GO:0005985 | 2.62% | sucrose metabolic process |
| GO:1901214 | 2.62% | regulation of neuron death |
| GO:0032350 | 2.62% | regulation of hormone metabolic process |
| GO:0002684 | 2.62% | positive regulation of immune system process |
| GO:0071495 | 2.61% | cellular response to endogenous stimulus |
| GO:0010648 | 2.61% | negative regulation of cell communication |
| GO:0009968 | 2.61% | negative regulation of signal transduction |
| GO:0030488 | 2.61% | tRNA methylation |
| GO:0071277 | 2.61% | cellular response to calcium ion |
| GO:0051189 | 2.60% | prosthetic group metabolic process |
| GO:0019362 | 2.60% | pyridine nucleotide metabolic process |
| GO:0043562 | 2.60% | cellular response to nitrogen levels |
| GO:0043112 | 2.60% | receptor metabolic process |
| GO:0009639 | 2.60% | response to red or far red light |
| GO:0055080 | 2.60% | cation homeostasis |
| GO:0032886 | 2.60% | regulation of microtubule-based process |
| GO:0030155 | 2.59% | regulation of cell adhesion |
| GO:0008214 | 2.59% | protein dealkylation |
| GO:0019720 | 2.59% | Mo-molybdopterin cofactor metabolic process |
| GO:0006030 | 2.59% | chitin metabolic process |
| GO:0001817 | 2.58% | regulation of cytokine production |
| GO:0006605 | 2.58% | protein targeting |
| GO:0030029 | 2.58% | actin filament-based process |
| GO:0017001 | 2.58% | antibiotic catabolic process |
| GO:0051262 | 2.58% | protein tetramerization |
| GO:1903509 | 2.58% | liposaccharide metabolic process |
| GO:0032984 | 2.58% | protein-containing complex disassembly |
| GO:0007616 | 2.57% | long-term memory |
| GO:0055065 | 2.57% | metal ion homeostasis |
| GO:0006476 | 2.57% | protein deacetylation |
| GO:0016143 | 2.57% | S-glycoside metabolic process |
| GO:0042176 | 2.57% | regulation of protein catabolic process |
| GO:0031365 | 2.57% | N-terminal protein amino acid modification |
| GO:0018208 | 2.57% | peptidyl-proline modification |
| GO:0051668 | 2.57% | localization within membrane |
| GO:0046390 | 2.56% | ribose phosphate biosynthetic process |
| GO:0044257 | 2.56% | cellular protein catabolic process |
| GO:0048582 | 2.56% | positive regulation of post-embryonic development |
| GO:0006415 | 2.56% | translational termination |
| GO:0001889 | 2.56% | liver development |
| GO:0046496 | 2.56% | nicotinamide nucleotide metabolic process |
| GO:0002066 | 2.56% | columnar/cuboidal epithelial cell development |
| GO:0120035 | 2.56% | regulation of plasma membrane bounded cell projection organization |
| GO:0000280 | 2.56% | nuclear division |
| GO:0043902 | 2.56% | positive regulation of multi-organism process |
| GO:0104004 | 2.55% | cellular response to environmental stimulus |
| GO:0010043 | 2.55% | response to zinc ion |
| GO:0001932 | 2.55% | regulation of protein phosphorylation |
| GO:0030031 | 2.55% | cell projection assembly |
| GO:0045727 | 2.55% | positive regulation of translation |
| GO:0007059 | 2.55% | chromosome segregation |
| GO:0051338 | 2.55% | regulation of transferase activity |
| GO:0018393 | 2.54% | internal peptidyl-lysine acetylation |
| GO:1903008 | 2.54% | organelle disassembly |
| GO:0050918 | 2.54% | positive chemotaxis |
| GO:0010676 | 2.54% | positive regulation of cellular carbohydrate metabolic process |
| GO:2000377 | 2.54% | regulation of reactive oxygen species metabolic process |
| GO:0042773 | 2.54% | ATP synthesis coupled electron transport |
| GO:0072522 | 2.54% | purine-containing compound biosynthetic process |
| GO:0060479 | 2.54% | lung cell differentiation |
| GO:0048545 | 2.53% | response to steroid hormone |
| GO:0007622 | 2.53% | rhythmic behavior |
| GO:0009723 | 2.53% | response to ethylene |
| GO:0045596 | 2.53% | negative regulation of cell differentiation |
| GO:0071214 | 2.53% | cellular response to abiotic stimulus |
| GO:0045664 | 2.53% | regulation of neuron differentiation |
| GO:0000729 | 2.53% | DNA double-strand break processing |
| GO:0007219 | 2.52% | Notch signaling pathway |
| GO:0046685 | 2.52% | response to arsenic-containing substance |
| GO:0061919 | 2.51% | process utilizing autophagic mechanism |
| GO:0050830 | 2.51% | defense response to Gram-positive bacterium |
| GO:0007033 | 2.51% | vacuole organization |
| GO:0042538 | 2.51% | hyperosmotic salinity response |
| GO:0031344 | 2.51% | regulation of cell projection organization |
| GO:0051291 | 2.51% | protein heterooligomerization |
| GO:0009068 | 2.51% | aspartate family amino acid catabolic process |
| GO:0009116 | 2.50% | nucleoside metabolic process |
| GO:0006914 | 2.50% | autophagy |
| GO:1902531 | 2.50% | regulation of intracellular signal transduction |
| GO:0045732 | 2.50% | positive regulation of protein catabolic process |
| GO:0006887 | 2.50% | exocytosis |
| GO:0006475 | 2.49% | internal protein amino acid acetylation |
| GO:0006777 | 2.49% | Mo-molybdopterin cofactor biosynthetic process |
| GO:0006549 | 2.49% | isoleucine metabolic process |
| GO:0009642 | 2.49% | response to light intensity |
| GO:0071852 | 2.49% | fungal-type cell wall organization or biogenesis |
| GO:0045787 | 2.48% | positive regulation of cell cycle |
| GO:0010975 | 2.48% | regulation of neuron projection development |
| GO:0009895 | 2.48% | negative regulation of catabolic process |
| GO:0032885 | 2.48% | regulation of polysaccharide biosynthetic process |
| GO:0099111 | 2.48% | microtubule-based transport |
| GO:0006783 | 2.48% | heme biosynthetic process |
| GO:0046434 | 2.47% | organophosphate catabolic process |
| GO:0043545 | 2.46% | molybdopterin cofactor metabolic process |
| GO:0007613 | 2.46% | memory |
| GO:0045995 | 2.46% | regulation of embryonic development |
| GO:0018904 | 2.46% | ether metabolic process |
| GO:0006022 | 2.46% | aminoglycan metabolic process |
| GO:1901570 | 2.46% | fatty acid derivative biosynthetic process |
| GO:0022406 | 2.46% | membrane docking |
| GO:0040014 | 2.46% | regulation of multicellular organism growth |
| GO:0009085 | 2.45% | lysine biosynthetic process |
| GO:0033206 | 2.45% | meiotic cytokinesis |
| GO:0051153 | 2.45% | regulation of striated muscle cell differentiation |
| GO:0006515 | 2.45% | protein quality control for misfolded or incompletely synthesized proteins |
| GO:0006954 | 2.45% | inflammatory response |
| GO:0043549 | 2.45% | regulation of kinase activity |
| GO:0051336 | 2.45% | regulation of hydrolase activity |
| GO:0006892 | 2.45% | post-Golgi vesicle-mediated transport |
| GO:0140029 | 2.45% | exocytic process |
| GO:0006448 | 2.44% | regulation of translational elongation |
| GO:0061245 | 2.44% | establishment or maintenance of bipolar cell polarity |
| GO:0006897 | 2.44% | endocytosis |
| GO:0008037 | 2.44% | cell recognition |
| GO:0098657 | 2.44% | import into cell |
| GO:0019344 | 2.44% | cysteine biosynthetic process |
| GO:0006779 | 2.43% | porphyrin-containing compound biosynthetic process |
| GO:0120031 | 2.43% | plasma membrane bounded cell projection assembly |
| GO:0048732 | 2.43% | gland development |
| GO:0009909 | 2.43% | regulation of flower development |
| GO:0031098 | 2.43% | stress-activated protein kinase signaling cascade |
| GO:0043624 | 2.43% | cellular protein complex disassembly |
| GO:0016575 | 2.43% | histone deacetylation |
| GO:0009742 | 2.43% | brassinosteroid mediated signaling pathway |
| GO:0062013 | 2.43% | positive regulation of small molecule metabolic process |
| GO:0040012 | 2.43% | regulation of locomotion |
| GO:0016050 | 2.43% | vesicle organization |
| GO:0090150 | 2.42% | establishment of protein localization to membrane |
| GO:0051783 | 2.42% | regulation of nuclear division |
| GO:0046473 | 2.42% | phosphatidic acid metabolic process |
| GO:0051147 | 2.41% | regulation of muscle cell differentiation |
| GO:0032104 | 2.41% | regulation of response to extracellular stimulus |
| GO:0006553 | 2.41% | lysine metabolic process |
| GO:0009132 | 2.41% | nucleoside diphosphate metabolic process |
| GO:0098732 | 2.41% | macromolecule deacylation |
| GO:0060537 | 2.40% | muscle tissue development |
| GO:0015914 | 2.40% | phospholipid transport |
| GO:0045913 | 2.40% | positive regulation of carbohydrate metabolic process |
| GO:0070525 | 2.40% | tRNA threonylcarbamoyladenosine metabolic process |
| GO:0002237 | 2.40% | response to molecule of bacterial origin |
| GO:1901654 | 2.40% | response to ketone |
| GO:0030437 | 2.40% | ascospore formation |
| GO:0000209 | 2.40% | protein polyubiquitination |
| GO:0065004 | 2.40% | protein-DNA complex assembly |
| GO:0071453 | 2.40% | cellular response to oxygen levels |
| GO:0045088 | 2.40% | regulation of innate immune response |
| GO:2001023 | 2.39% | regulation of response to drug |
| GO:0019760 | 2.39% | glucosinolate metabolic process |
| GO:0090066 | 2.39% | regulation of anatomical structure size |
| GO:0009101 | 2.39% | glycoprotein biosynthetic process |
| GO:0051223 | 2.39% | regulation of protein transport |
| GO:0016241 | 2.39% | regulation of macroautophagy |
| GO:0007034 | 2.39% | vacuolar transport |
| GO:0042752 | 2.38% | regulation of circadian rhythm |
| GO:0031647 | 2.38% | regulation of protein stability |
| GO:0006004 | 2.38% | fucose metabolic process |
| GO:0006935 | 2.38% | chemotaxis |
| GO:0007286 | 2.38% | spermatid development |
| GO:0046488 | 2.38% | phosphatidylinositol metabolic process |
| GO:0042135 | 2.38% | neurotransmitter catabolic process |
| GO:1903311 | 2.38% | regulation of mRNA metabolic process |
| GO:0007163 | 2.38% | establishment or maintenance of cell polarity |
| GO:0007528 | 2.38% | neuromuscular junction development |
| GO:0043523 | 2.37% | regulation of neuron apoptotic process |
| GO:0003002 | 2.37% | regionalization |
| GO:0010769 | 2.37% | regulation of cell morphogenesis involved in differentiation |
| GO:0051193 | 2.37% | regulation of cofactor metabolic process |
| GO:0044036 | 2.37% | cell wall macromolecule metabolic process |
| GO:0051923 | 2.37% | sulfation |
| GO:0045862 | 2.37% | positive regulation of proteolysis |
| GO:0006497 | 2.36% | protein lipidation |
| GO:0046939 | 2.36% | nucleotide phosphorylation |
| GO:0007619 | 2.36% | courtship behavior |
| GO:0051017 | 2.36% | actin filament bundle assembly |
| GO:0046501 | 2.36% | protoporphyrinogen IX metabolic process |
| GO:0140013 | 2.36% | meiotic nuclear division |
| GO:0009712 | 2.36% | catechol-containing compound metabolic process |
| GO:0019646 | 2.36% | aerobic electron transport chain |
| GO:1901861 | 2.35% | regulation of muscle tissue development |
| GO:0001578 | 2.35% | microtubule bundle formation |
| GO:0031167 | 2.35% | rRNA methylation |
| GO:0009738 | 2.35% | abscisic acid-activated signaling pathway |
| GO:0072659 | 2.35% | protein localization to plasma membrane |
| GO:0008284 | 2.34% | positive regulation of cell population proliferation |
| GO:0051705 | 2.34% | multi-organism behavior |
| GO:0048827 | 2.34% | phyllome development |
| GO:0002244 | 2.34% | hematopoietic progenitor cell differentiation |
| GO:0006517 | 2.34% | protein deglycosylation |
| GO:0009635 | 2.34% | response to herbicide |
| GO:0007127 | 2.34% | meiosis I |
| GO:0048639 | 2.33% | positive regulation of developmental growth |
| GO:0051353 | 2.33% | positive regulation of oxidoreductase activity |
| GO:0006566 | 2.33% | threonine metabolic process |
| GO:0006936 | 2.33% | muscle contraction |
| GO:0042436 | 2.33% | indole-containing compound catabolic process |
| GO:1901616 | 2.33% | organic hydroxy compound catabolic process |
| GO:0055001 | 2.33% | muscle cell development |
| GO:0016197 | 2.33% | endosomal transport |
| GO:0006893 | 2.33% | Golgi to plasma membrane transport |
| GO:1903312 | 2.33% | negative regulation of mRNA metabolic process |
| GO:0007517 | 2.32% | muscle organ development |
| GO:0016540 | 2.32% | protein autoprocessing |
| GO:0035592 | 2.32% | establishment of protein localization to extracellular region |
| GO:0051248 | 2.32% | negative regulation of protein metabolic process |
| GO:0051403 | 2.32% | stress-activated MAPK cascade |
| GO:1902275 | 2.32% | regulation of chromatin organization |
| GO:1903827 | 2.32% | regulation of cellular protein localization |
| GO:0043470 | 2.32% | regulation of carbohydrate catabolic process |
| GO:0016571 | 2.31% | histone methylation |
| GO:0043487 | 2.31% | regulation of RNA stability |
| GO:0060429 | 2.31% | epithelium development |
| GO:0002790 | 2.31% | peptide secretion |
| GO:0001678 | 2.31% | cellular glucose homeostasis |
| GO:0006352 | 2.31% | DNA-templated transcription, initiation |
| GO:0050807 | 2.31% | regulation of synapse organization |
| GO:0010720 | 2.31% | positive regulation of cell development |
| GO:2001252 | 2.31% | positive regulation of chromosome organization |
| GO:0048469 | 2.30% | cell maturation |
| GO:0006869 | 2.30% | lipid transport |
| GO:0090140 | 2.30% | regulation of mitochondrial fission |
| GO:0016102 | 2.30% | diterpenoid biosynthetic process |
| GO:0061512 | 2.30% | protein localization to cilium |
| GO:0045471 | 2.30% | response to ethanol |
| GO:0072665 | 2.29% | protein localization to vacuole |
| GO:0045926 | 2.29% | negative regulation of growth |
| GO:0098876 | 2.29% | vesicle-mediated transport to the plasma membrane |
| GO:0042753 | 2.29% | positive regulation of circadian rhythm |
| GO:0098609 | 2.29% | cell-cell adhesion |
| GO:0007015 | 2.29% | actin filament organization |
| GO:0051983 | 2.29% | regulation of chromosome segregation |
| GO:0034404 | 2.29% | nucleobase-containing small molecule biosynthetic process |
| GO:0046686 | 2.29% | response to cadmium ion |
| GO:0048520 | 2.29% | positive regulation of behavior |
| GO:0009112 | 2.29% | nucleobase metabolic process |
| GO:0051606 | 2.29% | detection of stimulus |
| GO:2001038 | 2.29% | regulation of cellular response to drug |
| GO:0048569 | 2.28% | post-embryonic animal organ development |
| GO:0000122 | 2.28% | negative regulation of transcription by RNA polymerase II |
| GO:0009141 | 2.28% | nucleoside triphosphate metabolic process |
| GO:0035418 | 2.28% | protein localization to synapse |
| GO:0035690 | 2.27% | cellular response to drug |
| GO:0046459 | 2.27% | short-chain fatty acid metabolic process |
| GO:0042816 | 2.27% | vitamin B6 metabolic process |
| GO:0071692 | 2.27% | protein localization to extracellular region |
| GO:0051046 | 2.27% | regulation of secretion |
| GO:0035601 | 2.27% | protein deacylation |
| GO:0002683 | 2.27% | negative regulation of immune system process |
| GO:2000145 | 2.27% | regulation of cell motility |
| GO:0034605 | 2.27% | cellular response to heat |
| GO:0018200 | 2.27% | peptidyl-glutamic acid modification |
| GO:0022008 | 2.26% | neurogenesis |
| GO:0001667 | 2.26% | ameboidal-type cell migration |
| GO:0042593 | 2.26% | glucose homeostasis |
| GO:0016577 | 2.26% | histone demethylation |
| GO:0006654 | 2.26% | phosphatidic acid biosynthetic process |
| GO:0033500 | 2.26% | carbohydrate homeostasis |
| GO:0031623 | 2.26% | receptor internalization |
| GO:0042219 | 2.26% | cellular modified amino acid catabolic process |
| GO:0097502 | 2.26% | mannosylation |
| GO:0009437 | 2.26% | carnitine metabolic process |
| GO:0019319 | 2.26% | hexose biosynthetic process |
| GO:0031960 | 2.26% | response to corticosteroid |
| GO:0046185 | 2.26% | aldehyde catabolic process |
| GO:0001764 | 2.26% | neuron migration |
| GO:0070475 | 2.25% | rRNA base methylation |
| GO:0043489 | 2.25% | RNA stabilization |
| GO:0048017 | 2.25% | inositol lipid-mediated signaling |
| GO:0009185 | 2.25% | ribonucleoside diphosphate metabolic process |
| GO:0051962 | 2.25% | positive regulation of nervous system development |
| GO:0048872 | 2.25% | homeostasis of number of cells |
| GO:0051384 | 2.25% | response to glucocorticoid |
| GO:0006888 | 2.25% | endoplasmic reticulum to Golgi vesicle-mediated transport |
| GO:0006164 | 2.25% | purine nucleotide biosynthetic process |
| GO:0090087 | 2.25% | regulation of peptide transport |
| GO:0016202 | 2.25% | regulation of striated muscle tissue development |
| GO:0055085 | 2.24% | transmembrane transport |
| GO:0030239 | 2.24% | myofibril assembly |
| GO:0043277 | 2.24% | apoptotic cell clearance |
| GO:0019359 | 2.24% | nicotinamide nucleotide biosynthetic process |
| GO:0032496 | 2.24% | response to lipopolysaccharide |
| GO:0051270 | 2.24% | regulation of cellular component movement |
| GO:0071103 | 2.24% | DNA conformation change |
| GO:1902883 | 2.24% | negative regulation of response to oxidative stress |
| GO:0051302 | 2.24% | regulation of cell division |
| GO:0018065 | 2.23% | protein-cofactor linkage |
| GO:0006584 | 2.23% | catecholamine metabolic process |
| GO:0006820 | 2.23% | anion transport |
| GO:0009867 | 2.23% | jasmonic acid mediated signaling pathway |
| GO:1990748 | 2.23% | cellular detoxification |
| GO:0031505 | 2.23% | fungal-type cell wall organization |
| GO:0019757 | 2.23% | glycosinolate metabolic process |
| GO:0018279 | 2.23% | protein N-linked glycosylation via asparagine |
| GO:0061025 | 2.22% | membrane fusion |
| GO:0046513 | 2.22% | ceramide biosynthetic process |
| GO:0006446 | 2.22% | regulation of translational initiation |
| GO:0006560 | 2.22% | proline metabolic process |
| GO:0070507 | 2.22% | regulation of microtubule cytoskeleton organization |
| GO:0036503 | 2.22% | ERAD pathway |
| GO:0019363 | 2.22% | pyridine nucleotide biosynthetic process |
| GO:0006094 | 2.22% | gluconeogenesis |
| GO:0007129 | 2.22% | synapsis |
| GO:0071456 | 2.22% | cellular response to hypoxia |
| GO:0043935 | 2.21% | sexual sporulation resulting in formation of a cellular spore |
| GO:0071265 | 2.21% | L-methionine biosynthetic process |
| GO:0006772 | 2.21% | thiamine metabolic process |
| GO:0050821 | 2.21% | protein stabilization |
| GO:0051100 | 2.21% | negative regulation of binding |
| GO:0000154 | 2.21% | rRNA modification |
| GO:0034614 | 2.21% | cellular response to reactive oxygen species |
| GO:0055081 | 2.21% | anion homeostasis |
| GO:0045682 | 2.21% | regulation of epidermis development |
| GO:0016128 | 2.21% | phytosteroid metabolic process |
| GO:0010562 | 2.20% | positive regulation of phosphorus metabolic process |
| GO:0002181 | 2.20% | cytoplasmic translation |
| GO:0000725 | 2.20% | recombinational repair |
| GO:0030111 | 2.20% | regulation of Wnt signaling pathway |
| GO:0022413 | 2.20% | reproductive process in single-celled organism |
| GO:0060918 | 2.20% | auxin transport |
| GO:0016573 | 2.20% | histone acetylation |
| GO:0043649 | 2.20% | dicarboxylic acid catabolic process |
| GO:0036294 | 2.20% | cellular response to decreased oxygen levels |
| GO:0051607 | 2.20% | defense response to virus |
| GO:0032535 | 2.20% | regulation of cellular component size |
| GO:0046470 | 2.20% | phosphatidylcholine metabolic process |
| GO:0070726 | 2.20% | cell wall assembly |
| GO:0008203 | 2.20% | cholesterol metabolic process |
| GO:0002252 | 2.20% | immune effector process |
| GO:0000387 | 2.19% | spliceosomal snRNP assembly |
| GO:0051289 | 2.19% | protein homotetramerization |
| GO:0005979 | 2.18% | regulation of glycogen biosynthetic process |
| GO:0048366 | 2.18% | leaf development |
| GO:0140056 | 2.18% | organelle localization by membrane tethering |
| GO:0048641 | 2.18% | regulation of skeletal muscle tissue development |
| GO:0032269 | 2.18% | negative regulation of cellular protein metabolic process |
| GO:0045912 | 2.18% | negative regulation of carbohydrate metabolic process |
| GO:0033875 | 2.17% | ribonucleoside bisphosphate metabolic process |
| GO:0060395 | 2.17% | SMAD protein signal transduction |
| GO:0061013 | 2.17% | regulation of mRNA catabolic process |
| GO:0042723 | 2.17% | thiamine-containing compound metabolic process |
| GO:1901136 | 2.17% | carbohydrate derivative catabolic process |
| GO:0000956 | 2.17% | nuclear-transcribed mRNA catabolic process |
| GO:0031589 | 2.17% | cell-substrate adhesion |
| GO:0043086 | 2.17% | negative regulation of catalytic activity |
| GO:0051098 | 2.17% | regulation of binding |
| GO:0097327 | 2.17% | response to antineoplastic agent |
| GO:0016482 | 2.17% | cytosolic transport |
| GO:0090598 | 2.17% | male anatomical structure morphogenesis |
| GO:0010508 | 2.17% | positive regulation of autophagy |
| GO:0006646 | 2.17% | phosphatidylethanolamine biosynthetic process |
| GO:0032506 | 2.17% | cytokinetic process |
| GO:0010948 | 2.16% | negative regulation of cell cycle process |
| GO:0006836 | 2.16% | neurotransmitter transport |
| GO:0006333 | 2.16% | chromatin assembly or disassembly |
| GO:0043401 | 2.16% | steroid hormone mediated signaling pathway |
| GO:0062014 | 2.16% | negative regulation of small molecule metabolic process |
| GO:0009306 | 2.16% | protein secretion |
| GO:0034032 | 2.16% | purine nucleoside bisphosphate metabolic process |
| GO:0033865 | 2.16% | nucleoside bisphosphate metabolic process |
| GO:0070646 | 2.16% | protein modification by small protein removal |
| GO:0048568 | 2.16% | embryonic organ development |
| GO:0035148 | 2.15% | tube formation |
| GO:0031348 | 2.15% | negative regulation of defense response |
| GO:0045116 | 2.15% | protein neddylation |
| GO:0009435 | 2.15% | NAD biosynthetic process |
| GO:0015748 | 2.15% | organophosphate ester transport |
| GO:0060415 | 2.15% | muscle tissue morphogenesis |
| GO:0043200 | 2.14% | response to amino acid |
| GO:0061572 | 2.14% | actin filament bundle organization |
| GO:0002700 | 2.14% | regulation of production of molecular mediator of immune response |
| GO:0007006 | 2.14% | mitochondrial membrane organization |
| GO:0031124 | 2.14% | mRNA 3'-end processing |
| GO:0045937 | 2.14% | positive regulation of phosphate metabolic process |
| GO:0048364 | 2.14% | root development |
| GO:0006023 | 2.14% | aminoglycan biosynthetic process |
| GO:0031146 | 2.14% | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process |
| GO:0006873 | 2.14% | cellular ion homeostasis |
| GO:0050688 | 2.14% | regulation of defense response to virus |
| GO:0051345 | 2.14% | positive regulation of hydrolase activity |
| GO:0002833 | 2.13% | positive regulation of response to biotic stimulus |
| GO:0032868 | 2.13% | response to insulin |
| GO:1903530 | 2.13% | regulation of secretion by cell |
| GO:0008593 | 2.13% | regulation of Notch signaling pathway |
| GO:0030199 | 2.13% | collagen fibril organization |
| GO:0045834 | 2.13% | positive regulation of lipid metabolic process |
| GO:0014706 | 2.13% | striated muscle tissue development |
| GO:0042762 | 2.13% | regulation of sulfur metabolic process |
| GO:0060249 | 2.12% | anatomical structure homeostasis |
| GO:0001732 | 2.12% | formation of cytoplasmic translation initiation complex |
| GO:0055008 | 2.12% | cardiac muscle tissue morphogenesis |
| GO:0030705 | 2.12% | cytoskeleton-dependent intracellular transport |
| GO:0001763 | 2.12% | morphogenesis of a branching structure |
| GO:1903829 | 2.12% | positive regulation of cellular protein localization |
| GO:0071216 | 2.12% | cellular response to biotic stimulus |
| GO:0046889 | 2.12% | positive regulation of lipid biosynthetic process |
| GO:0031156 | 2.12% | regulation of sorocarp development |
| GO:0034063 | 2.12% | stress granule assembly |
| GO:0048634 | 2.12% | regulation of muscle organ development |
| GO:0060179 | 2.12% | male mating behavior |
| GO:0009071 | 2.11% | serine family amino acid catabolic process |
| GO:0097120 | 2.11% | receptor localization to synapse |
| GO:0070584 | 2.11% | mitochondrion morphogenesis |
| GO:0040028 | 2.11% | regulation of vulval development |
| GO:0035268 | 2.11% | protein mannosylation |
| GO:1905037 | 2.11% | autophagosome organization |
| GO:0030003 | 2.11% | cellular cation homeostasis |
| GO:0045661 | 2.11% | regulation of myoblast differentiation |
| GO:0070988 | 2.10% | demethylation |
| GO:1905952 | 2.10% | regulation of lipid localization |
| GO:0006383 | 2.10% | transcription by RNA polymerase III |
| GO:0043102 | 2.10% | amino acid salvage |
| GO:0007272 | 2.10% | ensheathment of neurons |
| GO:0032963 | 2.10% | collagen metabolic process |
| GO:0035295 | 2.10% | tube development |
| GO:0050795 | 2.10% | regulation of behavior |
| GO:0045785 | 2.10% | positive regulation of cell adhesion |
| GO:0040018 | 2.10% | positive regulation of multicellular organism growth |
| GO:0051347 | 2.10% | positive regulation of transferase activity |
| GO:0006334 | 2.09% | nucleosome assembly |
| GO:0007088 | 2.09% | regulation of mitotic nuclear division |
| GO:1900408 | 2.09% | negative regulation of cellular response to oxidative stress |
| GO:0009845 | 2.09% | seed germination |
| GO:0031401 | 2.09% | positive regulation of protein modification process |
| GO:0006995 | 2.09% | cellular response to nitrogen starvation |
| GO:0060359 | 2.09% | response to ammonium ion |
| GO:0040034 | 2.09% | regulation of development, heterochronic |
| GO:0043393 | 2.08% | regulation of protein binding |
| GO:0034587 | 2.08% | piRNA metabolic process |
| GO:0045944 | 2.08% | positive regulation of transcription by RNA polymerase II |
| GO:0006839 | 2.08% | mitochondrial transport |
| GO:0043903 | 2.08% | regulation of symbiosis, encompassing mutualism through parasitism |
| GO:0003341 | 2.08% | cilium movement |
| GO:0032102 | 2.08% | negative regulation of response to external stimulus |
| GO:0043248 | 2.08% | proteasome assembly |
| GO:0043001 | 2.08% | Golgi to plasma membrane protein transport |
| GO:0034285 | 2.07% | response to disaccharide |
| GO:0097064 | 2.07% | ncRNA export from nucleus |
| GO:0031670 | 2.07% | cellular response to nutrient |
| GO:0009135 | 2.07% | purine nucleoside diphosphate metabolic process |
| GO:0034311 | 2.07% | diol metabolic process |
| GO:0002250 | 2.07% | adaptive immune response |
| GO:0035264 | 2.07% | multicellular organism growth |
| GO:0010962 | 2.07% | regulation of glucan biosynthetic process |
| GO:0062125 | 2.07% | regulation of mitochondrial gene expression |
| GO:0009251 | 2.07% | glucan catabolic process |
| GO:0035914 | 2.07% | skeletal muscle cell differentiation |
| GO:0006301 | 2.07% | postreplication repair |
| GO:0007601 | 2.07% | visual perception |
| GO:0030865 | 2.07% | cortical cytoskeleton organization |
| GO:0007606 | 2.06% | sensory perception of chemical stimulus |
| GO:0009407 | 2.06% | toxin catabolic process |
| GO:0036230 | 2.06% | granulocyte activation |
| GO:0042178 | 2.06% | xenobiotic catabolic process |
| GO:0015711 | 2.06% | organic anion transport |
| GO:0010907 | 2.06% | positive regulation of glucose metabolic process |
| GO:1901990 | 2.06% | regulation of mitotic cell cycle phase transition |
| GO:0006206 | 2.06% | pyrimidine nucleobase metabolic process |
| GO:0002064 | 2.05% | epithelial cell development |
| GO:1901800 | 2.05% | positive regulation of proteasomal protein catabolic process |
| GO:1901419 | 2.05% | regulation of response to alcohol |
| GO:0043488 | 2.05% | regulation of mRNA stability |
| GO:0022616 | 2.05% | DNA strand elongation |
| GO:0050804 | 2.05% | modulation of chemical synaptic transmission |
| GO:0006308 | 2.05% | DNA catabolic process |
| GO:0006812 | 2.05% | cation transport |
| GO:0035269 | 2.05% | protein O-linked mannosylation |
| GO:0007416 | 2.05% | synapse assembly |
| GO:0042447 | 2.04% | hormone catabolic process |
| GO:0045930 | 2.04% | negative regulation of mitotic cell cycle |
| GO:0000160 | 2.04% | phosphorelay signal transduction system |
| GO:0043113 | 2.04% | receptor clustering |
| GO:0030307 | 2.04% | positive regulation of cell growth |
| GO:0051656 | 2.04% | establishment of organelle localization |
| GO:0042327 | 2.04% | positive regulation of phosphorylation |
| GO:0048311 | 2.04% | mitochondrion distribution |
| GO:0010639 | 2.04% | negative regulation of organelle organization |
| GO:0006782 | 2.04% | protoporphyrinogen IX biosynthetic process |
| GO:0000712 | 2.04% | resolution of meiotic recombination intermediates |
| GO:0032526 | 2.03% | response to retinoic acid |
| GO:0031349 | 2.03% | positive regulation of defense response |
| GO:0070828 | 2.03% | heterochromatin organization |
| GO:0006165 | 2.03% | nucleoside diphosphate phosphorylation |
| GO:0070589 | 2.03% | cellular component macromolecule biosynthetic process |
| GO:0030100 | 2.03% | regulation of endocytosis |
| GO:0048255 | 2.03% | mRNA stabilization |
| GO:0071478 | 2.03% | cellular response to radiation |
| GO:0043631 | 2.03% | RNA polyadenylation |
| GO:0016075 | 2.03% | rRNA catabolic process |
| GO:0017004 | 2.03% | cytochrome complex assembly |
| GO:0022404 | 2.02% | molting cycle process |
| GO:0034502 | 2.02% | protein localization to chromosome |
| GO:0006270 | 2.02% | DNA replication initiation |
| GO:0002253 | 2.02% | activation of immune response |
| GO:0000045 | 2.02% | autophagosome assembly |
| GO:0030072 | 2.02% | peptide hormone secretion |
| GO:0031334 | 2.02% | positive regulation of protein complex assembly |
| GO:0009260 | 2.02% | ribonucleotide biosynthetic process |
| GO:0006801 | 2.02% | superoxide metabolic process |
| GO:0042147 | 2.02% | retrograde transport, endosome to Golgi |
| GO:0009313 | 2.02% | oligosaccharide catabolic process |
| GO:0050832 | 2.02% | defense response to fungus |
| GO:1900407 | 2.02% | regulation of cellular response to oxidative stress |
| GO:0006691 | 2.02% | leukotriene metabolic process |
| GO:0061351 | 2.01% | neural precursor cell proliferation |
| GO:0010970 | 2.01% | transport along microtubule |
| GO:1902373 | 2.01% | negative regulation of mRNA catabolic process |
| GO:1901987 | 2.01% | regulation of cell cycle phase transition |
| GO:0006298 | 2.01% | mismatch repair |
| GO:0001573 | 2.01% | ganglioside metabolic process |
| GO:0033157 | 2.01% | regulation of intracellular protein transport |
| GO:0006875 | 2.01% | cellular metal ion homeostasis |
| GO:0042048 | 2.01% | olfactory behavior |
| GO:1902533 | 2.01% | positive regulation of intracellular signal transduction |
| GO:0071267 | 2.01% | L-methionine salvage |
| GO:0007062 | 2.01% | sister chromatid cohesion |
| GO:0009744 | 2.01% | response to sucrose |
| GO:0120161 | 2.00% | regulation of cold-induced thermogenesis |
| GO:0000731 | 2.00% | DNA synthesis involved in DNA repair |
| GO:0030099 | 2.00% | myeloid cell differentiation |
| GO:0043279 | 2.00% | response to alkaloid |
| GO:0045185 | 2.00% | maintenance of protein location |
| GO:0008366 | 2.00% | axon ensheathment |
| GO:0050953 | 2.00% | sensory perception of light stimulus |
| GO:0099177 | 2.00% | regulation of trans-synaptic signaling |
| GO:0006757 | 2.00% | ATP generation from ADP |
| GO:2000378 | 2.00% | negative regulation of reactive oxygen species metabolic process |
| GO:1901342 | 2.00% | regulation of vasculature development |
| GO:0010165 | 1.99% | response to X-ray |
| GO:1900424 | 1.99% | regulation of defense response to bacterium |
| GO:0090529 | 1.99% | cell septum assembly |
| GO:0034698 | 1.99% | response to gonadotropin |
| GO:0042417 | 1.99% | dopamine metabolic process |
| GO:0001649 | 1.99% | osteoblast differentiation |
| GO:0090257 | 1.99% | regulation of muscle system process |
| GO:0000726 | 1.99% | non-recombinational repair |
| GO:0030334 | 1.99% | regulation of cell migration |
| GO:0035966 | 1.99% | response to topologically incorrect protein |
| GO:0044038 | 1.99% | cell wall macromolecule biosynthetic process |
| GO:0006582 | 1.99% | melanin metabolic process |
| GO:0006303 | 1.99% | double-strand break repair via nonhomologous end joining |
| GO:0010677 | 1.98% | negative regulation of cellular carbohydrate metabolic process |
| GO:0042246 | 1.98% | tissue regeneration |
| GO:0000105 | 1.98% | histidine biosynthetic process |
| GO:0055010 | 1.98% | ventricular cardiac muscle tissue morphogenesis |
| GO:0070050 | 1.98% | neuron cellular homeostasis |
| GO:0048278 | 1.98% | vesicle docking |
| GO:0052548 | 1.98% | regulation of endopeptidase activity |
| GO:0019953 | 1.97% | sexual reproduction |
| GO:0006688 | 1.97% | glycosphingolipid biosynthetic process |
| GO:0072666 | 1.97% | establishment of protein localization to vacuole |
| GO:0019218 | 1.97% | regulation of steroid metabolic process |
| GO:1902532 | 1.97% | negative regulation of intracellular signal transduction |
| GO:0032103 | 1.97% | positive regulation of response to external stimulus |
| GO:0016579 | 1.97% | protein deubiquitination |
| GO:0006997 | 1.97% | nucleus organization |
| GO:0000422 | 1.96% | autophagy of mitochondrion |
| GO:0006221 | 1.96% | pyrimidine nucleotide biosynthetic process |
| GO:0016236 | 1.96% | macroautophagy |
| GO:0051273 | 1.96% | beta-glucan metabolic process |
| GO:0061726 | 1.96% | mitochondrion disassembly |
| GO:0032436 | 1.96% | positive regulation of proteasomal ubiquitin-dependent protein catabolic process |
| GO:1901699 | 1.96% | cellular response to nitrogen compound |
| GO:0006662 | 1.96% | glycerol ether metabolic process |
| GO:0034312 | 1.96% | diol biosynthetic process |
| GO:0070897 | 1.96% | transcription preinitiation complex assembly |
| GO:0006904 | 1.96% | vesicle docking involved in exocytosis |
| GO:0031330 | 1.96% | negative regulation of cellular catabolic process |
| GO:0050878 | 1.96% | regulation of body fluid levels |
| GO:0048284 | 1.95% | organelle fusion |
| GO:0021766 | 1.95% | hippocampus development |
| GO:0009156 | 1.95% | ribonucleoside monophosphate biosynthetic process |
| GO:0003007 | 1.95% | heart morphogenesis |
| GO:0030433 | 1.95% | ubiquitin-dependent ERAD pathway |
| GO:0034293 | 1.95% | sexual sporulation |
| GO:1901215 | 1.95% | negative regulation of neuron death |
| GO:0046031 | 1.95% | ADP metabolic process |
| GO:0051591 | 1.95% | response to cAMP |
| GO:0050708 | 1.95% | regulation of protein secretion |
| GO:0001822 | 1.95% | kidney development |
| GO:0006637 | 1.95% | acyl-CoA metabolic process |
| GO:0044247 | 1.95% | cellular polysaccharide catabolic process |
| GO:0044786 | 1.95% | cell cycle DNA replication |
| GO:0009787 | 1.95% | regulation of abscisic acid-activated signaling pathway |
| GO:0009648 | 1.94% | photoperiodism |
| GO:0007140 | 1.94% | male meiotic nuclear division |
| GO:0009179 | 1.94% | purine ribonucleoside diphosphate metabolic process |
| GO:0008585 | 1.94% | female gonad development |
| GO:1903202 | 1.94% | negative regulation of oxidative stress-induced cell death |
| GO:0000266 | 1.94% | mitochondrial fission |
| GO:0052547 | 1.94% | regulation of peptidase activity |
| GO:0051701 | 1.94% | interaction with host |
| GO:0071482 | 1.94% | cellular response to light stimulus |
| GO:0051445 | 1.94% | regulation of meiotic cell cycle |
| GO:0098781 | 1.94% | ncRNA transcription |
| GO:0006378 | 1.93% | mRNA polyadenylation |
| GO:0045197 | 1.93% | establishment or maintenance of epithelial cell apical/basal polarity |
| GO:0006096 | 1.93% | glycolytic process |
| GO:0060968 | 1.93% | regulation of gene silencing |
| GO:0033280 | 1.93% | response to vitamin D |
| GO:0046879 | 1.93% | hormone secretion |
| GO:0072655 | 1.93% | establishment of protein localization to mitochondrion |
| GO:0048813 | 1.93% | dendrite morphogenesis |
| GO:0061951 | 1.93% | establishment of protein localization to plasma membrane |
| GO:0110154 | 1.93% | RNA decapping |
| GO:0046519 | 1.93% | sphingoid metabolic process |
| GO:0035383 | 1.93% | thioester metabolic process |
| GO:0045089 | 1.93% | positive regulation of innate immune response |
| GO:0034308 | 1.93% | primary alcohol metabolic process |
| GO:0051881 | 1.93% | regulation of mitochondrial membrane potential |
| GO:0050769 | 1.93% | positive regulation of neurogenesis |
| GO:0010824 | 1.93% | regulation of centrosome duplication |
| GO:0009734 | 1.93% | auxin-activated signaling pathway |
| GO:0009626 | 1.93% | plant-type hypersensitive response |
| GO:0006323 | 1.93% | DNA packaging |
| GO:0000724 | 1.92% | double-strand break repair via homologous recombination |
| GO:0051646 | 1.92% | mitochondrion localization |
| GO:0030308 | 1.92% | negative regulation of cell growth |
| GO:0016358 | 1.92% | dendrite development |
| GO:1901160 | 1.92% | primary amino compound metabolic process |
| GO:0045070 | 1.92% | positive regulation of viral genome replication |
| GO:0042391 | 1.92% | regulation of membrane potential |
| GO:0006623 | 1.92% | protein targeting to vacuole |
| GO:0033674 | 1.92% | positive regulation of kinase activity |
| GO:1900140 | 1.92% | regulation of seedling development |
| GO:0007565 | 1.92% | female pregnancy |
| GO:0097421 | 1.92% | liver regeneration |
| GO:0045879 | 1.92% | negative regulation of smoothened signaling pathway |
| GO:0010029 | 1.91% | regulation of seed germination |
| GO:0046683 | 1.91% | response to organophosphorus |
| GO:0006140 | 1.91% | regulation of nucleotide metabolic process |
| GO:1903052 | 1.91% | positive regulation of proteolysis involved in cellular protein catabolic process |
| GO:0061062 | 1.91% | regulation of nematode larval development |
| GO:0033273 | 1.91% | response to vitamin |
| GO:0006144 | 1.90% | purine nucleobase metabolic process |
| GO:0006638 | 1.90% | neutral lipid metabolic process |
| GO:0045187 | 1.90% | regulation of circadian sleep/wake cycle, sleep |
| GO:0070585 | 1.90% | protein localization to mitochondrion |
| GO:0000413 | 1.90% | protein peptidyl-prolyl isomerization |
| GO:0000462 | 1.90% | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) |
| GO:1903902 | 1.90% | positive regulation of viral life cycle |
| GO:0043087 | 1.90% | regulation of GTPase activity |
| GO:0018108 | 1.90% | peptidyl-tyrosine phosphorylation |
| GO:0031122 | 1.90% | cytoplasmic microtubule organization |
| GO:1905954 | 1.90% | positive regulation of lipid localization |
| GO:1904951 | 1.90% | positive regulation of establishment of protein localization |
| GO:0120162 | 1.90% | positive regulation of cold-induced thermogenesis |
| GO:1901031 | 1.90% | regulation of response to reactive oxygen species |
| GO:0006271 | 1.90% | DNA strand elongation involved in DNA replication |
| GO:0043901 | 1.90% | negative regulation of multi-organism process |
| GO:2000024 | 1.90% | regulation of leaf development |
| GO:0046839 | 1.90% | phospholipid dephosphorylation |
| GO:0035088 | 1.90% | establishment or maintenance of apical/basal cell polarity |
| GO:0098813 | 1.90% | nuclear chromosome segregation |
| GO:0000966 | 1.90% | RNA 5'-end processing |
| GO:0007160 | 1.89% | cell-matrix adhesion |
| GO:0099643 | 1.89% | signal release from synapse |
| GO:0001819 | 1.89% | positive regulation of cytokine production |
| GO:0009124 | 1.89% | nucleoside monophosphate biosynthetic process |
| GO:0046466 | 1.89% | membrane lipid catabolic process |
| GO:0045684 | 1.89% | positive regulation of epidermis development |
| GO:0007040 | 1.89% | lysosome organization |
| GO:0046626 | 1.89% | regulation of insulin receptor signaling pathway |
| GO:0000917 | 1.88% | division septum assembly |
| GO:0033045 | 1.88% | regulation of sister chromatid segregation |
| GO:0010883 | 1.88% | regulation of lipid storage |
| GO:0046348 | 1.88% | amino sugar catabolic process |
| GO:0010830 | 1.88% | regulation of myotube differentiation |
| GO:0003013 | 1.88% | circulatory system process |
| GO:1903201 | 1.88% | regulation of oxidative stress-induced cell death |
| GO:0045604 | 1.88% | regulation of epidermal cell differentiation |
| GO:0006656 | 1.87% | phosphatidylcholine biosynthetic process |
| GO:0010228 | 1.87% | vegetative to reproductive phase transition of meristem |
| GO:0006937 | 1.87% | regulation of muscle contraction |
| GO:0007409 | 1.87% | axonogenesis |
| GO:0098727 | 1.87% | maintenance of cell number |
| GO:0048666 | 1.87% | neuron development |
| GO:0044770 | 1.87% | cell cycle phase transition |
| GO:0045055 | 1.87% | regulated exocytosis |
| GO:0031400 | 1.87% | negative regulation of protein modification process |
| GO:0051963 | 1.87% | regulation of synapse assembly |
| GO:0033363 | 1.87% | secretory granule organization |
| GO:0006563 | 1.86% | L-serine metabolic process |
| GO:0045444 | 1.86% | fat cell differentiation |
| GO:0010822 | 1.86% | positive regulation of mitochondrion organization |
| GO:0009751 | 1.86% | response to salicylic acid |
| GO:0010042 | 1.86% | response to manganese ion |
| GO:0046184 | 1.86% | aldehyde biosynthetic process |
| GO:0031060 | 1.86% | regulation of histone methylation |
| GO:0097190 | 1.86% | apoptotic signaling pathway |
| GO:1904396 | 1.86% | regulation of neuromuscular junction development |
| GO:0110156 | 1.86% | methylguanosine-cap decapping |
| GO:0048581 | 1.86% | negative regulation of post-embryonic development |
| GO:0007130 | 1.86% | synaptonemal complex assembly |
| GO:0042255 | 1.86% | ribosome assembly |
| GO:0051651 | 1.86% | maintenance of location in cell |
| GO:0008361 | 1.86% | regulation of cell size |
| GO:0019400 | 1.86% | alditol metabolic process |
| GO:0008582 | 1.86% | regulation of synaptic growth at neuromuscular junction |
| GO:0046688 | 1.86% | response to copper ion |
| GO:0008584 | 1.86% | male gonad development |
| GO:0016055 | 1.85% | Wnt signaling pathway |
| GO:0006220 | 1.85% | pyrimidine nucleotide metabolic process |
| GO:0031056 | 1.85% | regulation of histone modification |
| GO:0009713 | 1.85% | catechol-containing compound biosynthetic process |
| GO:0010212 | 1.85% | response to ionizing radiation |
| GO:0006639 | 1.85% | acylglycerol metabolic process |
| GO:0000245 | 1.85% | spliceosomal complex assembly |
| GO:0070076 | 1.85% | histone lysine demethylation |
| GO:0019221 | 1.85% | cytokine-mediated signaling pathway |
| GO:0042542 | 1.85% | response to hydrogen peroxide |
| GO:0048871 | 1.85% | multicellular organismal homeostasis |
| GO:0019932 | 1.85% | second-messenger-mediated signaling |
| GO:0022407 | 1.85% | regulation of cell-cell adhesion |
| GO:1905957 | 1.85% | regulation of cellular response to alcohol |
| GO:0032507 | 1.85% | maintenance of protein location in cell |
| GO:0045814 | 1.85% | negative regulation of gene expression, epigenetic |
| GO:0045765 | 1.84% | regulation of angiogenesis |
| GO:0019915 | 1.84% | lipid storage |
| GO:0006354 | 1.84% | DNA-templated transcription, elongation |
| GO:0072523 | 1.84% | purine-containing compound catabolic process |
| GO:0031929 | 1.84% | TOR signaling |
| GO:0032091 | 1.84% | negative regulation of protein binding |
| GO:0008589 | 1.84% | regulation of smoothened signaling pathway |
| GO:0042157 | 1.84% | lipoprotein metabolic process |
| GO:0045859 | 1.84% | regulation of protein kinase activity |
| GO:0003351 | 1.84% | epithelial cilium movement involved in extracellular fluid movement |
| GO:0099118 | 1.84% | microtubule-based protein transport |
| GO:0046337 | 1.84% | phosphatidylethanolamine metabolic process |
| GO:0071407 | 1.84% | cellular response to organic cyclic compound |
| GO:0007519 | 1.84% | skeletal muscle tissue development |
| GO:0048015 | 1.84% | phosphatidylinositol-mediated signaling |
| GO:0045005 | 1.84% | DNA-dependent DNA replication maintenance of fidelity |
| GO:0031507 | 1.83% | heterochromatin assembly |
| GO:0007297 | 1.83% | ovarian follicle cell migration |
| GO:0042749 | 1.83% | regulation of circadian sleep/wake cycle |
| GO:0007141 | 1.83% | male meiosis I |
| GO:0021885 | 1.83% | forebrain cell migration |
| GO:0032434 | 1.83% | regulation of proteasomal ubiquitin-dependent protein catabolic process |
| GO:0002702 | 1.83% | positive regulation of production of molecular mediator of immune response |
| GO:2000060 | 1.83% | positive regulation of ubiquitin-dependent protein catabolic process |
| GO:0046113 | 1.83% | nucleobase catabolic process |
| GO:0099003 | 1.83% | vesicle-mediated transport in synapse |
| GO:0051225 | 1.83% | spindle assembly |
| GO:0019184 | 1.82% | nonribosomal peptide biosynthetic process |
| GO:0042552 | 1.82% | myelination |
| GO:0046605 | 1.82% | regulation of centrosome cycle |
| GO:0009163 | 1.82% | nucleoside biosynthetic process |
| GO:0050905 | 1.82% | neuromuscular process |
| GO:1905114 | 1.82% | cell surface receptor signaling pathway involved in cell-cell signaling |
| GO:0051149 | 1.82% | positive regulation of muscle cell differentiation |
| GO:0006342 | 1.82% | chromatin silencing |
| GO:0051354 | 1.82% | negative regulation of oxidoreductase activity |
| GO:0010529 | 1.82% | negative regulation of transposition |
| GO:0051274 | 1.82% | beta-glucan biosynthetic process |
| GO:0009612 | 1.82% | response to mechanical stimulus |
| GO:1903146 | 1.82% | regulation of autophagy of mitochondrion |
| GO:1990928 | 1.82% | response to amino acid starvation |
| GO:0009142 | 1.81% | nucleoside triphosphate biosynthetic process |
| GO:0046834 | 1.81% | lipid phosphorylation |
| GO:0009119 | 1.81% | ribonucleoside metabolic process |
| GO:0030490 | 1.81% | maturation of SSU-rRNA |
| GO:0009161 | 1.81% | ribonucleoside monophosphate metabolic process |
| GO:0002699 | 1.81% | positive regulation of immune effector process |
| GO:0042182 | 1.81% | ketone catabolic process |
| GO:0098693 | 1.81% | regulation of synaptic vesicle cycle |
| GO:0006123 | 1.81% | mitochondrial electron transport, cytochrome c to oxygen |
| GO:0006695 | 1.81% | cholesterol biosynthetic process |
| GO:0002791 | 1.81% | regulation of peptide secretion |
| GO:0035112 | 1.81% | genitalia morphogenesis |
| GO:0002040 | 1.81% | sprouting angiogenesis |
| GO:0009581 | 1.80% | detection of external stimulus |
| GO:0032956 | 1.80% | regulation of actin cytoskeleton organization |
| GO:0000002 | 1.80% | mitochondrial genome maintenance |
| GO:0010476 | 1.80% | gibberellin mediated signaling pathway |
| GO:0031509 | 1.80% | telomeric heterochromatin assembly |
| GO:0016556 | 1.80% | mRNA modification |
| GO:0055002 | 1.80% | striated muscle cell development |
| GO:0043455 | 1.80% | regulation of secondary metabolic process |
| GO:0045454 | 1.80% | cell redox homeostasis |
| GO:0070129 | 1.79% | regulation of mitochondrial translation |
| GO:0006687 | 1.79% | glycosphingolipid metabolic process |
| GO:0006879 | 1.79% | cellular iron ion homeostasis |
| GO:0007605 | 1.79% | sensory perception of sound |
| GO:0042073 | 1.79% | intraciliary transport |
| GO:0006275 | 1.79% | regulation of DNA replication |
| GO:0050792 | 1.79% | regulation of viral process |
| GO:0019985 | 1.79% | translesion synthesis |
| GO:0051047 | 1.79% | positive regulation of secretion |
| GO:1903364 | 1.78% | positive regulation of cellular protein catabolic process |
| GO:0018210 | 1.78% | peptidyl-threonine modification |
| GO:0045931 | 1.78% | positive regulation of mitotic cell cycle |
| GO:0050777 | 1.78% | negative regulation of immune response |
| GO:0048524 | 1.78% | positive regulation of viral process |
| GO:0006858 | 1.78% | extracellular transport |
| GO:0051495 | 1.78% | positive regulation of cytoskeleton organization |
| GO:0007635 | 1.78% | chemosensory behavior |
| GO:0061136 | 1.78% | regulation of proteasomal protein catabolic process |
| GO:0043123 | 1.78% | positive regulation of I-kappaB kinase/NF-kappaB signaling |
| GO:1903539 | 1.78% | protein localization to postsynaptic membrane |
| GO:1902903 | 1.78% | regulation of supramolecular fiber organization |
| GO:0009123 | 1.78% | nucleoside monophosphate metabolic process |
| GO:0048514 | 1.78% | blood vessel morphogenesis |
| GO:0046822 | 1.78% | regulation of nucleocytoplasmic transport |
| GO:0050810 | 1.77% | regulation of steroid biosynthetic process |
| GO:0006284 | 1.77% | base-excision repair |
| GO:0048512 | 1.77% | circadian behavior |
| GO:0007586 | 1.77% | digestion |
| GO:0000291 | 1.77% | nuclear-transcribed mRNA catabolic process, exonucleolytic |
| GO:0007288 | 1.77% | sperm axoneme assembly |
| GO:0018198 | 1.77% | peptidyl-cysteine modification |
| GO:0022405 | 1.77% | hair cycle process |
| GO:1902117 | 1.77% | positive regulation of organelle assembly |
| GO:0051782 | 1.77% | negative regulation of cell division |
| GO:1900542 | 1.76% | regulation of purine nucleotide metabolic process |
| GO:0009873 | 1.76% | ethylene-activated signaling pathway |
| GO:0032970 | 1.76% | regulation of actin filament-based process |
| GO:0046916 | 1.76% | cellular transition metal ion homeostasis |
| GO:0009644 | 1.76% | response to high light intensity |
| GO:0046856 | 1.76% | phosphatidylinositol dephosphorylation |
| GO:0001541 | 1.76% | ovarian follicle development |
| GO:0048705 | 1.76% | skeletal system morphogenesis |
| GO:1900076 | 1.75% | regulation of cellular response to insulin stimulus |
| GO:1901216 | 1.75% | positive regulation of neuron death |
| GO:0042278 | 1.75% | purine nucleoside metabolic process |
| GO:0033047 | 1.75% | regulation of mitotic sister chromatid segregation |
| GO:0010087 | 1.75% | phloem or xylem histogenesis |
| GO:0030203 | 1.75% | glycosaminoglycan metabolic process |
| GO:0071417 | 1.75% | cellular response to organonitrogen compound |
| GO:1901292 | 1.75% | nucleoside phosphate catabolic process |
| GO:0007031 | 1.75% | peroxisome organization |
| GO:0034401 | 1.74% | chromatin organization involved in regulation of transcription |
| GO:0002886 | 1.74% | regulation of myeloid leukocyte mediated immunity |
| GO:0006612 | 1.74% | protein targeting to membrane |
| GO:0043122 | 1.74% | regulation of I-kappaB kinase/NF-kappaB signaling |
| GO:0080171 | 1.74% | lytic vacuole organization |
| GO:0003208 | 1.74% | cardiac ventricle morphogenesis |
| GO:0007178 | 1.74% | transmembrane receptor protein serine/threonine kinase signaling pathway |
| GO:0045214 | 1.74% | sarcomere organization |
| GO:1902749 | 1.74% | regulation of cell cycle G2/M phase transition |
| GO:0061515 | 1.74% | myeloid cell development |
| GO:0032479 | 1.74% | regulation of type I interferon production |
| GO:0046456 | 1.74% | icosanoid biosynthetic process |
| GO:0032392 | 1.74% | DNA geometric change |
| GO:0010721 | 1.74% | negative regulation of cell development |
| GO:1902170 | 1.74% | cellular response to reactive nitrogen species |
| GO:0044772 | 1.74% | mitotic cell cycle phase transition |
| GO:0000075 | 1.74% | cell cycle checkpoint |
| GO:0034471 | 1.74% | ncRNA 5'-end processing |
| GO:0019827 | 1.74% | stem cell population maintenance |
| GO:1903533 | 1.73% | regulation of protein targeting |
| GO:0008637 | 1.73% | apoptotic mitochondrial changes |
| GO:0034198 | 1.73% | cellular response to amino acid starvation |
| GO:0014074 | 1.73% | response to purine-containing compound |
| GO:0000184 | 1.73% | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay |
| GO:0097549 | 1.73% | chromatin organization involved in negative regulation of transcription |
| GO:0097366 | 1.73% | response to bronchodilator |
| GO:0031497 | 1.73% | chromatin assembly |
| GO:0009303 | 1.73% | rRNA transcription |
| GO:0031333 | 1.73% | negative regulation of protein complex assembly |
| GO:0098840 | 1.73% | protein transport along microtubule |
| GO:0010119 | 1.73% | regulation of stomatal movement |
| GO:0010528 | 1.73% | regulation of transposition |
| GO:0010842 | 1.73% | retina layer formation |
| GO:0016441 | 1.73% | posttranscriptional gene silencing |
| GO:0007032 | 1.73% | endosome organization |
| GO:0071806 | 1.73% | protein transmembrane transport |
| GO:1903205 | 1.72% | regulation of hydrogen peroxide-induced cell death |
| GO:0034050 | 1.72% | host programmed cell death induced by symbiont |
| GO:0030001 | 1.72% | metal ion transport |
| GO:0033962 | 1.72% | cytoplasmic mRNA processing body assembly |
| GO:0042060 | 1.72% | wound healing |
| GO:0035456 | 1.72% | response to interferon-beta |
| GO:0007507 | 1.72% | heart development |
| GO:0032508 | 1.72% | DNA duplex unwinding |
| GO:0009220 | 1.72% | pyrimidine ribonucleotide biosynthetic process |
| GO:0070193 | 1.71% | synaptonemal complex organization |
| GO:0060828 | 1.71% | regulation of canonical Wnt signaling pathway |
| GO:0017038 | 1.71% | protein import |
| GO:0010389 | 1.71% | regulation of G2/M transition of mitotic cell cycle |
| GO:0009218 | 1.71% | pyrimidine ribonucleotide metabolic process |
| GO:0009798 | 1.71% | axis specification |
| GO:0007498 | 1.71% | mesoderm development |
| GO:0007224 | 1.71% | smoothened signaling pathway |
| GO:0002759 | 1.71% | regulation of antimicrobial humoral response |
| GO:0034762 | 1.71% | regulation of transmembrane transport |
| GO:0008209 | 1.71% | androgen metabolic process |
| GO:0044088 | 1.71% | regulation of vacuole organization |
| GO:0050764 | 1.71% | regulation of phagocytosis |
| GO:0042455 | 1.71% | ribonucleoside biosynthetic process |
| GO:0050994 | 1.71% | regulation of lipid catabolic process |
| GO:0071470 | 1.71% | cellular response to osmotic stress |
| GO:1900426 | 1.71% | positive regulation of defense response to bacterium |
| GO:0006119 | 1.70% | oxidative phosphorylation |
| GO:0046164 | 1.70% | alcohol catabolic process |
| GO:0050727 | 1.70% | regulation of inflammatory response |
| GO:0042545 | 1.70% | cell wall modification |
| GO:0009166 | 1.70% | nucleotide catabolic process |
| GO:0090101 | 1.70% | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
| GO:0007269 | 1.70% | neurotransmitter secretion |
| GO:0009583 | 1.70% | detection of light stimulus |
| GO:0098586 | 1.70% | cellular response to virus |
| GO:0006986 | 1.70% | response to unfolded protein |
| GO:0007156 | 1.70% | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO:0031032 | 1.70% | actomyosin structure organization |
| GO:0009152 | 1.70% | purine ribonucleotide biosynthetic process |
| GO:0043244 | 1.70% | regulation of protein complex disassembly |
| GO:0003014 | 1.70% | renal system process |
| GO:0097193 | 1.70% | intrinsic apoptotic signaling pathway |
| GO:0006959 | 1.70% | humoral immune response |
| GO:0030216 | 1.69% | keratinocyte differentiation |
| GO:0010810 | 1.69% | regulation of cell-substrate adhesion |
| GO:0046174 | 1.69% | polyol catabolic process |
| GO:0009593 | 1.69% | detection of chemical stimulus |
| GO:0031214 | 1.69% | biomineral tissue development |
| GO:0051052 | 1.69% | regulation of DNA metabolic process |
| GO:0051222 | 1.69% | positive regulation of protein transport |
| GO:0099072 | 1.69% | regulation of postsynaptic membrane neurotransmitter receptor levels |
| GO:1903510 | 1.69% | mucopolysaccharide metabolic process |
| GO:0051155 | 1.69% | positive regulation of striated muscle cell differentiation |
| GO:0090068 | 1.69% | positive regulation of cell cycle process |
| GO:0010383 | 1.68% | cell wall polysaccharide metabolic process |
| GO:0043269 | 1.68% | regulation of ion transport |
| GO:0002920 | 1.68% | regulation of humoral immune response |
| GO:1902905 | 1.68% | positive regulation of supramolecular fiber organization |
| GO:0006898 | 1.68% | receptor-mediated endocytosis |
| GO:0045069 | 1.68% | regulation of viral genome replication |
| GO:0043392 | 1.68% | negative regulation of DNA binding |
| GO:0009395 | 1.68% | phospholipid catabolic process |
| GO:0043473 | 1.68% | pigmentation |
| GO:0008217 | 1.67% | regulation of blood pressure |
| GO:1990542 | 1.67% | mitochondrial transmembrane transport |
| GO:0016242 | 1.67% | negative regulation of macroautophagy |
| GO:0035330 | 1.67% | regulation of hippo signaling |
| GO:0001934 | 1.67% | positive regulation of protein phosphorylation |
| GO:0007029 | 1.67% | endoplasmic reticulum organization |
| GO:2000785 | 1.67% | regulation of autophagosome assembly |
| GO:0006670 | 1.67% | sphingosine metabolic process |
| GO:0019236 | 1.67% | response to pheromone |
| GO:0000338 | 1.67% | protein deneddylation |
| GO:0009582 | 1.67% | detection of abiotic stimulus |
| GO:0032388 | 1.66% | positive regulation of intracellular transport |
| GO:0046503 | 1.66% | glycerolipid catabolic process |
| GO:0070555 | 1.66% | response to interleukin-1 |
| GO:0006356 | 1.66% | regulation of transcription by RNA polymerase I |
| GO:0051056 | 1.66% | regulation of small GTPase mediated signal transduction |
| GO:0046530 | 1.66% | photoreceptor cell differentiation |
| GO:2001025 | 1.66% | positive regulation of response to drug |
| GO:0032784 | 1.66% | regulation of DNA-templated transcription, elongation |
| GO:0042423 | 1.66% | catecholamine biosynthetic process |
| GO:0015698 | 1.66% | inorganic anion transport |
| GO:0001890 | 1.66% | placenta development |
| GO:1903900 | 1.66% | regulation of viral life cycle |
| GO:0042335 | 1.66% | cuticle development |
| GO:0006636 | 1.65% | unsaturated fatty acid biosynthetic process |
| GO:0030149 | 1.65% | sphingolipid catabolic process |
| GO:0110020 | 1.65% | regulation of actomyosin structure organization |
| GO:0009740 | 1.65% | gibberellic acid mediated signaling pathway |
| GO:0046471 | 1.65% | phosphatidylglycerol metabolic process |
| GO:1903050 | 1.65% | regulation of proteolysis involved in cellular protein catabolic process |
| GO:0060562 | 1.65% | epithelial tube morphogenesis |
| GO:0050691 | 1.65% | regulation of defense response to virus by host |
| GO:0006942 | 1.65% | regulation of striated muscle contraction |
| GO:0050954 | 1.65% | sensory perception of mechanical stimulus |
| GO:0002028 | 1.65% | regulation of sodium ion transport |
| GO:0002832 | 1.65% | negative regulation of response to biotic stimulus |
| GO:0006458 | 1.65% | 'de novo' protein folding |
| GO:0007612 | 1.65% | learning |
| GO:0110148 | 1.65% | biomineralization |
| GO:0043966 | 1.65% | histone H3 acetylation |
| GO:0001503 | 1.64% | ossification |
| GO:0006366 | 1.64% | transcription by RNA polymerase II |
| GO:2001020 | 1.64% | regulation of response to DNA damage stimulus |
| GO:0000469 | 1.64% | cleavage involved in rRNA processing |
| GO:0001570 | 1.64% | vasculogenesis |
| GO:2000242 | 1.64% | negative regulation of reproductive process |
| GO:0022029 | 1.64% | telencephalon cell migration |
| GO:0097306 | 1.64% | cellular response to alcohol |
| GO:0006084 | 1.64% | acetyl-CoA metabolic process |
| GO:0098742 | 1.64% | cell-cell adhesion via plasma-membrane adhesion molecules |
| GO:0035459 | 1.63% | vesicle cargo loading |
| GO:0034644 | 1.63% | cellular response to UV |
| GO:0032648 | 1.63% | regulation of interferon-beta production |
| GO:0019954 | 1.63% | asexual reproduction |
| GO:0034389 | 1.63% | lipid droplet organization |
| GO:0071219 | 1.63% | cellular response to molecule of bacterial origin |
| GO:0070536 | 1.63% | protein K63-linked deubiquitination |
| GO:0046716 | 1.63% | muscle cell cellular homeostasis |
| GO:0034724 | 1.62% | DNA replication-independent nucleosome organization |
| GO:0061138 | 1.62% | morphogenesis of a branching epithelium |
| GO:0002526 | 1.62% | acute inflammatory response |
| GO:0045861 | 1.62% | negative regulation of proteolysis |
| GO:0019217 | 1.62% | regulation of fatty acid metabolic process |
| GO:0043524 | 1.62% | negative regulation of neuron apoptotic process |
| GO:2000027 | 1.62% | regulation of animal organ morphogenesis |
| GO:0040013 | 1.62% | negative regulation of locomotion |
| GO:0048857 | 1.62% | neural nucleus development |
| GO:0060348 | 1.62% | bone development |
| GO:0008306 | 1.62% | associative learning |
| GO:0030178 | 1.62% | negative regulation of Wnt signaling pathway |
| GO:0017157 | 1.61% | regulation of exocytosis |
| GO:0018149 | 1.61% | peptide cross-linking |
| GO:0046578 | 1.61% | regulation of Ras protein signal transduction |
| GO:2001251 | 1.61% | negative regulation of chromosome organization |
| GO:0051271 | 1.61% | negative regulation of cellular component movement |
| GO:0016180 | 1.61% | snRNA processing |
| GO:2000058 | 1.61% | regulation of ubiquitin-dependent protein catabolic process |
| GO:0048532 | 1.61% | anatomical structure arrangement |
| GO:0140253 | 1.61% | cell-cell fusion |
| GO:0030218 | 1.61% | erythrocyte differentiation |
| GO:0002218 | 1.61% | activation of innate immune response |
| GO:0018107 | 1.61% | peptidyl-threonine phosphorylation |
| GO:0050773 | 1.61% | regulation of dendrite development |
| GO:0007264 | 1.60% | small GTPase mediated signal transduction |
| GO:0008643 | 1.60% | carbohydrate transport |
| GO:0048544 | 1.60% | recognition of pollen |
| GO:0046128 | 1.60% | purine ribonucleoside metabolic process |
| GO:0050817 | 1.60% | coagulation |
| GO:0030010 | 1.60% | establishment of cell polarity |
| GO:0051216 | 1.60% | cartilage development |
| GO:0071375 | 1.60% | cellular response to peptide hormone stimulus |
| GO:0042462 | 1.60% | eye photoreceptor cell development |
| GO:0018022 | 1.60% | peptidyl-lysine methylation |
| GO:0010662 | 1.60% | regulation of striated muscle cell apoptotic process |
| GO:0035458 | 1.60% | cellular response to interferon-beta |
| GO:0016239 | 1.60% | positive regulation of macroautophagy |
| GO:0002251 | 1.60% | organ or tissue specific immune response |
| GO:0007608 | 1.60% | sensory perception of smell |
| GO:0050865 | 1.60% | regulation of cell activation |
| GO:0045216 | 1.60% | cell-cell junction organization |
| GO:0045132 | 1.60% | meiotic chromosome segregation |
| GO:0010226 | 1.60% | response to lithium ion |
| GO:0002784 | 1.60% | regulation of antimicrobial peptide production |
| GO:0007093 | 1.60% | mitotic cell cycle checkpoint |
| GO:0042149 | 1.60% | cellular response to glucose starvation |
| GO:0030968 | 1.60% | endoplasmic reticulum unfolded protein response |
| GO:0045666 | 1.59% | positive regulation of neuron differentiation |
| GO:0046883 | 1.59% | regulation of hormone secretion |
| GO:0072595 | 1.59% | maintenance of protein localization in organelle |
| GO:0010823 | 1.59% | negative regulation of mitochondrion organization |
| GO:0031644 | 1.59% | regulation of nervous system process |
| GO:0034629 | 1.59% | cellular protein-containing complex localization |
| GO:0048754 | 1.59% | branching morphogenesis of an epithelial tube |
| GO:0043331 | 1.59% | response to dsRNA |
| GO:0007602 | 1.59% | phototransduction |
| GO:0046854 | 1.59% | phosphatidylinositol phosphorylation |
| GO:0007009 | 1.59% | plasma membrane organization |
| GO:0042326 | 1.59% | negative regulation of phosphorylation |
| GO:0000289 | 1.58% | nuclear-transcribed mRNA poly(A) tail shortening |
| GO:0048738 | 1.58% | cardiac muscle tissue development |
| GO:0071426 | 1.58% | ribonucleoprotein complex export from nucleus |
| GO:0042546 | 1.58% | cell wall biogenesis |
| GO:0006289 | 1.58% | nucleotide-excision repair |
| GO:0006544 | 1.58% | glycine metabolic process |
| GO:0045598 | 1.58% | regulation of fat cell differentiation |
| GO:0040017 | 1.58% | positive regulation of locomotion |
| GO:0010171 | 1.58% | body morphogenesis |
| GO:1904018 | 1.58% | positive regulation of vasculature development |
| GO:0045721 | 1.58% | negative regulation of gluconeogenesis |
| GO:1903828 | 1.58% | negative regulation of cellular protein localization |
| GO:0040020 | 1.58% | regulation of meiotic nuclear division |
| GO:0050806 | 1.58% | positive regulation of synaptic transmission |
| GO:0000083 | 1.58% | regulation of transcription involved in G1/S transition of mitotic cell cycle |
| GO:0008038 | 1.58% | neuron recognition |
| GO:0031023 | 1.58% | microtubule organizing center organization |
| GO:0034330 | 1.57% | cell junction organization |
| GO:0120032 | 1.57% | regulation of plasma membrane bounded cell projection assembly |
| GO:0000479 | 1.57% | endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) |
| GO:0000027 | 1.57% | ribosomal large subunit assembly |
| GO:0090287 | 1.57% | regulation of cellular response to growth factor stimulus |
| GO:0010631 | 1.57% | epithelial cell migration |
| GO:1903706 | 1.57% | regulation of hemopoiesis |
| GO:1901991 | 1.57% | negative regulation of mitotic cell cycle phase transition |
| GO:0061564 | 1.57% | axon development |
| GO:0006641 | 1.57% | triglyceride metabolic process |
| GO:0000478 | 1.57% | endonucleolytic cleavage involved in rRNA processing |
| GO:1905392 | 1.57% | plant organ morphogenesis |
| GO:0009913 | 1.56% | epidermal cell differentiation |
| GO:0010632 | 1.56% | regulation of epithelial cell migration |
| GO:2000280 | 1.56% | regulation of root development |
| GO:0051084 | 1.56% | 'de novo' posttranslational protein folding |
| GO:0030522 | 1.56% | intracellular receptor signaling pathway |
| GO:1903320 | 1.56% | regulation of protein modification by small protein conjugation or removal |
| GO:0071514 | 1.56% | genetic imprinting |
| GO:0015672 | 1.56% | monovalent inorganic cation transport |
| GO:0009268 | 1.56% | response to pH |
| GO:0034220 | 1.56% | ion transmembrane transport |
| GO:0043174 | 1.56% | nucleoside salvage |
| GO:1900180 | 1.56% | regulation of protein localization to nucleus |
| GO:0097009 | 1.55% | energy homeostasis |
| GO:0051090 | 1.55% | regulation of DNA-binding transcription factor activity |
| GO:0042044 | 1.55% | fluid transport |
| GO:0002239 | 1.55% | response to oomycetes |
| GO:0098534 | 1.55% | centriole assembly |
| GO:1901989 | 1.55% | positive regulation of cell cycle phase transition |
| GO:0045936 | 1.55% | negative regulation of phosphate metabolic process |
| GO:0002229 | 1.55% | defense response to oomycetes |
| GO:0001818 | 1.55% | negative regulation of cytokine production |
| GO:0043457 | 1.55% | regulation of cellular respiration |
| GO:0006071 | 1.55% | glycerol metabolic process |
| GO:0002698 | 1.55% | negative regulation of immune effector process |
| GO:0007596 | 1.55% | blood coagulation |
| GO:0007599 | 1.55% | hemostasis |
| GO:0009880 | 1.55% | embryonic pattern specification |
| GO:0001501 | 1.55% | skeletal system development |
| GO:0007254 | 1.55% | JNK cascade |
| GO:0080154 | 1.55% | regulation of fertilization |
| GO:0071230 | 1.55% | cellular response to amino acid stimulus |
| GO:0007164 | 1.55% | establishment of tissue polarity |
| GO:0032878 | 1.55% | regulation of establishment or maintenance of cell polarity |
| GO:1905818 | 1.55% | regulation of chromosome separation |
| GO:0030728 | 1.54% | ovulation |
| GO:0021795 | 1.54% | cerebral cortex cell migration |
| GO:0042744 | 1.54% | hydrogen peroxide catabolic process |
| GO:0031152 | 1.54% | aggregation involved in sorocarp development |
| GO:0000737 | 1.54% | DNA catabolic process, endonucleolytic |
| GO:0007179 | 1.54% | transforming growth factor beta receptor signaling pathway |
| GO:1902099 | 1.54% | regulation of metaphase/anaphase transition of cell cycle |
| GO:0009584 | 1.54% | detection of visible light |
| GO:0006359 | 1.54% | regulation of transcription by RNA polymerase III |
| GO:0050000 | 1.54% | chromosome localization |
| GO:0046339 | 1.54% | diacylglycerol metabolic process |
| GO:0003206 | 1.54% | cardiac chamber morphogenesis |
| GO:2000146 | 1.54% | negative regulation of cell motility |
| GO:0007229 | 1.54% | integrin-mediated signaling pathway |
| GO:0007631 | 1.54% | feeding behavior |
| GO:0008045 | 1.54% | motor neuron axon guidance |
| GO:0010972 | 1.54% | negative regulation of G2/M transition of mitotic cell cycle |
| GO:0034394 | 1.53% | protein localization to cell surface |
| GO:0007444 | 1.53% | imaginal disc development |
| GO:0071545 | 1.53% | inositol phosphate catabolic process |
| GO:0016073 | 1.53% | snRNA metabolic process |
| GO:0030278 | 1.53% | regulation of ossification |
| GO:0010563 | 1.53% | negative regulation of phosphorus metabolic process |
| GO:0042439 | 1.53% | ethanolamine-containing compound metabolic process |
| GO:0090316 | 1.53% | positive regulation of intracellular protein transport |
| GO:0046999 | 1.53% | regulation of conjugation |
| GO:1903362 | 1.52% | regulation of cellular protein catabolic process |
| GO:0007186 | 1.52% | G protein-coupled receptor signaling pathway |
| GO:0045488 | 1.52% | pectin metabolic process |
| GO:0030166 | 1.52% | proteoglycan biosynthetic process |
| GO:0030336 | 1.52% | negative regulation of cell migration |
| GO:0042461 | 1.52% | photoreceptor cell development |
| GO:0022612 | 1.52% | gland morphogenesis |
| GO:0006024 | 1.52% | glycosaminoglycan biosynthetic process |
| GO:0120178 | 1.52% | steroid hormone biosynthetic process |
| GO:1903317 | 1.52% | regulation of protein maturation |
| GO:0033046 | 1.52% | negative regulation of sister chromatid segregation |
| GO:0022409 | 1.52% | positive regulation of cell-cell adhesion |
| GO:0048259 | 1.52% | regulation of receptor-mediated endocytosis |
| GO:0030856 | 1.52% | regulation of epithelial cell differentiation |
| GO:0051170 | 1.52% | import into nucleus |
| GO:0014072 | 1.52% | response to isoquinoline alkaloid |
| GO:0045292 | 1.52% | mRNA cis splicing, via spliceosome |
| GO:0044458 | 1.52% | motile cilium assembly |
| GO:0032944 | 1.52% | regulation of mononuclear cell proliferation |
| GO:1901988 | 1.52% | negative regulation of cell cycle phase transition |
| GO:0045663 | 1.51% | positive regulation of myoblast differentiation |
| GO:0045494 | 1.51% | photoreceptor cell maintenance |
| GO:1903522 | 1.51% | regulation of blood circulation |
| GO:0032456 | 1.51% | endocytic recycling |
| GO:0006353 | 1.51% | DNA-templated transcription, termination |
| GO:1903421 | 1.51% | regulation of synaptic vesicle recycling |
| GO:0043462 | 1.51% | regulation of ATPase activity |
| GO:0034504 | 1.51% | protein localization to nucleus |
| GO:0030866 | 1.51% | cortical actin cytoskeleton organization |
| GO:0046838 | 1.51% | phosphorylated carbohydrate dephosphorylation |
| GO:0006379 | 1.51% | mRNA cleavage |
| GO:0006450 | 1.51% | regulation of translational fidelity |
| GO:0010453 | 1.51% | regulation of cell fate commitment |
| GO:1905477 | 1.51% | positive regulation of protein localization to membrane |
| GO:0051784 | 1.51% | negative regulation of nuclear division |
| GO:0030073 | 1.50% | insulin secretion |
| GO:0031346 | 1.50% | positive regulation of cell projection organization |
| GO:1903725 | 1.50% | regulation of phospholipid metabolic process |
| GO:0006611 | 1.50% | protein export from nucleus |
| GO:0043484 | 1.50% | regulation of RNA splicing |
| GO:0044839 | 1.50% | cell cycle G2/M phase transition |
| GO:0006029 | 1.50% | proteoglycan metabolic process |
| GO:0007423 | 1.50% | sensory organ development |
| GO:0030858 | 1.50% | positive regulation of epithelial cell differentiation |
| GO:0032069 | 1.50% | regulation of nuclease activity |
| GO:0070663 | 1.50% | regulation of leukocyte proliferation |
| GO:0007007 | 1.50% | inner mitochondrial membrane organization |
| GO:0014823 | 1.50% | response to activity |
| GO:0070303 | 1.50% | negative regulation of stress-activated protein kinase signaling cascade |
| GO:0060047 | 1.50% | heart contraction |
| GO:0070592 | 1.50% | cell wall polysaccharide biosynthetic process |
| GO:0014075 | 1.50% | response to amine |
| GO:0043627 | 1.50% | response to estrogen |
| GO:0006007 | 1.50% | glucose catabolic process |
| GO:0060674 | 1.49% | placenta blood vessel development |
| GO:0051985 | 1.49% | negative regulation of chromosome segregation |
| GO:0002385 | 1.49% | mucosal immune response |
| GO:0043547 | 1.49% | positive regulation of GTPase activity |
| GO:0016578 | 1.49% | histone deubiquitination |
| GO:0050678 | 1.49% | regulation of epithelial cell proliferation |
| GO:2000106 | 1.49% | regulation of leukocyte apoptotic process |
| GO:0010665 | 1.49% | regulation of cardiac muscle cell apoptotic process |
| GO:0044804 | 1.49% | autophagy of nucleus |
| GO:0006941 | 1.49% | striated muscle contraction |
| GO:0051653 | 1.49% | spindle localization |
| GO:0050770 | 1.49% | regulation of axonogenesis |
| GO:0007043 | 1.49% | cell-cell junction assembly |
| GO:0030260 | 1.49% | entry into host cell |
| GO:0007143 | 1.49% | female meiotic nuclear division |
| GO:0010286 | 1.49% | heat acclimation |
| GO:0070286 | 1.48% | axonemal dynein complex assembly |
| GO:0021987 | 1.48% | cerebral cortex development |
| GO:0006775 | 1.48% | fat-soluble vitamin metabolic process |
| GO:0002757 | 1.48% | immune response-activating signal transduction |
| GO:0033048 | 1.48% | negative regulation of mitotic sister chromatid segregation |
| GO:0006906 | 1.48% | vesicle fusion |
| GO:0031570 | 1.48% | DNA integrity checkpoint |
| GO:0098660 | 1.48% | inorganic ion transmembrane transport |
| GO:0043408 | 1.48% | regulation of MAPK cascade |
| GO:0010965 | 1.48% | regulation of mitotic sister chromatid separation |
| GO:0070328 | 1.48% | triglyceride homeostasis |
| GO:0042659 | 1.48% | regulation of cell fate specification |
| GO:0010324 | 1.48% | membrane invagination |
| GO:1904029 | 1.48% | regulation of cyclin-dependent protein kinase activity |
| GO:1902074 | 1.48% | response to salt |
| GO:0015850 | 1.48% | organic hydroxy compound transport |
| GO:0032786 | 1.48% | positive regulation of DNA-templated transcription, elongation |
| GO:0007041 | 1.48% | lysosomal transport |
| GO:0032873 | 1.48% | negative regulation of stress-activated MAPK cascade |
| GO:0051961 | 1.47% | negative regulation of nervous system development |
| GO:0048771 | 1.47% | tissue remodeling |
| GO:0000054 | 1.47% | ribosomal subunit export from nucleus |
| GO:0048704 | 1.47% | embryonic skeletal system morphogenesis |
| GO:0001775 | 1.47% | cell activation |
| GO:0035176 | 1.47% | social behavior |
| GO:0021915 | 1.47% | neural tube development |
| GO:0018298 | 1.47% | protein-chromophore linkage |
| GO:1900024 | 1.47% | regulation of substrate adhesion-dependent cell spreading |
| GO:0060541 | 1.47% | respiratory system development |
| GO:1900182 | 1.47% | positive regulation of protein localization to nucleus |
| GO:2001039 | 1.47% | negative regulation of cellular response to drug |
| GO:0051865 | 1.47% | protein autoubiquitination |
| GO:0008016 | 1.47% | regulation of heart contraction |
| GO:0090162 | 1.47% | establishment of epithelial cell polarity |
| GO:0032370 | 1.47% | positive regulation of lipid transport |
| GO:0006661 | 1.47% | phosphatidylinositol biosynthetic process |
| GO:0006891 | 1.47% | intra-Golgi vesicle-mediated transport |
| GO:1902750 | 1.47% | negative regulation of cell cycle G2/M phase transition |
| GO:1901992 | 1.47% | positive regulation of mitotic cell cycle phase transition |
| GO:1905475 | 1.46% | regulation of protein localization to membrane |
| GO:0071222 | 1.46% | cellular response to lipopolysaccharide |
| GO:0055083 | 1.46% | monovalent inorganic anion homeostasis |
| GO:0042451 | 1.46% | purine nucleoside biosynthetic process |
| GO:0097191 | 1.46% | extrinsic apoptotic signaling pathway |
| GO:0071322 | 1.46% | cellular response to carbohydrate stimulus |
| GO:0010507 | 1.46% | negative regulation of autophagy |
| GO:0016237 | 1.46% | lysosomal microautophagy |
| GO:0033866 | 1.46% | nucleoside bisphosphate biosynthetic process |
| GO:0045637 | 1.46% | regulation of myeloid cell differentiation |
| GO:0009103 | 1.46% | lipopolysaccharide biosynthetic process |
| GO:0071331 | 1.46% | cellular response to hexose stimulus |
| GO:0006521 | 1.46% | regulation of cellular amino acid metabolic process |
| GO:0030091 | 1.46% | protein repair |
| GO:0010288 | 1.46% | response to lead ion |
| GO:0051051 | 1.46% | negative regulation of transport |
| GO:0035150 | 1.46% | regulation of tube size |
| GO:0051781 | 1.46% | positive regulation of cell division |
| GO:0002573 | 1.46% | myeloid leukocyte differentiation |
| GO:0016553 | 1.46% | base conversion or substitution editing |
| GO:0071300 | 1.46% | cellular response to retinoic acid |
| GO:0055090 | 1.46% | acylglycerol homeostasis |
| GO:0032271 | 1.46% | regulation of protein polymerization |
| GO:0001894 | 1.46% | tissue homeostasis |
| GO:0031396 | 1.45% | regulation of protein ubiquitination |
| GO:0044409 | 1.45% | entry into host |
| GO:1902930 | 1.45% | regulation of alcohol biosynthetic process |
| GO:0008298 | 1.45% | intracellular mRNA localization |
| GO:1905819 | 1.45% | negative regulation of chromosome separation |
| GO:0008286 | 1.45% | insulin receptor signaling pathway |
| GO:0002703 | 1.45% | regulation of leukocyte mediated immunity |
| GO:0022602 | 1.45% | ovulation cycle process |
| GO:0032374 | 1.45% | regulation of cholesterol transport |
| GO:0010410 | 1.45% | hemicellulose metabolic process |
| GO:0043954 | 1.45% | cellular component maintenance |
| GO:1903055 | 1.45% | positive regulation of extracellular matrix organization |
| GO:0001933 | 1.45% | negative regulation of protein phosphorylation |
| GO:2000116 | 1.45% | regulation of cysteine-type endopeptidase activity |
| GO:0060606 | 1.45% | tube closure |
| GO:0061077 | 1.45% | chaperone-mediated protein folding |
| GO:0010811 | 1.45% | positive regulation of cell-substrate adhesion |
| GO:0032869 | 1.45% | cellular response to insulin stimulus |
| GO:0006368 | 1.45% | transcription elongation from RNA polymerase II promoter |
| GO:0030201 | 1.44% | heparan sulfate proteoglycan metabolic process |
| GO:0001843 | 1.44% | neural tube closure |
| GO:0051054 | 1.44% | positive regulation of DNA metabolic process |
| GO:0007638 | 1.44% | mechanosensory behavior |
| GO:0035437 | 1.44% | maintenance of protein localization in endoplasmic reticulum |
| GO:0046855 | 1.44% | inositol phosphate dephosphorylation |
| GO:0006376 | 1.44% | mRNA splice site selection |
| GO:0016525 | 1.44% | negative regulation of angiogenesis |
| GO:1905897 | 1.44% | regulation of response to endoplasmic reticulum stress |
| GO:0002694 | 1.44% | regulation of leukocyte activation |
| GO:2000181 | 1.44% | negative regulation of blood vessel morphogenesis |
| GO:0048863 | 1.44% | stem cell differentiation |
| GO:0007020 | 1.44% | microtubule nucleation |
| GO:0046718 | 1.44% | viral entry into host cell |
| GO:0000079 | 1.44% | regulation of cyclin-dependent protein serine/threonine kinase activity |
| GO:0090276 | 1.44% | regulation of peptide hormone secretion |
| GO:1902410 | 1.44% | mitotic cytokinetic process |
| GO:0032481 | 1.44% | positive regulation of type I interferon production |
| GO:1901072 | 1.43% | glucosamine-containing compound catabolic process |
| GO:0061912 | 1.43% | selective autophagy |
| GO:0030574 | 1.43% | collagen catabolic process |
| GO:1905269 | 1.43% | positive regulation of chromatin organization |
| GO:0010393 | 1.43% | galacturonan metabolic process |
| GO:1901343 | 1.43% | negative regulation of vasculature development |
| GO:0006336 | 1.43% | DNA replication-independent nucleosome assembly |
| GO:0006403 | 1.43% | RNA localization |
| GO:0008156 | 1.43% | negative regulation of DNA replication |
| GO:0048563 | 1.43% | post-embryonic animal organ morphogenesis |
| GO:0001707 | 1.43% | mesoderm formation |
| GO:0030204 | 1.43% | chondroitin sulfate metabolic process |
| GO:0071071 | 1.43% | regulation of phospholipid biosynthetic process |
| GO:0000460 | 1.43% | maturation of 5.8S rRNA |
| GO:0034243 | 1.43% | regulation of transcription elongation from RNA polymerase II promoter |
| GO:0051447 | 1.43% | negative regulation of meiotic cell cycle |
| GO:0008630 | 1.43% | intrinsic apoptotic signaling pathway in response to DNA damage |
| GO:0050796 | 1.43% | regulation of insulin secretion |
| GO:1901653 | 1.43% | cellular response to peptide |
| GO:2000816 | 1.43% | negative regulation of mitotic sister chromatid separation |
| GO:2000142 | 1.43% | regulation of DNA-templated transcription, initiation |
| GO:0042026 | 1.42% | protein refolding |
| GO:1901655 | 1.42% | cellular response to ketone |
| GO:0043967 | 1.42% | histone H4 acetylation |
| GO:0031137 | 1.42% | regulation of conjugation with cellular fusion |
| GO:0034030 | 1.42% | ribonucleoside bisphosphate biosynthetic process |
| GO:1900046 | 1.42% | regulation of hemostasis |
| GO:1905515 | 1.42% | non-motile cilium assembly |
| GO:0001708 | 1.42% | cell fate specification |
| GO:0032094 | 1.42% | response to food |
| GO:0051785 | 1.42% | positive regulation of nuclear division |
| GO:0009401 | 1.42% | phosphoenolpyruvate-dependent sugar phosphotransferase system |
| GO:0098630 | 1.42% | aggregation of unicellular organisms |
| GO:0060148 | 1.42% | positive regulation of posttranscriptional gene silencing |
| GO:0051346 | 1.42% | negative regulation of hydrolase activity |
| GO:0050768 | 1.42% | negative regulation of neurogenesis |
| GO:0098662 | 1.42% | inorganic cation transmembrane transport |
| GO:0042403 | 1.42% | thyroid hormone metabolic process |
| GO:0098655 | 1.42% | cation transmembrane transport |
| GO:0007476 | 1.42% | imaginal disc-derived wing morphogenesis |
| GO:0043330 | 1.42% | response to exogenous dsRNA |
| GO:0046129 | 1.42% | purine ribonucleoside biosynthetic process |
| GO:0035194 | 1.41% | posttranscriptional gene silencing by RNA |
| GO:0033750 | 1.41% | ribosome localization |
| GO:0060021 | 1.41% | roof of mouth development |
| GO:0007099 | 1.41% | centriole replication |
| GO:0048640 | 1.41% | negative regulation of developmental growth |
| GO:0071731 | 1.41% | response to nitric oxide |
| GO:1901998 | 1.41% | toxin transport |
| GO:0070542 | 1.41% | response to fatty acid |
| GO:0006278 | 1.41% | RNA-dependent DNA biosynthetic process |
| GO:0034033 | 1.41% | purine nucleoside bisphosphate biosynthetic process |
| GO:0030243 | 1.41% | cellulose metabolic process |
| GO:0042119 | 1.41% | neutrophil activation |
| GO:0045665 | 1.40% | negative regulation of neuron differentiation |
| GO:0030071 | 1.40% | regulation of mitotic metaphase/anaphase transition |
| GO:0070997 | 1.40% | neuron death |
| GO:0002062 | 1.40% | chondrocyte differentiation |
| GO:0010976 | 1.40% | positive regulation of neuron projection development |
| GO:0048741 | 1.40% | skeletal muscle fiber development |
| GO:0045948 | 1.40% | positive regulation of translational initiation |
| GO:0034329 | 1.40% | cell junction assembly |
| GO:0006282 | 1.40% | regulation of DNA repair |
| GO:0010765 | 1.40% | positive regulation of sodium ion transport |
| GO:1905393 | 1.40% | plant organ formation |
| GO:0032368 | 1.40% | regulation of lipid transport |
| GO:0048821 | 1.40% | erythrocyte development |
| GO:0060966 | 1.40% | regulation of gene silencing by RNA |
| GO:0099024 | 1.40% | plasma membrane invagination |
| GO:0000082 | 1.40% | G1/S transition of mitotic cell cycle |
| GO:0034472 | 1.40% | snRNA 3'-end processing |
| GO:0015936 | 1.40% | coenzyme A metabolic process |
| GO:0000768 | 1.40% | syncytium formation by plasma membrane fusion |
| GO:0021954 | 1.40% | central nervous system neuron development |
| GO:2001238 | 1.40% | positive regulation of extrinsic apoptotic signaling pathway |
| GO:0032480 | 1.40% | negative regulation of type I interferon production |
| GO:0010667 | 1.40% | negative regulation of cardiac muscle cell apoptotic process |
| GO:0070613 | 1.40% | regulation of protein processing |
| GO:0070570 | 1.40% | regulation of neuron projection regeneration |
| GO:1903053 | 1.40% | regulation of extracellular matrix organization |
| GO:0010594 | 1.39% | regulation of endothelial cell migration |
| GO:0046112 | 1.39% | nucleobase biosynthetic process |
| GO:0006626 | 1.39% | protein targeting to mitochondrion |
| GO:0048747 | 1.39% | muscle fiber development |
| GO:0090313 | 1.39% | regulation of protein targeting to membrane |
| GO:0030301 | 1.39% | cholesterol transport |
| GO:0048008 | 1.39% | platelet-derived growth factor receptor signaling pathway |
| GO:0060491 | 1.39% | regulation of cell projection assembly |
| GO:0010717 | 1.39% | regulation of epithelial to mesenchymal transition |
| GO:0003143 | 1.39% | embryonic heart tube morphogenesis |
| GO:0007338 | 1.39% | single fertilization |
| GO:0090092 | 1.39% | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
| GO:0051650 | 1.39% | establishment of vesicle localization |
| GO:0002429 | 1.39% | immune response-activating cell surface receptor signaling pathway |
| GO:0035967 | 1.39% | cellular response to topologically incorrect protein |
| GO:0010884 | 1.39% | positive regulation of lipid storage |
| GO:0030500 | 1.39% | regulation of bone mineralization |
| GO:0006968 | 1.39% | cellular defense response |
| GO:2001024 | 1.39% | negative regulation of response to drug |
| GO:0002764 | 1.39% | immune response-regulating signaling pathway |
| GO:1903034 | 1.39% | regulation of response to wounding |
| GO:0038127 | 1.38% | ERBB signaling pathway |
| GO:0042177 | 1.38% | negative regulation of protein catabolic process |
| GO:0006110 | 1.38% | regulation of glycolytic process |
| GO:0050851 | 1.38% | antigen receptor-mediated signaling pathway |
| GO:0032371 | 1.38% | regulation of sterol transport |
| GO:0008088 | 1.38% | axo-dendritic transport |
| GO:0032465 | 1.38% | regulation of cytokinesis |
| GO:0071459 | 1.38% | protein localization to chromosome, centromeric region |
| GO:0009637 | 1.38% | response to blue light |
| GO:0042273 | 1.38% | ribosomal large subunit biogenesis |
| GO:0050909 | 1.38% | sensory perception of taste |
| GO:0098743 | 1.38% | cell aggregation |
| GO:0002027 | 1.38% | regulation of heart rate |
| GO:0097237 | 1.38% | cellular response to toxic substance |
| GO:0030261 | 1.38% | chromosome condensation |
| GO:0043101 | 1.38% | purine-containing compound salvage |
| GO:0010950 | 1.38% | positive regulation of endopeptidase activity |
| GO:1903532 | 1.38% | positive regulation of secretion by cell |
| GO:0007628 | 1.37% | adult walking behavior |
| GO:0051648 | 1.37% | vesicle localization |
| GO:0051965 | 1.37% | positive regulation of synapse assembly |
| GO:0007435 | 1.37% | salivary gland morphogenesis |
| GO:0071333 | 1.37% | cellular response to glucose stimulus |
| GO:0090181 | 1.37% | regulation of cholesterol metabolic process |
| GO:0007632 | 1.37% | visual behavior |
| GO:0035337 | 1.37% | fatty-acyl-CoA metabolic process |
| GO:0034968 | 1.37% | histone lysine methylation |
| GO:0090174 | 1.37% | organelle membrane fusion |
| GO:0030244 | 1.37% | cellulose biosynthetic process |
| GO:0006890 | 1.37% | retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum |
| GO:0043278 | 1.37% | response to morphine |
| GO:0043173 | 1.37% | nucleotide salvage |
| GO:0032728 | 1.37% | positive regulation of interferon-beta production |
| GO:0000018 | 1.37% | regulation of DNA recombination |
| GO:0006953 | 1.37% | acute-phase response |
| GO:0072529 | 1.37% | pyrimidine-containing compound catabolic process |
| GO:1901222 | 1.37% | regulation of NIK/NF-kappaB signaling |
| GO:0001824 | 1.37% | blastocyst development |
| GO:0051101 | 1.37% | regulation of DNA binding |
| GO:0003018 | 1.37% | vascular process in circulatory system |
| GO:1903845 | 1.37% | negative regulation of cellular response to transforming growth factor beta stimulus |
| GO:0048709 | 1.37% | oligodendrocyte differentiation |
| GO:0070167 | 1.37% | regulation of biomineral tissue development |
| GO:0019856 | 1.36% | pyrimidine nucleobase biosynthetic process |
| GO:0007595 | 1.36% | lactation |
| GO:0008544 | 1.36% | epidermis development |
| GO:0007162 | 1.36% | negative regulation of cell adhesion |
| GO:0017156 | 1.36% | calcium-ion regulated exocytosis |
| GO:0071326 | 1.36% | cellular response to monosaccharide stimulus |
| GO:0051446 | 1.36% | positive regulation of meiotic cell cycle |
| GO:1990138 | 1.36% | neuron projection extension |
| GO:0017148 | 1.36% | negative regulation of translation |
| GO:0008356 | 1.36% | asymmetric cell division |
| GO:0032781 | 1.36% | positive regulation of ATPase activity |
| GO:0017145 | 1.36% | stem cell division |
| GO:0070071 | 1.36% | proton-transporting two-sector ATPase complex assembly |
| GO:0000819 | 1.36% | sister chromatid segregation |
| GO:0045943 | 1.36% | positive regulation of transcription by RNA polymerase I |
| GO:0036075 | 1.36% | replacement ossification |
| GO:0051339 | 1.36% | regulation of lyase activity |
| GO:0050906 | 1.35% | detection of stimulus involved in sensory perception |
| GO:0007588 | 1.35% | excretion |
| GO:0000463 | 1.35% | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) |
| GO:0060325 | 1.35% | face morphogenesis |
| GO:0002274 | 1.35% | myeloid leukocyte activation |
| GO:0009649 | 1.35% | entrainment of circadian clock |
| GO:0071363 | 1.35% | cellular response to growth factor stimulus |
| GO:0017085 | 1.35% | response to insecticide |
| GO:0085029 | 1.35% | extracellular matrix assembly |
| GO:0010977 | 1.35% | negative regulation of neuron projection development |
| GO:0071025 | 1.35% | RNA surveillance |
| GO:0050714 | 1.35% | positive regulation of protein secretion |
| GO:0009262 | 1.35% | deoxyribonucleotide metabolic process |
| GO:0035336 | 1.35% | long-chain fatty-acyl-CoA metabolic process |
| GO:0050805 | 1.35% | negative regulation of synaptic transmission |
| GO:0046902 | 1.35% | regulation of mitochondrial membrane permeability |
| GO:0034249 | 1.34% | negative regulation of cellular amide metabolic process |
| GO:0006998 | 1.34% | nuclear envelope organization |
| GO:0007369 | 1.34% | gastrulation |
| GO:0045472 | 1.34% | response to ether |
| GO:0050435 | 1.34% | amyloid-beta metabolic process |
| GO:0090503 | 1.34% | RNA phosphodiester bond hydrolysis, exonucleolytic |
| GO:0010001 | 1.34% | glial cell differentiation |
| GO:0051348 | 1.34% | negative regulation of transferase activity |
| GO:0034764 | 1.34% | positive regulation of transmembrane transport |
| GO:1901658 | 1.34% | glycosyl compound catabolic process |
| GO:0010039 | 1.34% | response to iron ion |
| GO:0065005 | 1.34% | protein-lipid complex assembly |
| GO:0050852 | 1.34% | T cell receptor signaling pathway |
| GO:0071548 | 1.34% | response to dexamethasone |
| GO:0050684 | 1.34% | regulation of mRNA processing |
| GO:0001654 | 1.33% | eye development |
| GO:0046825 | 1.33% | regulation of protein export from nucleus |
| GO:2000177 | 1.33% | regulation of neural precursor cell proliferation |
| GO:0140238 | 1.33% | presynaptic endocytosis |
| GO:0035902 | 1.33% | response to immobilization stress |
| GO:0031288 | 1.33% | sorocarp morphogenesis |
| GO:0000086 | 1.33% | G2/M transition of mitotic cell cycle |
| GO:0010660 | 1.33% | regulation of muscle cell apoptotic process |
| GO:0001947 | 1.33% | heart looping |
| GO:0016331 | 1.33% | morphogenesis of embryonic epithelium |
| GO:1902019 | 1.33% | regulation of cilium-dependent cell motility |
| GO:0071900 | 1.33% | regulation of protein serine/threonine kinase activity |
| GO:0001958 | 1.33% | endochondral ossification |
| GO:0007520 | 1.33% | myoblast fusion |
| GO:0048167 | 1.33% | regulation of synaptic plasticity |
| GO:0046320 | 1.33% | regulation of fatty acid oxidation |
| GO:0001672 | 1.33% | regulation of chromatin assembly or disassembly |
| GO:0021953 | 1.33% | central nervous system neuron differentiation |
| GO:0071371 | 1.33% | cellular response to gonadotropin stimulus |
| GO:0030833 | 1.33% | regulation of actin filament polymerization |
| GO:0061387 | 1.33% | regulation of extent of cell growth |
| GO:0032365 | 1.33% | intracellular lipid transport |
| GO:0044843 | 1.32% | cell cycle G1/S phase transition |
| GO:0007098 | 1.32% | centrosome cycle |
| GO:0048562 | 1.32% | embryonic organ morphogenesis |
| GO:0051272 | 1.32% | positive regulation of cellular component movement |
| GO:0046928 | 1.32% | regulation of neurotransmitter secretion |
| GO:0050686 | 1.32% | negative regulation of mRNA processing |
| GO:0031058 | 1.32% | positive regulation of histone modification |
| GO:0001838 | 1.32% | embryonic epithelial tube formation |
| GO:2000147 | 1.32% | positive regulation of cell motility |
| GO:0016925 | 1.32% | protein sumoylation |
| GO:0048103 | 1.32% | somatic stem cell division |
| GO:0032200 | 1.32% | telomere organization |
| GO:0002275 | 1.32% | myeloid cell activation involved in immune response |
| GO:1903578 | 1.32% | regulation of ATP metabolic process |
| GO:0002263 | 1.32% | cell activation involved in immune response |
| GO:0031397 | 1.32% | negative regulation of protein ubiquitination |
| GO:0072348 | 1.32% | sulfur compound transport |
| GO:0002230 | 1.32% | positive regulation of defense response to virus by host |
| GO:0006166 | 1.32% | purine ribonucleoside salvage |
| GO:1902100 | 1.32% | negative regulation of metaphase/anaphase transition of cell cycle |
| GO:0110149 | 1.32% | regulation of biomineralization |
| GO:0051303 | 1.32% | establishment of chromosome localization |
| GO:0042129 | 1.32% | regulation of T cell proliferation |
| GO:0090329 | 1.31% | regulation of DNA-dependent DNA replication |
| GO:0043525 | 1.31% | positive regulation of neuron apoptotic process |
| GO:0000270 | 1.31% | peptidoglycan metabolic process |
| GO:0010951 | 1.31% | negative regulation of endopeptidase activity |
| GO:0006241 | 1.31% | CTP biosynthetic process |
| GO:0008535 | 1.31% | respiratory chain complex IV assembly |
| GO:0019722 | 1.31% | calcium-mediated signaling |
| GO:0021533 | 1.31% | cell differentiation in hindbrain |
| GO:0045109 | 1.31% | intermediate filament organization |
| GO:0015074 | 1.31% | DNA integration |
| GO:0090322 | 1.31% | regulation of superoxide metabolic process |
| GO:0006207 | 1.31% | 'de novo' pyrimidine nucleobase biosynthetic process |
| GO:0071428 | 1.31% | rRNA-containing ribonucleoprotein complex export from nucleus |
| GO:0055067 | 1.31% | monovalent inorganic cation homeostasis |
| GO:0009199 | 1.31% | ribonucleoside triphosphate metabolic process |
| GO:0008653 | 1.31% | lipopolysaccharide metabolic process |
| GO:0035094 | 1.31% | response to nicotine |
| GO:0043620 | 1.31% | regulation of DNA-templated transcription in response to stress |
| GO:0002768 | 1.31% | immune response-regulating cell surface receptor signaling pathway |
| GO:0048679 | 1.31% | regulation of axon regeneration |
| GO:0055074 | 1.31% | calcium ion homeostasis |
| GO:0050670 | 1.31% | regulation of lymphocyte proliferation |
| GO:0045766 | 1.31% | positive regulation of angiogenesis |
| GO:0035114 | 1.30% | imaginal disc-derived appendage morphogenesis |
| GO:0018027 | 1.30% | peptidyl-lysine dimethylation |
| GO:0042634 | 1.30% | regulation of hair cycle |
| GO:0035296 | 1.30% | regulation of tube diameter |
| GO:0051091 | 1.30% | positive regulation of DNA-binding transcription factor activity |
| GO:0000076 | 1.30% | DNA replication checkpoint |
| GO:0030282 | 1.30% | bone mineralization |
| GO:0030177 | 1.30% | positive regulation of Wnt signaling pathway |
| GO:0050996 | 1.30% | positive regulation of lipid catabolic process |
| GO:0030512 | 1.30% | negative regulation of transforming growth factor beta receptor signaling pathway |
| GO:0006465 | 1.30% | signal peptide processing |
| GO:0048525 | 1.30% | negative regulation of viral process |
| GO:0006911 | 1.30% | phagocytosis, engulfment |
| GO:0034332 | 1.30% | adherens junction organization |
| GO:0032048 | 1.30% | cardiolipin metabolic process |
| GO:0009953 | 1.30% | dorsal/ventral pattern formation |
| GO:0010959 | 1.30% | regulation of metal ion transport |
| GO:0002437 | 1.30% | inflammatory response to antigenic stimulus |
| GO:0014904 | 1.29% | myotube cell development |
| GO:0032006 | 1.29% | regulation of TOR signaling |
| GO:0019369 | 1.29% | arachidonic acid metabolic process |
| GO:0051131 | 1.29% | chaperone-mediated protein complex assembly |
| GO:0045841 | 1.29% | negative regulation of mitotic metaphase/anaphase transition |
| GO:0044743 | 1.29% | protein transmembrane import into intracellular organelle |
| GO:0034497 | 1.29% | protein localization to phagophore assembly site |
| GO:0007589 | 1.29% | body fluid secretion |
| GO:0031139 | 1.29% | positive regulation of conjugation with cellular fusion |
| GO:0032007 | 1.29% | negative regulation of TOR signaling |
| GO:0035120 | 1.29% | post-embryonic appendage morphogenesis |
| GO:0009174 | 1.29% | pyrimidine ribonucleoside monophosphate biosynthetic process |
| GO:2000736 | 1.29% | regulation of stem cell differentiation |
| GO:0051249 | 1.29% | regulation of lymphocyte activation |
| GO:0030832 | 1.29% | regulation of actin filament length |
| GO:0032376 | 1.29% | positive regulation of cholesterol transport |
| GO:0046460 | 1.29% | neutral lipid biosynthetic process |
| GO:0090659 | 1.29% | walking behavior |
| GO:0034109 | 1.29% | homotypic cell-cell adhesion |
| GO:0008333 | 1.29% | endosome to lysosome transport |
| GO:0010952 | 1.29% | positive regulation of peptidase activity |
| GO:0001709 | 1.29% | cell fate determination |
| GO:0033032 | 1.29% | regulation of myeloid cell apoptotic process |
| GO:0090208 | 1.29% | positive regulation of triglyceride metabolic process |
| GO:0065002 | 1.29% | intracellular protein transmembrane transport |
| GO:0070848 | 1.28% | response to growth factor |
| GO:2000045 | 1.28% | regulation of G1/S transition of mitotic cell cycle |
| GO:0010466 | 1.28% | negative regulation of peptidase activity |
| GO:0051293 | 1.28% | establishment of spindle localization |
| GO:2001056 | 1.28% | positive regulation of cysteine-type endopeptidase activity |
| GO:0048240 | 1.28% | sperm capacitation |
| GO:0051092 | 1.28% | positive regulation of NF-kappaB transcription factor activity |
| GO:0009832 | 1.28% | plant-type cell wall biogenesis |
| GO:0006874 | 1.28% | cellular calcium ion homeostasis |
| GO:0001523 | 1.28% | retinoid metabolic process |
| GO:0009147 | 1.28% | pyrimidine nucleoside triphosphate metabolic process |
| GO:0045321 | 1.28% | leukocyte activation |
| GO:1903844 | 1.28% | regulation of cellular response to transforming growth factor beta stimulus |
| GO:0030004 | 1.28% | cellular monovalent inorganic cation homeostasis |
| GO:0051966 | 1.28% | regulation of synaptic transmission, glutamatergic |
| GO:1903305 | 1.28% | regulation of regulated secretory pathway |
| GO:0003015 | 1.28% | heart process |
| GO:2000104 | 1.28% | negative regulation of DNA-dependent DNA replication |
| GO:2000756 | 1.28% | regulation of peptidyl-lysine acetylation |
| GO:0009126 | 1.28% | purine nucleoside monophosphate metabolic process |
| GO:0031345 | 1.28% | negative regulation of cell projection organization |
| GO:0090314 | 1.27% | positive regulation of protein targeting to membrane |
| GO:0016137 | 1.27% | glycoside metabolic process |
| GO:0009208 | 1.27% | pyrimidine ribonucleoside triphosphate metabolic process |
| GO:0048488 | 1.27% | synaptic vesicle endocytosis |
| GO:1902751 | 1.27% | positive regulation of cell cycle G2/M phase transition |
| GO:0046627 | 1.27% | negative regulation of insulin receptor signaling pathway |
| GO:0002521 | 1.27% | leukocyte differentiation |
| GO:0051148 | 1.27% | negative regulation of muscle cell differentiation |
| GO:0009129 | 1.27% | pyrimidine nucleoside monophosphate metabolic process |
| GO:0032872 | 1.27% | regulation of stress-activated MAPK cascade |
| GO:0032354 | 1.27% | response to follicle-stimulating hormone |
| GO:0001776 | 1.27% | leukocyte homeostasis |
| GO:0017015 | 1.27% | regulation of transforming growth factor beta receptor signaling pathway |
| GO:0030518 | 1.27% | intracellular steroid hormone receptor signaling pathway |
| GO:0045880 | 1.27% | positive regulation of smoothened signaling pathway |
| GO:0036297 | 1.27% | interstrand cross-link repair |
| GO:0032467 | 1.27% | positive regulation of cytokinesis |
| GO:0010664 | 1.27% | negative regulation of striated muscle cell apoptotic process |
| GO:0045907 | 1.27% | positive regulation of vasoconstriction |
| GO:0006814 | 1.27% | sodium ion transport |
| GO:0009952 | 1.27% | anterior/posterior pattern specification |
| GO:0007614 | 1.27% | short-term memory |
| GO:0043281 | 1.27% | regulation of cysteine-type endopeptidase activity involved in apoptotic process |
| GO:0000212 | 1.27% | meiotic spindle organization |
| GO:0071825 | 1.27% | protein-lipid complex subunit organization |
| GO:0022617 | 1.27% | extracellular matrix disassembly |
| GO:0030900 | 1.27% | forebrain development |
| GO:0021549 | 1.27% | cerebellum development |
| GO:0048844 | 1.27% | artery morphogenesis |
| GO:0050728 | 1.26% | negative regulation of inflammatory response |
| GO:0000077 | 1.26% | DNA damage checkpoint |
| GO:0061448 | 1.26% | connective tissue development |
| GO:0048873 | 1.26% | homeostasis of number of cells within a tissue |
| GO:0002861 | 1.26% | regulation of inflammatory response to antigenic stimulus |
| GO:0045807 | 1.26% | positive regulation of endocytosis |
| GO:0051294 | 1.26% | establishment of spindle orientation |
| GO:0009629 | 1.26% | response to gravity |
| GO:0009606 | 1.26% | tropism |
| GO:1904375 | 1.26% | regulation of protein localization to cell periphery |
| GO:0072384 | 1.26% | organelle transport along microtubule |
| GO:0051952 | 1.26% | regulation of amine transport |
| GO:0007530 | 1.26% | sex determination |
| GO:0046464 | 1.26% | acylglycerol catabolic process |
| GO:0043029 | 1.25% | T cell homeostasis |
| GO:0009950 | 1.25% | dorsal/ventral axis specification |
| GO:0018023 | 1.25% | peptidyl-lysine trimethylation |
| GO:0008543 | 1.25% | fibroblast growth factor receptor signaling pathway |
| GO:0045047 | 1.25% | protein targeting to ER |
| GO:0050766 | 1.25% | positive regulation of phagocytosis |
| GO:0030516 | 1.25% | regulation of axon extension |
| GO:0031577 | 1.25% | spindle checkpoint |
| GO:0042759 | 1.25% | long-chain fatty acid biosynthetic process |
| GO:0002922 | 1.25% | positive regulation of humoral immune response |
| GO:0014013 | 1.25% | regulation of gliogenesis |
| GO:0009127 | 1.25% | purine nucleoside monophosphate biosynthetic process |
| GO:0051875 | 1.25% | pigment granule localization |
| GO:0072507 | 1.25% | divalent inorganic cation homeostasis |
| GO:0071174 | 1.25% | mitotic spindle checkpoint |
| GO:0031136 | 1.25% | positive regulation of conjugation |
| GO:0050673 | 1.25% | epithelial cell proliferation |
| GO:0006474 | 1.25% | N-terminal protein amino acid acetylation |
| GO:0070633 | 1.25% | transepithelial transport |
| GO:0055021 | 1.25% | regulation of cardiac muscle tissue growth |
| GO:0000727 | 1.25% | double-strand break repair via break-induced replication |
| GO:0042220 | 1.25% | response to cocaine |
| GO:0010971 | 1.25% | positive regulation of G2/M transition of mitotic cell cycle |
| GO:0000746 | 1.25% | conjugation |
| GO:0019882 | 1.25% | antigen processing and presentation |
| GO:1903321 | 1.25% | negative regulation of protein modification by small protein conjugation or removal |
| GO:0071347 | 1.25% | cellular response to interleukin-1 |
| GO:0006606 | 1.25% | protein import into nucleus |
| GO:0045600 | 1.25% | positive regulation of fat cell differentiation |
| GO:0045839 | 1.25% | negative regulation of mitotic nuclear division |
| GO:0060147 | 1.25% | regulation of posttranscriptional gene silencing |
| GO:0051123 | 1.24% | RNA polymerase II preinitiation complex assembly |
| GO:1900181 | 1.24% | negative regulation of protein localization to nucleus |
| GO:0043270 | 1.24% | positive regulation of ion transport |
| GO:0043280 | 1.24% | positive regulation of cysteine-type endopeptidase activity involved in apoptotic process |
| GO:0071669 | 1.24% | plant-type cell wall organization or biogenesis |
| GO:0001959 | 1.24% | regulation of cytokine-mediated signaling pathway |
| GO:0002366 | 1.24% | leukocyte activation involved in immune response |
| GO:0051570 | 1.24% | regulation of histone H3-K9 methylation |
| GO:0002793 | 1.24% | positive regulation of peptide secretion |
| GO:0051647 | 1.24% | nucleus localization |
| GO:0048678 | 1.24% | response to axon injury |
| GO:0009130 | 1.24% | pyrimidine nucleoside monophosphate biosynthetic process |
| GO:0090698 | 1.24% | post-embryonic plant morphogenesis |
| GO:0031062 | 1.24% | positive regulation of histone methylation |
| GO:0009144 | 1.24% | purine nucleoside triphosphate metabolic process |
| GO:0031338 | 1.24% | regulation of vesicle fusion |
| GO:0051402 | 1.24% | neuron apoptotic process |
| GO:0046328 | 1.24% | regulation of JNK cascade |
| GO:0046475 | 1.24% | glycerophospholipid catabolic process |
| GO:0032946 | 1.24% | positive regulation of mononuclear cell proliferation |
| GO:1901983 | 1.24% | regulation of protein acetylation |
| GO:0046461 | 1.24% | neutral lipid catabolic process |
| GO:0000028 | 1.24% | ribosomal small subunit assembly |
| GO:0006949 | 1.24% | syncytium formation |
| GO:0045835 | 1.24% | negative regulation of meiotic nuclear division |
| GO:0090342 | 1.23% | regulation of cell aging |
| GO:0001837 | 1.23% | epithelial to mesenchymal transition |
| GO:1903901 | 1.23% | negative regulation of viral life cycle |
| GO:0006817 | 1.23% | phosphate ion transport |
| GO:0045746 | 1.23% | negative regulation of Notch signaling pathway |
| GO:0045124 | 1.23% | regulation of bone resorption |
| GO:1902806 | 1.23% | regulation of cell cycle G1/S phase transition |
| GO:0006706 | 1.23% | steroid catabolic process |
| GO:1900087 | 1.23% | positive regulation of G1/S transition of mitotic cell cycle |
| GO:0030335 | 1.23% | positive regulation of cell migration |
| GO:1990845 | 1.23% | adaptive thermogenesis |
| GO:0000723 | 1.23% | telomere maintenance |
| GO:0046620 | 1.23% | regulation of organ growth |
| GO:1902600 | 1.23% | proton transmembrane transport |
| GO:0006513 | 1.23% | protein monoubiquitination |
| GO:0007094 | 1.23% | mitotic spindle assembly checkpoint |
| GO:0000041 | 1.23% | transition metal ion transport |
| GO:0044774 | 1.23% | mitotic DNA integrity checkpoint |
| GO:1903649 | 1.23% | regulation of cytoplasmic transport |
| GO:0035162 | 1.23% | embryonic hemopoiesis |
| GO:0032409 | 1.23% | regulation of transporter activity |
| GO:0045836 | 1.23% | positive regulation of meiotic nuclear division |
| GO:0050873 | 1.22% | brown fat cell differentiation |
| GO:0051588 | 1.22% | regulation of neurotransmitter transport |
| GO:0009201 | 1.22% | ribonucleoside triphosphate biosynthetic process |
| GO:0050679 | 1.22% | positive regulation of epithelial cell proliferation |
| GO:0046463 | 1.22% | acylglycerol biosynthetic process |
| GO:0006896 | 1.22% | Golgi to vacuole transport |
| GO:0002090 | 1.22% | regulation of receptor internalization |
| GO:0051154 | 1.22% | negative regulation of striated muscle cell differentiation |
| GO:0071236 | 1.22% | cellular response to antibiotic |
| GO:1905268 | 1.22% | negative regulation of chromatin organization |
| GO:0046033 | 1.22% | AMP metabolic process |
| GO:0006027 | 1.22% | glycosaminoglycan catabolic process |
| GO:0009168 | 1.22% | purine ribonucleoside monophosphate biosynthetic process |
| GO:0006222 | 1.22% | UMP biosynthetic process |
| GO:0009209 | 1.22% | pyrimidine ribonucleoside triphosphate biosynthetic process |
| GO:0009109 | 1.22% | coenzyme catabolic process |
| GO:0080182 | 1.22% | histone H3-K4 trimethylation |
| GO:0021510 | 1.22% | spinal cord development |
| GO:0032373 | 1.22% | positive regulation of sterol transport |
| GO:0043500 | 1.21% | muscle adaptation |
| GO:1901888 | 1.21% | regulation of cell junction assembly |
| GO:2001233 | 1.21% | regulation of apoptotic signaling pathway |
| GO:0047484 | 1.21% | regulation of response to osmotic stress |
| GO:0060628 | 1.21% | regulation of ER to Golgi vesicle-mediated transport |
| GO:0071466 | 1.21% | cellular response to xenobiotic stimulus |
| GO:0043570 | 1.21% | maintenance of DNA repeat elements |
| GO:0032387 | 1.21% | negative regulation of intracellular transport |
| GO:0000070 | 1.20% | mitotic sister chromatid segregation |
| GO:0050870 | 1.20% | positive regulation of T cell activation |
| GO:0009173 | 1.20% | pyrimidine ribonucleoside monophosphate metabolic process |
| GO:0071709 | 1.20% | membrane assembly |
| GO:0002065 | 1.20% | columnar/cuboidal epithelial cell differentiation |
| GO:0031297 | 1.20% | replication fork processing |
| GO:0009263 | 1.20% | deoxyribonucleotide biosynthetic process |
| GO:0001736 | 1.20% | establishment of planar polarity |
| GO:0006885 | 1.20% | regulation of pH |
| GO:0019731 | 1.20% | antibacterial humoral response |
| GO:0008608 | 1.20% | attachment of spindle microtubules to kinetochore |
| GO:0019432 | 1.20% | triglyceride biosynthetic process |
| GO:0051954 | 1.20% | positive regulation of amine transport |
| GO:0051055 | 1.20% | negative regulation of lipid biosynthetic process |
| GO:0051058 | 1.20% | negative regulation of small GTPase mediated signal transduction |
| GO:0033574 | 1.20% | response to testosterone |
| GO:0033006 | 1.19% | regulation of mast cell activation involved in immune response |
| GO:0010874 | 1.19% | regulation of cholesterol efflux |
| GO:0110053 | 1.19% | regulation of actin filament organization |
| GO:1900006 | 1.19% | positive regulation of dendrite development |
| GO:0010656 | 1.19% | negative regulation of muscle cell apoptotic process |
| GO:0045833 | 1.19% | negative regulation of lipid metabolic process |
| GO:0000470 | 1.19% | maturation of LSU-rRNA |
| GO:0042761 | 1.19% | very long-chain fatty acid biosynthetic process |
| GO:0070374 | 1.19% | positive regulation of ERK1 and ERK2 cascade |
| GO:0046850 | 1.19% | regulation of bone remodeling |
| GO:0008064 | 1.19% | regulation of actin polymerization or depolymerization |
| GO:2001235 | 1.19% | positive regulation of apoptotic signaling pathway |
| GO:0043153 | 1.19% | entrainment of circadian clock by photoperiod |
| GO:0070302 | 1.19% | regulation of stress-activated protein kinase signaling cascade |
| GO:2000278 | 1.19% | regulation of DNA biosynthetic process |
| GO:0033003 | 1.19% | regulation of mast cell activation |
| GO:0097746 | 1.19% | regulation of blood vessel diameter |
| GO:0090559 | 1.19% | regulation of membrane permeability |
| GO:0006085 | 1.19% | acetyl-CoA biosynthetic process |
| GO:0015849 | 1.19% | organic acid transport |
| GO:0030279 | 1.18% | negative regulation of ossification |
| GO:0055024 | 1.18% | regulation of cardiac muscle tissue development |
| GO:0032273 | 1.18% | positive regulation of protein polymerization |
| GO:0009167 | 1.18% | purine ribonucleoside monophosphate metabolic process |
| GO:0051251 | 1.18% | positive regulation of lymphocyte activation |
| GO:0070527 | 1.18% | platelet aggregation |
| GO:0090090 | 1.18% | negative regulation of canonical Wnt signaling pathway |
| GO:0048762 | 1.18% | mesenchymal cell differentiation |
| GO:0071173 | 1.18% | spindle assembly checkpoint |
| GO:0031057 | 1.18% | negative regulation of histone modification |
| GO:0019233 | 1.18% | sensory perception of pain |
| GO:0032352 | 1.18% | positive regulation of hormone metabolic process |
| GO:1904950 | 1.18% | negative regulation of establishment of protein localization |
| GO:0034765 | 1.18% | regulation of ion transmembrane transport |
| GO:0002761 | 1.18% | regulation of myeloid leukocyte differentiation |
| GO:1905330 | 1.17% | regulation of morphogenesis of an epithelium |
| GO:0043588 | 1.17% | skin development |
| GO:1901797 | 1.17% | negative regulation of signal transduction by p53 class mediator |
| GO:0006268 | 1.17% | DNA unwinding involved in DNA replication |
| GO:0045844 | 1.17% | positive regulation of striated muscle tissue development |
| GO:0048701 | 1.17% | embryonic cranial skeleton morphogenesis |
| GO:2000107 | 1.17% | negative regulation of leukocyte apoptotic process |
| GO:0015918 | 1.17% | sterol transport |
| GO:0019692 | 1.17% | deoxyribose phosphate metabolic process |
| GO:0014015 | 1.17% | positive regulation of gliogenesis |
| GO:0010770 | 1.17% | positive regulation of cell morphogenesis involved in differentiation |
| GO:0033617 | 1.17% | mitochondrial respiratory chain complex IV assembly |
| GO:0031061 | 1.17% | negative regulation of histone methylation |
| GO:0045793 | 1.17% | positive regulation of cell size |
| GO:0060631 | 1.17% | regulation of meiosis I |
| GO:0099518 | 1.17% | vesicle cytoskeletal trafficking |
| GO:0035107 | 1.17% | appendage morphogenesis |
| GO:0006026 | 1.17% | aminoglycan catabolic process |
| GO:0002718 | 1.17% | regulation of cytokine production involved in immune response |
| GO:0051984 | 1.16% | positive regulation of chromosome segregation |
| GO:2001234 | 1.16% | negative regulation of apoptotic signaling pathway |
| GO:0035065 | 1.16% | regulation of histone acetylation |
| GO:0001731 | 1.16% | formation of translation preinitiation complex |
| GO:0008655 | 1.16% | pyrimidine-containing compound salvage |
| GO:0046049 | 1.16% | UMP metabolic process |
| GO:0032954 | 1.16% | regulation of cytokinetic process |
| GO:0051569 | 1.16% | regulation of histone H3-K4 methylation |
| GO:0022898 | 1.16% | regulation of transmembrane transporter activity |
| GO:0060612 | 1.16% | adipose tissue development |
| GO:0010669 | 1.16% | epithelial structure maintenance |
| GO:0034121 | 1.16% | regulation of toll-like receptor signaling pathway |
| GO:2001021 | 1.16% | negative regulation of response to DNA damage stimulus |
| GO:1901863 | 1.16% | positive regulation of muscle tissue development |
| GO:0033238 | 1.16% | regulation of cellular amine metabolic process |
| GO:2001239 | 1.16% | regulation of extrinsic apoptotic signaling pathway in absence of ligand |
| GO:0036314 | 1.16% | response to sterol |
| GO:1903426 | 1.16% | regulation of reactive oxygen species biosynthetic process |
| GO:0034341 | 1.16% | response to interferon-gamma |
| GO:0090207 | 1.16% | regulation of triglyceride metabolic process |
| GO:0050867 | 1.16% | positive regulation of cell activation |
| GO:0061687 | 1.15% | detoxification of inorganic compound |
| GO:0042274 | 1.15% | ribosomal small subunit biogenesis |
| GO:0030497 | 1.15% | fatty acid elongation |
| GO:0097588 | 1.15% | archaeal or bacterial-type flagellum-dependent cell motility |
| GO:0060688 | 1.15% | regulation of morphogenesis of a branching structure |
| GO:0071108 | 1.15% | protein K48-linked deubiquitination |
| GO:0007004 | 1.15% | telomere maintenance via telomerase |
| GO:0061339 | 1.15% | establishment or maintenance of monopolar cell polarity |
| GO:1903727 | 1.15% | positive regulation of phospholipid metabolic process |
| GO:0046622 | 1.15% | positive regulation of organ growth |
| GO:0070372 | 1.15% | regulation of ERK1 and ERK2 cascade |
| GO:0062033 | 1.14% | positive regulation of mitotic sister chromatid segregation |
| GO:0090288 | 1.14% | negative regulation of cellular response to growth factor stimulus |
| GO:1903319 | 1.14% | positive regulation of protein maturation |
| GO:0030447 | 1.14% | filamentous growth |
| GO:0045824 | 1.14% | negative regulation of innate immune response |
| GO:0042102 | 1.14% | positive regulation of T cell proliferation |
| GO:0034310 | 1.14% | primary alcohol catabolic process |
| GO:0001954 | 1.14% | positive regulation of cell-matrix adhesion |
| GO:0009394 | 1.14% | 2'-deoxyribonucleotide metabolic process |
| GO:2000379 | 1.14% | positive regulation of reactive oxygen species metabolic process |
| GO:0046040 | 1.14% | IMP metabolic process |
| GO:0002696 | 1.14% | positive regulation of leukocyte activation |
| GO:0071869 | 1.14% | response to catecholamine |
| GO:1902116 | 1.14% | negative regulation of organelle assembly |
| GO:0072503 | 1.14% | cellular divalent inorganic cation homeostasis |
| GO:0043433 | 1.14% | negative regulation of DNA-binding transcription factor activity |
| GO:0034103 | 1.14% | regulation of tissue remodeling |
| GO:0060420 | 1.14% | regulation of heart growth |
| GO:0035640 | 1.13% | exploration behavior |
| GO:1990089 | 1.13% | response to nerve growth factor |
| GO:0007064 | 1.13% | mitotic sister chromatid cohesion |
| GO:0090596 | 1.13% | sensory organ morphogenesis |
| GO:0046036 | 1.13% | CTP metabolic process |
| GO:0009148 | 1.13% | pyrimidine nucleoside triphosphate biosynthetic process |
| GO:0032196 | 1.13% | transposition |
| GO:0001975 | 1.13% | response to amphetamine |
| GO:0042551 | 1.13% | neuron maturation |
| GO:0090151 | 1.13% | establishment of protein localization to mitochondrial membrane |
| GO:0070269 | 1.13% | pyroptosis |
| GO:0071398 | 1.13% | cellular response to fatty acid |
| GO:0007585 | 1.13% | respiratory gaseous exchange by respiratory system |
| GO:0032986 | 1.13% | protein-DNA complex disassembly |
| GO:0042074 | 1.13% | cell migration involved in gastrulation |
| GO:0072331 | 1.13% | signal transduction by p53 class mediator |
| GO:0030641 | 1.13% | regulation of cellular pH |
| GO:1905879 | 1.13% | regulation of oogenesis |
| GO:0050892 | 1.13% | intestinal absorption |
| GO:0007379 | 1.13% | segment specification |
| GO:0033673 | 1.13% | negative regulation of kinase activity |
| GO:0060122 | 1.13% | inner ear receptor cell stereocilium organization |
| GO:0051099 | 1.13% | positive regulation of binding |
| GO:0048706 | 1.13% | embryonic skeletal system development |
| GO:0008210 | 1.12% | estrogen metabolic process |
| GO:0070059 | 1.12% | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress |
| GO:0045599 | 1.12% | negative regulation of fat cell differentiation |
| GO:0042304 | 1.12% | regulation of fatty acid biosynthetic process |
| GO:0032206 | 1.12% | positive regulation of telomere maintenance |
| GO:0021782 | 1.12% | glial cell development |
| GO:0060759 | 1.12% | regulation of response to cytokine stimulus |
| GO:0006613 | 1.12% | cotranslational protein targeting to membrane |
| GO:0090224 | 1.12% | regulation of spindle organization |
| GO:1903115 | 1.12% | regulation of actin filament-based movement |
| GO:0090263 | 1.12% | positive regulation of canonical Wnt signaling pathway |
| GO:0010623 | 1.12% | programmed cell death involved in cell development |
| GO:0015696 | 1.12% | ammonium transport |
| GO:0072175 | 1.12% | epithelial tube formation |
| GO:0009252 | 1.12% | peptidoglycan biosynthetic process |
| GO:0051224 | 1.12% | negative regulation of protein transport |
| GO:0034501 | 1.12% | protein localization to kinetochore |
| GO:0098815 | 1.12% | modulation of excitatory postsynaptic potential |
| GO:0046942 | 1.12% | carboxylic acid transport |
| GO:0099174 | 1.12% | regulation of presynapse organization |
| GO:0031110 | 1.12% | regulation of microtubule polymerization or depolymerization |
| GO:1900027 | 1.12% | regulation of ruffle assembly |
| GO:0048636 | 1.12% | positive regulation of muscle organ development |
| GO:0060048 | 1.12% | cardiac muscle contraction |
| GO:1903859 | 1.12% | regulation of dendrite extension |
| GO:0045910 | 1.11% | negative regulation of DNA recombination |
| GO:0046580 | 1.11% | negative regulation of Ras protein signal transduction |
| GO:0010833 | 1.11% | telomere maintenance via telomere lengthening |
| GO:0072663 | 1.11% | establishment of protein localization to peroxisome |
| GO:1903338 | 1.11% | regulation of cell wall organization or biogenesis |
| GO:1903039 | 1.11% | positive regulation of leukocyte cell-cell adhesion |
| GO:0032570 | 1.11% | response to progesterone |
| GO:0060281 | 1.11% | regulation of oocyte development |
| GO:0009264 | 1.11% | deoxyribonucleotide catabolic process |
| GO:0050885 | 1.11% | neuromuscular process controlling balance |
| GO:0060041 | 1.11% | retina development in camera-type eye |
| GO:0007569 | 1.11% | cell aging |
| GO:0031554 | 1.11% | regulation of DNA-templated transcription, termination |
| GO:0002262 | 1.11% | myeloid cell homeostasis |
| GO:0099175 | 1.11% | regulation of postsynapse organization |
| GO:0009954 | 1.11% | proximal/distal pattern formation |
| GO:0001895 | 1.11% | retina homeostasis |
| GO:0001936 | 1.11% | regulation of endothelial cell proliferation |
| GO:1904377 | 1.10% | positive regulation of protein localization to cell periphery |
| GO:2000573 | 1.10% | positive regulation of DNA biosynthetic process |
| GO:0060326 | 1.10% | cell chemotaxis |
| GO:0001568 | 1.10% | blood vessel development |
| GO:0030514 | 1.10% | negative regulation of BMP signaling pathway |
| GO:1902101 | 1.10% | positive regulation of metaphase/anaphase transition of cell cycle |
| GO:1902412 | 1.10% | regulation of mitotic cytokinesis |
| GO:0010633 | 1.10% | negative regulation of epithelial cell migration |
| GO:0031125 | 1.10% | rRNA 3'-end processing |
| GO:1903322 | 1.10% | positive regulation of protein modification by small protein conjugation or removal |
| GO:0008207 | 1.10% | C21-steroid hormone metabolic process |
| GO:0045740 | 1.10% | positive regulation of DNA replication |
| GO:0120163 | 1.10% | negative regulation of cold-induced thermogenesis |
| GO:0051048 | 1.10% | negative regulation of secretion |
| GO:0032968 | 1.10% | positive regulation of transcription elongation from RNA polymerase II promoter |
| GO:0031646 | 1.10% | positive regulation of nervous system process |
| GO:0002088 | 1.09% | lens development in camera-type eye |
| GO:0045165 | 1.09% | cell fate commitment |
| GO:0032642 | 1.09% | regulation of chemokine production |
| GO:0009948 | 1.09% | anterior/posterior axis specification |
| GO:0006884 | 1.09% | cell volume homeostasis |
| GO:0006367 | 1.09% | transcription initiation from RNA polymerase II promoter |
| GO:0051204 | 1.09% | protein insertion into mitochondrial membrane |
| GO:0048146 | 1.09% | positive regulation of fibroblast proliferation |
| GO:0070723 | 1.09% | response to cholesterol |
| GO:0051205 | 1.09% | protein insertion into membrane |
| GO:0030002 | 1.09% | cellular anion homeostasis |
| GO:1903429 | 1.09% | regulation of cell maturation |
| GO:1902808 | 1.09% | positive regulation of cell cycle G1/S phase transition |
| GO:1901068 | 1.09% | guanosine-containing compound metabolic process |
| GO:0048736 | 1.09% | appendage development |
| GO:0061162 | 1.09% | establishment of monopolar cell polarity |
| GO:0046887 | 1.09% | positive regulation of hormone secretion |
| GO:0070918 | 1.09% | production of small RNA involved in gene silencing by RNA |
| GO:0019405 | 1.09% | alditol catabolic process |
| GO:0045687 | 1.09% | positive regulation of glial cell differentiation |
| GO:0051085 | 1.09% | chaperone cofactor-dependent protein refolding |
| GO:0098930 | 1.09% | axonal transport |
| GO:1901224 | 1.09% | positive regulation of NIK/NF-kappaB signaling |
| GO:0006188 | 1.09% | IMP biosynthetic process |
| GO:0071479 | 1.08% | cellular response to ionizing radiation |
| GO:0001961 | 1.08% | positive regulation of cytokine-mediated signaling pathway |
| GO:1903708 | 1.08% | positive regulation of hemopoiesis |
| GO:0045667 | 1.08% | regulation of osteoblast differentiation |
| GO:0060135 | 1.08% | maternal process involved in female pregnancy |
| GO:2000677 | 1.08% | regulation of transcription regulatory region DNA binding |
| GO:0007339 | 1.08% | binding of sperm to zona pellucida |
| GO:0030808 | 1.08% | regulation of nucleotide biosynthetic process |
| GO:0009219 | 1.08% | pyrimidine deoxyribonucleotide metabolic process |
| GO:0043010 | 1.08% | camera-type eye development |
| GO:0060390 | 1.08% | regulation of SMAD protein signal transduction |
| GO:0051568 | 1.08% | histone H3-K4 methylation |
| GO:0032731 | 1.08% | positive regulation of interleukin-1 beta production |
| GO:0031532 | 1.08% | actin cytoskeleton reorganization |
| GO:0044773 | 1.08% | mitotic DNA damage checkpoint |
| GO:0042476 | 1.08% | odontogenesis |
| GO:0035510 | 1.08% | DNA dealkylation |
| GO:0006213 | 1.08% | pyrimidine nucleoside metabolic process |
| GO:0009630 | 1.08% | gravitropism |
| GO:0051438 | 1.08% | regulation of ubiquitin-protein transferase activity |
| GO:0007422 | 1.08% | peripheral nervous system development |
| GO:0010447 | 1.08% | response to acidic pH |
| GO:0009265 | 1.08% | 2'-deoxyribonucleotide biosynthetic process |
| GO:0050920 | 1.08% | regulation of chemotaxis |
| GO:0046847 | 1.08% | filopodium assembly |
| GO:0035384 | 1.08% | thioester biosynthetic process |
| GO:0010470 | 1.07% | regulation of gastrulation |
| GO:0001556 | 1.07% | oocyte maturation |
| GO:0061178 | 1.07% | regulation of insulin secretion involved in cellular response to glucose stimulus |
| GO:2001032 | 1.07% | regulation of double-strand break repair via nonhomologous end joining |
| GO:0098900 | 1.07% | regulation of action potential |
| GO:0032355 | 1.07% | response to estradiol |
| GO:0010893 | 1.07% | positive regulation of steroid biosynthetic process |
| GO:0042755 | 1.07% | eating behavior |
| GO:0001778 | 1.07% | plasma membrane repair |
| GO:0000578 | 1.07% | embryonic axis specification |
| GO:0034453 | 1.07% | microtubule anchoring |
| GO:0044070 | 1.07% | regulation of anion transport |
| GO:0010155 | 1.07% | regulation of proton transport |
| GO:1905476 | 1.07% | negative regulation of protein localization to membrane |
| GO:1903035 | 1.07% | negative regulation of response to wounding |
| GO:0048013 | 1.07% | ephrin receptor signaling pathway |
| GO:1903779 | 1.07% | regulation of cardiac conduction |
| GO:0071867 | 1.07% | response to monoamine |
| GO:0071276 | 1.07% | cellular response to cadmium ion |
| GO:0031118 | 1.07% | rRNA pseudouridine synthesis |
| GO:0071827 | 1.06% | plasma lipoprotein particle organization |
| GO:0060632 | 1.06% | regulation of microtubule-based movement |
| GO:0072511 | 1.06% | divalent inorganic cation transport |
| GO:1903531 | 1.06% | negative regulation of secretion by cell |
| GO:0051590 | 1.06% | positive regulation of neurotransmitter transport |
| GO:0071616 | 1.06% | acyl-CoA biosynthetic process |
| GO:0006625 | 1.06% | protein targeting to peroxisome |
| GO:0048854 | 1.06% | brain morphogenesis |
| GO:0031102 | 1.06% | neuron projection regeneration |
| GO:0002758 | 1.06% | innate immune response-activating signal transduction |
| GO:0061462 | 1.06% | protein localization to lysosome |
| GO:0055013 | 1.06% | cardiac muscle cell development |
| GO:0052126 | 1.06% | movement in host environment |
| GO:0046649 | 1.06% | lymphocyte activation |
| GO:0045773 | 1.06% | positive regulation of axon extension |
| GO:0031050 | 1.06% | dsRNA processing |
| GO:1900376 | 1.06% | regulation of secondary metabolite biosynthetic process |
| GO:0022600 | 1.06% | digestive system process |
| GO:0042475 | 1.06% | odontogenesis of dentin-containing tooth |
| GO:0007548 | 1.06% | sex differentiation |
| GO:0050919 | 1.06% | negative chemotaxis |
| GO:0048565 | 1.06% | digestive tract development |
| GO:0042733 | 1.06% | embryonic digit morphogenesis |
| GO:0072599 | 1.06% | establishment of protein localization to endoplasmic reticulum |
| GO:1903037 | 1.06% | regulation of leukocyte cell-cell adhesion |
| GO:0034122 | 1.06% | negative regulation of toll-like receptor signaling pathway |
| GO:0098787 | 1.06% | mRNA cleavage involved in mRNA processing |
| GO:0009113 | 1.06% | purine nucleobase biosynthetic process |
| GO:0034367 | 1.06% | protein-containing complex remodeling |
| GO:0106027 | 1.05% | neuron projection organization |
| GO:0033143 | 1.05% | regulation of intracellular steroid hormone receptor signaling pathway |
| GO:1990090 | 1.05% | cellular response to nerve growth factor stimulus |
| GO:0050818 | 1.05% | regulation of coagulation |
| GO:0007265 | 1.05% | Ras protein signal transduction |
| GO:0060236 | 1.05% | regulation of mitotic spindle organization |
| GO:0002221 | 1.05% | pattern recognition receptor signaling pathway |
| GO:0003009 | 1.05% | skeletal muscle contraction |
| GO:0032197 | 1.05% | transposition, RNA-mediated |
| GO:0042771 | 1.05% | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator |
| GO:0050680 | 1.05% | negative regulation of epithelial cell proliferation |
| GO:0034620 | 1.05% | cellular response to unfolded protein |
| GO:1904591 | 1.05% | positive regulation of protein import |
| GO:1905820 | 1.05% | positive regulation of chromosome separation |
| GO:0070665 | 1.05% | positive regulation of leukocyte proliferation |
| GO:0030011 | 1.05% | maintenance of cell polarity |
| GO:0034656 | 1.04% | nucleobase-containing small molecule catabolic process |
| GO:0044030 | 1.04% | regulation of DNA methylation |
| GO:0032509 | 1.04% | endosome transport via multivesicular body sorting pathway |
| GO:0034612 | 1.04% | response to tumor necrosis factor |
| GO:0035821 | 1.04% | modification of morphology or physiology of other organism |
| GO:0034446 | 1.04% | substrate adhesion-dependent cell spreading |
| GO:0048041 | 1.04% | focal adhesion assembly |
| GO:0031103 | 1.04% | axon regeneration |
| GO:0008154 | 1.04% | actin polymerization or depolymerization |
| GO:0032210 | 1.04% | regulation of telomere maintenance via telomerase |
| GO:0045742 | 1.04% | positive regulation of epidermal growth factor receptor signaling pathway |
| GO:0072662 | 1.04% | protein localization to peroxisome |
| GO:0045616 | 1.04% | regulation of keratinocyte differentiation |
| GO:0019730 | 1.04% | antimicrobial humoral response |
| GO:1903203 | 1.04% | regulation of oxidative stress-induced neuron death |
| GO:0043409 | 1.04% | negative regulation of MAPK cascade |
| GO:0072332 | 1.04% | intrinsic apoptotic signaling pathway by p53 class mediator |
| GO:0034727 | 1.04% | piecemeal microautophagy of the nucleus |
| GO:0044818 | 1.04% | mitotic G2/M transition checkpoint |
| GO:0007045 | 1.04% | cell-substrate adherens junction assembly |
| GO:0051702 | 1.04% | interaction with symbiont |
| GO:0035303 | 1.04% | regulation of dephosphorylation |
| GO:0006865 | 1.04% | amino acid transport |
| GO:2000725 | 1.04% | regulation of cardiac muscle cell differentiation |
| GO:0006265 | 1.04% | DNA topological change |
| GO:0006821 | 1.03% | chloride transport |
| GO:0051896 | 1.03% | regulation of protein kinase B signaling |
| GO:0043304 | 1.03% | regulation of mast cell degranulation |
| GO:1903747 | 1.03% | regulation of establishment of protein localization to mitochondrion |
| GO:0014743 | 1.03% | regulation of muscle hypertrophy |
| GO:0106030 | 1.03% | neuron projection fasciculation |
| GO:0051851 | 1.03% | modification by host of symbiont morphology or physiology |
| GO:0060760 | 1.03% | positive regulation of response to cytokine stimulus |
| GO:1903076 | 1.03% | regulation of protein localization to plasma membrane |
| GO:0071985 | 1.03% | multivesicular body sorting pathway |
| GO:1905898 | 1.03% | positive regulation of response to endoplasmic reticulum stress |
| GO:0045453 | 1.03% | bone resorption |
| GO:0070838 | 1.03% | divalent metal ion transport |
| GO:1903670 | 1.03% | regulation of sprouting angiogenesis |
| GO:0097756 | 1.03% | negative regulation of blood vessel diameter |
| GO:0031398 | 1.03% | positive regulation of protein ubiquitination |
| GO:0045860 | 1.03% | positive regulation of protein kinase activity |
| GO:0043242 | 1.03% | negative regulation of protein complex disassembly |
| GO:2000758 | 1.03% | positive regulation of peptidyl-lysine acetylation |
| GO:1903432 | 1.03% | regulation of TORC1 signaling |
| GO:0090311 | 1.03% | regulation of protein deacetylation |
| GO:1901976 | 1.03% | regulation of cell cycle checkpoint |
| GO:2000144 | 1.03% | positive regulation of DNA-templated transcription, initiation |
| GO:0003073 | 1.02% | regulation of systemic arterial blood pressure |
| GO:1901186 | 1.02% | positive regulation of ERBB signaling pathway |
| GO:0043410 | 1.02% | positive regulation of MAPK cascade |
| GO:0070417 | 1.02% | cellular response to cold |
| GO:0051642 | 1.02% | centrosome localization |
| GO:0007097 | 1.02% | nuclear migration |
| GO:1903524 | 1.02% | positive regulation of blood circulation |
| GO:0000447 | 1.02% | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) |
| GO:0015695 | 1.02% | organic cation transport |
| GO:1904589 | 1.02% | regulation of protein import |
| GO:0032435 | 1.02% | negative regulation of proteasomal ubiquitin-dependent protein catabolic process |
| GO:0035051 | 1.02% | cardiocyte differentiation |
| GO:0050863 | 1.02% | regulation of T cell activation |
| GO:0007173 | 1.02% | epidermal growth factor receptor signaling pathway |
| GO:0050819 | 1.02% | negative regulation of coagulation |
| GO:0044182 | 1.02% | filamentous growth of a population of unicellular organisms |
| GO:0099515 | 1.02% | actin filament-based transport |
| GO:1904705 | 1.02% | regulation of vascular smooth muscle cell proliferation |
| GO:0042310 | 1.02% | vasoconstriction |
| GO:0050848 | 1.02% | regulation of calcium-mediated signaling |
| GO:0055006 | 1.02% | cardiac cell development |
| GO:1901796 | 1.02% | regulation of signal transduction by p53 class mediator |
| GO:0030509 | 1.02% | BMP signaling pathway |
| GO:0002260 | 1.02% | lymphocyte homeostasis |
| GO:0045851 | 1.02% | pH reduction |
| GO:1904356 | 1.02% | regulation of telomere maintenance via telomere lengthening |
| GO:1901184 | 1.02% | regulation of ERBB signaling pathway |
| GO:0098661 | 1.02% | inorganic anion transmembrane transport |
| GO:2000772 | 1.02% | regulation of cellular senescence |
| GO:0042303 | 1.02% | molting cycle |
| GO:0032651 | 1.02% | regulation of interleukin-1 beta production |
| GO:0006505 | 1.02% | GPI anchor metabolic process |
| GO:1905207 | 1.02% | regulation of cardiocyte differentiation |
| GO:0043574 | 1.01% | peroxisomal transport |
| GO:1903861 | 1.01% | positive regulation of dendrite extension |
| GO:0007035 | 1.01% | vacuolar acidification |
| GO:0006826 | 1.01% | iron ion transport |
| GO:1902105 | 1.01% | regulation of leukocyte differentiation |
| GO:0016486 | 1.01% | peptide hormone processing |
| GO:0060411 | 1.01% | cardiac septum morphogenesis |
| GO:0046385 | 1.01% | deoxyribose phosphate biosynthetic process |
| GO:1904062 | 1.01% | regulation of cation transmembrane transport |
| GO:0045842 | 1.01% | positive regulation of mitotic metaphase/anaphase transition |
| GO:0051817 | 1.01% | modification of morphology or physiology of other organism involved in symbiotic interaction |
| GO:0043516 | 1.01% | regulation of DNA damage response, signal transduction by p53 class mediator |
| GO:0042454 | 1.01% | ribonucleoside catabolic process |
| GO:0048635 | 1.01% | negative regulation of muscle organ development |
| GO:1901532 | 1.01% | regulation of hematopoietic progenitor cell differentiation |
| GO:0070301 | 1.01% | cellular response to hydrogen peroxide |
| GO:0046824 | 1.01% | positive regulation of nucleocytoplasmic transport |
| GO:0035036 | 1.01% | sperm-egg recognition |
| GO:0060260 | 1.01% | regulation of transcription initiation from RNA polymerase II promoter |
| GO:1902305 | 1.01% | regulation of sodium ion transmembrane transport |
| GO:0045071 | 1.01% | negative regulation of viral genome replication |
| GO:0010743 | 1.01% | regulation of macrophage derived foam cell differentiation |
| GO:0072089 | 1.01% | stem cell proliferation |
| GO:0044380 | 1.00% | protein localization to cytoskeleton |
| GO:0051315 | 1.00% | attachment of mitotic spindle microtubules to kinetochore |
| GO:0033146 | 1.00% | regulation of intracellular estrogen receptor signaling pathway |
| GO:0045670 | 1.00% | regulation of osteoclast differentiation |
| GO:0010939 | 1.00% | regulation of necrotic cell death |
| GO:1900077 | 1.00% | negative regulation of cellular response to insulin stimulus |
| GO:0030431 | 1.00% | sleep |
| GO:1901070 | 1.00% | guanosine-containing compound biosynthetic process |
| GO:1900271 | 1.00% | regulation of long-term synaptic potentiation |
| GO:0051053 | 1.00% | negative regulation of DNA metabolic process |